{
    "testId": 396302452,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 107,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 0,
    "testModeName": "Timed",
    "questionModeId": 4,
    "questionModeName": "CUSTOM",
    "testName": "",
    "totalQuestionCorrect": 23,
    "correctToIncorrect": 1,
    "incorrectToCorrect": 0,
    "incorrectToIncorrect": 0,
    "timeInSeconds": 1334,
    "averageTimeSpentInSeconds": 142,
    "otherAverageTimeSpentInSeconds": 67,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 35,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "4",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 4889,
            "questionIndex": 4889,
            "questionText": "<p>A male newborn infant born at 39 weeks gestation is evaluated in the newborn nursery.&nbsp; The mother is a 24-year-old primigravida whose pregnancy was complicated by preeclampsia with severe features.&nbsp; Magnesium sulfate was initiated for seizure prophylaxis and induction of labor started, but an emergency cesarean delivery was performed due to uncontrollable maternal hypertension and nonreassuring fetal heart rate status.&nbsp; Apgar scores were 8 and 8 at 1 minute and 5 minutes, respectively, for poor tone.&nbsp; On examination, the infant&#39;s weight is 2.3 kg (5 lb 1 oz), placing him in the 3rd percentile; height is 46 cm (18 in), placing him in the 5th percentile; and head circumference is 33 cm (13 in), placing him in the 10th percentile.&nbsp; There is a paucity of subcutaneous fat and areas of skin peeling on the soles and trunk of the infant.&nbsp; The remainder of the physical examination is unremarkable.&nbsp; This infant is at risk for which of the following complications?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t59301\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Fetal growth restriction</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Symmetric</strong></p></td><td><p align=\"center\"><strong>Asymmetric</strong></p></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td colspan=\"2\"><ul><li>Estimated fetal weight &lt;10th percentile or birth weight &lt;3rd percentile for gestational age</li></ul></td></tr><tr><td><p align=\"center\"><strong>Onset</strong></p></td><td><ul><li>1st trimester</li></ul></td><td><ul><li>2nd/3rd trimester</li></ul></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>Chromosomal abnormalities</li><li>Congenital infection</li></ul></td><td><ul><li>Uteroplacental insufficiency</li><li>Maternal malnutrition</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td><ul><li>Global growth lag</li></ul></td><td><ul><li>Head-sparing&nbsp;growth lag</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td colspan=\"2\"><ul><li>Monitor/treat complications (eg,&nbsp;hypoglycemia, hypothermia, polycythemia)</li><li>Hypoglycemia: frequent screening and frequent feedings</li><li>Hypothermia: skin to skin with mother, examinations in incubator</li><li>Polycythemia and hypocalcemia: screen if symptoms develop (eg, poor feeding, vomiting, jitteriness)</li></ul></td></tr></tbody></table></div><p>This infant has <strong>fetal growth restriction</strong> (FGR), which is defined as an estimated fetal weight &lt;10th percentile or a <strong>birth weight &lt;3rd percentile</strong> for gestational age.</p><p>FGR occurs from a variety of etiologies, including maternal, placental, or fetal factors.&nbsp; Maternal factors include malnutrition (eg, hyperemesis gravidarum), substance use, and conditions leading to vasculopathies (eg, preeclampsia, pregestational diabetes).&nbsp; Fetal conditions include chromosomal aneuploidies and congenital infections.</p><p>Most cases of FGR are a result of <strong>uteroplacental insufficiency</strong>, which is impaired blood flow to the fetus with subsequent decreased oxygen and nutrient delivery.&nbsp; Fetuses adapt to a hypoxic, nutrient-depleted in utero environment by shunting blood from nonvital organs (eg, liver, subcutaneous fat) to preserve blood flow to vital organs (eg, brain), which can lead to the following complications at birth:</p><ul><li><p><strong>Polycythemia:</strong>&nbsp; chronic hypoxia induces increased erythropoietin and red blood cell expansion</p></li><li><p><strong>Hypoglycemia:</strong>&nbsp; chronic nutrient deprivation results in lower plasma glucose and insulin concentrations, leading to decreased liver and muscle glycogen stores <strong>(Choice A)</strong></p></li><li><p><strong>Hypothermia:</strong>&nbsp; shunting blood to vital organs causes a decrease in subcutaneous fat and increased heat loss <strong>(Choice B)</strong></p></li><li><p><strong>Hypocalcemia:</strong>&nbsp; placental dysfunction decreases calcium transfer to the fetus</p></li><li><p><strong>Perinatal asphyxia and meconium aspiration:</strong>&nbsp; growth-restricted infants have a difficult respiratory transition following birth and may experience hypoxic events leading to organ damage; placental dysfunction can cause intrauterine stress during labor and increase the likelihood of meconium-stained fluid</p></li></ul><p><strong>(Choice C)</strong>&nbsp; Magnesium freely crosses the placenta; therefore, the fetus&#39;s serum concentration equals the mother&#39;s serum concentration.&nbsp; Infants born to mothers receiving magnesium sulfate for either seizure prevention or fetal neuroprotection have hypermagnesemia at birth, resulting in respiratory depression and hypotonia.</p><p><strong>(Choice E)</strong>&nbsp; Infants born to mothers with preeclampsia are at risk of thrombocytopenia due to decreased platelet production, which typically normalizes by 7 to 10 days of life.</p><p><strong>Educational objective:</strong><br>Fetal growth restriction is defined as an estimated fetal weight &lt;10th percentile or a birth weight &lt;3rd percentile for gestational age.&nbsp; The fetal adaptation to uteroplacental insufficiency places infants at risk for complications at birth, including polycythemia, hypoglycemia, hypothermia, and hypocalcemia.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 22123,
            "topic": "Fetal growth restriction",
            "titleId": 22123,
            "title": "Fetal growth restriction",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Hyperglycemia",
                    "choiceNumber": 1,
                    "correctTaken": 1514,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hyperthermia",
                    "choiceNumber": 2,
                    "correctTaken": 1830,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypomagnesemia",
                    "choiceNumber": 3,
                    "correctTaken": 3166,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Polycythemia",
                    "choiceNumber": 4,
                    "correctTaken": 7719,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thrombocytosis",
                    "choiceNumber": 5,
                    "correctTaken": 1956,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 216,
            "othersAvgTimeSpent": 74,
            "notes": null,
            "peopleTaken": 16185,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 216,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 2567,
            "questionIndex": 2567,
            "questionText": "<p>A 29-year-old woman, gravida 2 para 0 aborta 1, comes to the office for a follow-up prenatal visit and to discuss recent test results.&nbsp; She previously had regular menses every 28 days and is at 18 weeks gestation based on her last menstrual period and physical examination.&nbsp; The patient had a first trimester miscarriage during her prior pregnancy.&nbsp; She has no other medical conditions.&nbsp; The patient is taking prenatal vitamins and does not use tobacco, alcohol, or recreational drugs.&nbsp; Prepregnancy BMI was 22 kg/m<font size=\"2\"><sup>2</sup></font>, and she has gained 3 kg (6.6 lb) during this pregnancy.&nbsp; Vital signs and physical examination are normal.&nbsp; The uterus is soft and palpable just below the umbilicus.&nbsp; The maternal serum alpha-fetoprotein level obtained last week is significantly elevated.&nbsp; Which of the following is the most likely abnormality associated with this finding?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T33869\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Maternal serum &#945;-fetoprotein screening</strong></p></td></tr><tr><td><p align=\"center\"><strong>&#8593; MSAFP</strong></p></td><td><p align=\"center\"><strong>&#8595; MSAFP</strong></p></td></tr><tr><td style=\"width: 50%;\"><ul><li>Open neural tube defects (eg, anencephaly, open spina bifida)</li><li>Ventral wall defects (eg, omphalocele, gastroschisis)</li><li>Multiple gestation</li></ul></td><td style=\"width: 50%; vertical-align: top;\"><ul><li>Aneuploidies (eg, trisomy 18 &amp; 21)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>MSAFP</strong> = maternal serum &#945;-fetoprotein.</p></td></tr></tbody></table></div><p>Alpha-fetoprotein (AFP) is a protein produced by the fetal liver and gastrointestinal tract and is present in fetal serum and amniotic fluid.&nbsp; It is absorbed into the maternal circulation and is measurable as <strong>maternal serum alpha-fetoprotein (MSAFP)</strong>.&nbsp; MSAFP is one of 4 markers (ie, MSAFP, unconjugated estriol, &#946;-hCG, inhibin A) comprising the quadruple marker test, a <strong>screening</strong> test for <strong>fetal aneuploidy</strong> and <strong>congenital defects</strong>.</p><p><strong>Elevated MSAFP levels</strong> commonly occur with:</p><ul><li>multiple gestation pregnancies (due to greater fetal tissue volume capable of producing AFP).</li><li>inaccurate pregnancy dating (because MSAFP fluctuates with gestational age).</li></ul><p>However, in patients with a singleton pregnancy and reasonably accurate pregnancy dating&mdash;such as this patient whose last menstrual period is consistent with <a href=\"1834\">fundal height</a> (eg, just below the umbilicus at 18 weeks gestation)&mdash;an elevated MSAFP level suggests a <strong>congenital defect</strong>&nbsp;<strong>(Choice E)</strong>.</p><p>Associated fetal anomalies include <strong>abdominal wall defects</strong> (eg, gastroschisis, omphalocele) and <strong>open neural tube defects</strong> (eg, anencephaly, myelomeningocele).&nbsp; These defects allow for greater leakage of AFP into the amniotic fluid, which elevates MSAFP levels.&nbsp; Further evaluation is with an <strong>ultrasound</strong> to evaluate fetal anatomy and confirm pregnancy dating.</p><p><strong>(Choice B)</strong>&nbsp; Unlike fetal abdominal wall defects, fetal cardiac anomalies do not increase MSAFP levels because AFP is not produced in fetal cardiac tissue.</p><p><strong>(Choice C)</strong>&nbsp; Elevated levels of AFP can be seen with liver disease (eg, hepatocellular carcinoma, viral hepatitis) and ovarian germ cell tumors (eg, endodermal sinus tumors, embryonal carcinoma).&nbsp; This patient has no symptoms of liver disease (eg, ascites, jaundice) or of an ovarian germ cell tumor (eg, abdominal distension and pain), making a fetal etiology more likely.</p><p><strong>(Choices D and F)</strong>&nbsp; Trisomy 21 (eg, due to Robertsonian translocation) produces a <a href=\"1708\">classic pattern</a> of abnormal marker levels: MSAFP and unconjugated estriol, which are fetal tissue products, are decreased (possibly due to suboptimal fetal tissue function).&nbsp; &#946;-hCG and inhibin A, which are placental secretory products, are increased (possibly due to compensatory placental hyperfunction).&nbsp; Trisomy 18 (eg, due to meiotic nondisjunction) is similarly associated with decreased MSAFP levels and unconjugated estriol, but typically leads to low &#946;-HCG and normal inhibin A levels (possibly due to lack of compensatory placental hyperfunction).</p><p><strong>Educational objective:</strong><br>In patients with a singleton pregnancy and reasonably accurate pregnancy dating, an elevated maternal serum alpha-fetoprotein (MSAFP) level suggests a congenital defect (eg, abdominal wall defect, open neural tube defect).&nbsp; Further evaluation involves fetal anatomy ultrasound.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 16357,
            "topic": "Omphalocele",
            "titleId": 16357,
            "title": "Omphalocele",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Fetal abdominal wall defect",
                    "choiceNumber": 1,
                    "correctTaken": 7378,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal cardiac anomaly",
                    "choiceNumber": 2,
                    "correctTaken": 274,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maternal hepatic neoplasm",
                    "choiceNumber": 3,
                    "correctTaken": 419,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Meiotic nondisjunction of fetal chromosome 18",
                    "choiceNumber": 4,
                    "correctTaken": 473,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Multiple gestation",
                    "choiceNumber": 5,
                    "correctTaken": 1496,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Robertsonian translocation involving fetal chromosome 21",
                    "choiceNumber": 6,
                    "correctTaken": 1958,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27358693",
                    "mediaDataId": 0,
                    "title": "Alpha-fetoprotein and its value for predicting pregnancy outcomes - a re-evaluation.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27358693",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "32293844",
                    "mediaDataId": 0,
                    "title": "Fetal aneuploidy: screening and diagnostic testing.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/32293844",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 103,
            "othersAvgTimeSpent": 60,
            "notes": null,
            "peopleTaken": 14377,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 51,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 103,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 3112,
            "questionIndex": 3112,
            "questionText": "<p>A 28-year-old woman, gravida 1 para 0, at 41 weeks gestation comes to the hospital for antepartum fetal surveillance.&nbsp; She has noticed decreased fetal movement for the past few hours but has had no abdominal pain, leakage of fluid, or vaginal bleeding.&nbsp; Blood pressure is 126/82 mm Hg.&nbsp; The patient&#39;s pre-pregnancy BMI was 40 kg/m<font size=\"2\"><sup>2</sup></font>, and she has gained 20 kg (44 lb) during the pregnancy.&nbsp; The pregnancy has otherwise been uncomplicated.&nbsp; Nonstress testing shows a baseline fetal heart rate of 140/min, moderate variability, and no accelerations for &gt;40 minutes.&nbsp; Two contractions are observed on the tocodynamometer.&nbsp; The fetal heart rate decreased to 130/min after the peak of each contraction and lasted for a minute, gradually returning to baseline after resolution of the contraction.&nbsp; Ultrasound shows a fetus in cephalic presentation, a loop of umbilical cord near the fetal neck, an estimated fetal weight at the 35th percentile for gestational age, and a single deepest pocket of amniotic fluid of 1 cm (normal: &#8805;2 and &lt;8).&nbsp; The biophysical profile results are shown below.</p><table class=\"table-default-style\"><tbody><tr><td style=\"vertical-align:middle;\"><strong>Biophysical profile component</strong></td><td style=\"vertical-align:middle;\"><strong>Score</strong></td></tr><tr><td style=\"vertical-align:middle;\">Nonstress test</td><td style=\"text-align: center;\">0</td></tr><tr><td style=\"vertical-align:middle;\">Amniotic fluid volume</td><td style=\"text-align: center;\">0</td></tr><tr><td style=\"vertical-align:middle;\">Fetal movements</td><td style=\"text-align: center;\">2</td></tr><tr><td style=\"vertical-align:middle;\">Fetal tone</td><td style=\"text-align: center;\">2</td></tr><tr><td style=\"vertical-align:middle;\">Fetal breathing movements</td><td style=\"text-align: center;\">0</td></tr></tbody></table><p>Which of the following is the most likely cause of this patient&#39;s biophysical profile results?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T41148\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Biophysical profile*</strong></p></td></tr><tr><td><p align=\"center\"><strong>Component</strong></p></td><td><p align=\"center\"><strong>Normal finding</strong></p></td></tr><tr><td><p align=\"center\"><strong>Nonstress test (NST)</strong></p></td><td><p>Reactive fetal heart rate monitoring</p></td></tr><tr><td><p align=\"center\"><strong>Amniotic fluid volume</strong></p></td><td><p>A single deepest vertical pocket &gt; 2 cm &times; 1 cm is present</p>or amniotic fluid index &gt; 5 cm</td></tr><tr><td><p align=\"center\"><strong>Fetal movements</strong></p></td><td><p>&#8805;3 discrete body or limb movements</p></td></tr><tr><td><p align=\"center\"><strong>Fetal tone</strong></p></td><td><p>&#8805;1 episodes of active extension &amp; flexion of an extremity<br>OR opening &amp; closing of a hand</p></td></tr><tr><td><p align=\"center\"><strong>Fetal breathing movements</strong></p></td><td><p>&#8805;1 breathing episodes for &#8805;30 sec</p></td></tr><tr><td colspan=\"2\"><p>*Continuous ultrasound observation up to 30 min.<br>0 = abnormal, 2 = normal, for each component; maximum score = 10.</p></td></tr></tbody></table></div><p>Pregnancies at <strong>&#8805;41 weeks gestation</strong> are at <strong>increased risk of stillbirth</strong>.&nbsp; In these pregnancies, <strong>placental aging</strong> leads to <strong>decreased placental function</strong>, which limits fetal perfusion during contractions and induces intermittent fetal hypoxemia.&nbsp; On nonstress testing, fetal hypoxemia presents as <a href=\"14218\">late decelerations</a>, decelerations that gradually nadir after the contraction&#39;s peak (as seen in this patient).</p><p>Progressive placental dysfunction can lead to <strong>chronic fetal hypoxemia</strong> (ie, <strong>uteroplacental insufficiency</strong>), which causes CNS suppression and potential fetal demise.&nbsp; To maintain CNS function, the hypoxemic fetus preferentially distributes blood to the brain. &nbsp;Decreased perfusion to the kidney results in decreased urine production and <strong>oligohydramnios</strong> (single deepest pocket &lt;2 cm).&nbsp; Decreased blood supply to peripheral muscle results in <strong>decreased fetal activity</strong> (eg, movement, tone)&nbsp;that may be felt by the mother.</p><p>Patients with signs of suspected fetal hypoxemia (eg, decreased fetal movement, late decelerations) require a <strong>biophysical profile (BPP)</strong> to <strong>evaluate fetal oxygenation</strong>.&nbsp; The BPP includes a nonstress test and ultrasound assessment of amniotic fluid volume and fetal activity.&nbsp; Each BPP component is scored 0 or 2 for a total score of 0-10.&nbsp; Normal scores (8 or 10) exclude fetal hypoxemia.&nbsp; In contrast, <strong>abnormal BPP scores</strong> (particularly &#8804;4) suggest severe hypoxemia with <strong>imminent risk of stillbirth</strong>;&nbsp; delivery is typically indicated.</p><p><strong>(Choice A)</strong>&nbsp; Fetal head compression causes a normal parasympathetic response that presents as <a href=\"16427\">early decelerations</a>, gradual heart rate decelerations that nadir at the peak of the contraction.&nbsp; Early decelerations do not indicate chronic hypoxemia and therefore do not cause an abnormal BPP score.</p><p><strong>(Choice B)</strong>&nbsp; Fetal sleep cycles can cause decreased fetal movement and nonreactive nonstress testing.&nbsp; However, they do not cause late decelerations or oligohydramnios.</p><p><strong>(Choice C)</strong>&nbsp; Intraamniotic infection can present with oligohydramnios if associated with premature rupture of membranes (not seen in this patient).&nbsp; Fetal monitoring usually reveals tachycardia (&gt;160/min).</p><p><strong>(Choice D)</strong>&nbsp; Nuchal cords (eg, loops of umbilical cord around the fetal neck) are associated with <a href=\"14217\">variable decelerations</a>, which are abrupt (&#8805;15/min) decreases in fetal heart rate below the baseline of varying depth and duration that represent acute cord compression and interruption of fetal perfusion.&nbsp; Nuchal cords do not cause oligohydramnios or decreased fetal breathing movements.</p><p><strong>(Choice E)</strong>&nbsp; Polyhydramnios (amniotic fluid index &#8805;24 cm or single deepest pocket &#8805;8 cm) does not affect BPP score.</p><p><strong>Educational objective:</strong><br>A biophysical profile (BPP) is performed in patients at risk for uteroplacental insufficiency (eg, &#8805;41 weeks gestation).&nbsp; Chronic hypoxemia causes an abnormal BPP score and suggests imminent risk of fetal demise; delivery is typically indicated.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 12035,
            "topic": "Postterm pregnancy",
            "titleId": 12035,
            "title": "Postterm pregnancy",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "6",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Fetal head compression",
                    "choiceNumber": 1,
                    "correctTaken": 1265,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal sleep cycle",
                    "choiceNumber": 2,
                    "correctTaken": 643,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intraamniotic infection",
                    "choiceNumber": 3,
                    "correctTaken": 81,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nuchal umbilical cord",
                    "choiceNumber": 4,
                    "correctTaken": 3728,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Polyhydramnios",
                    "choiceNumber": 5,
                    "correctTaken": 188,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uteroplacental insufficiency",
                    "choiceNumber": 6,
                    "correctTaken": 10899,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25050770",
                    "mediaDataId": 0,
                    "title": "Practice bulletin no. 146: management of late-term and postterm pregnancies.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25050770",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26496004",
                    "mediaDataId": 0,
                    "title": "The fetal brain sparing response to hypoxia: physiological mechanisms.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26496004",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 139,
            "othersAvgTimeSpent": 76,
            "notes": null,
            "peopleTaken": 16804,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 139,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 11376,
            "questionIndex": 12531,
            "questionText": "<p>A 23-year-old primigravid woman comes to the labor and delivery department due to decreased fetal movement for the past few days.&nbsp; She also has some regular, nonpainful uterine contractions but no vaginal bleeding or leakage of fluid.&nbsp; The patient has had no prenatal care but is estimated to be at 38 weeks gestation by her last menstrual period.&nbsp; She has no known medical conditions but has had fatigue and joint stiffness for the past month.&nbsp; Temperature is 99.1 F (37.2 C), blood pressure is 128/86 mm Hg, and pulse is 94/min.&nbsp; Fundal height is 37 cm.&nbsp; Physical examination shows an erythematous, confluent facial rash.&nbsp; The neck is supple.&nbsp; Cardiopulmonary examination is normal.&nbsp; The uterus is nontender.&nbsp; Fetal heart rate tracing is shown in the following <a href=\"28463\">exhibit</a>.&nbsp; Which of the following is the most likely cause of this patient&#39;s fetal heart rate tracing?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient with fatigue, joint pain, and a <a href=\"372\">malar facial rash</a> most likely has <strong>systemic lupus erythematosus</strong> (SLE).&nbsp; SLE, like other autoimmune diseases, may improve, worsen, or initially present during pregnancy.&nbsp; Patients with SLE have an increased risk of <strong>obstetric complications</strong>, which can be maternal (eg, preeclampsia) or fetal (eg, neonatal lupus, intrauterine fetal demise).</p><p><strong>Neonatal lupus</strong> occurs due to <strong>passive placental transfer</strong> of maternal <strong>anti-SSA (Ro)</strong> and <strong>anti-SSB (La) antibodies</strong> (which commonly occur in Sjogren but are also seen in ~30% of patients with SLE).&nbsp; Fetal findings are primarily cardiac and cutaneous (eg, scalp or periorbital rash).&nbsp; The most serious complication is <strong>fetal atrioventricular (AV) block</strong>, which develops at 18 to 24 weeks gestation.&nbsp; This likely occurs due to maternal autoantibodies binding to fetal cardiac cells and causing <strong>irreversible injury to the AV node</strong>.&nbsp; Without normal AV conduction, the ventricular heart rate (eg, 50-80/min) determines the baseline fetal heart rate.&nbsp; On <a href=\"28464\">fetal heart rate tracing</a>, this appears as persistent <strong>fetal bradycardia</strong> (ie, &lt;110/min).</p><p>With prolonged complete heart block, cardiomyopathy and <a href=\"23610\">hydrops fetalis</a> may develop.&nbsp; Therefore, this patient with decreased fetal movement requires additional testing (eg, biophysical profile, fetal growth ultrasound) and possible delivery.</p><p><strong>(Choice A)</strong>&nbsp; Congenital hypothyroidism can present with lethargy and bradycardia days to weeks after delivery; however, fetuses in utero are typically unaffected because some maternal thyroid hormone crosses the placenta.</p><p><strong>(Choice C)</strong>&nbsp; A fetal sleep cycle can present with minimal or absent variability and decreased frequency of accelerations; however, the baseline fetal heart rate remains normal (eg, 110-160/min).</p><p><strong>(Choice D)</strong>&nbsp; Incorrect gestational age dating can affect interpretation of the fetal heart rate tracing because fetuses at &lt;32 weeks gestation have lower-amplitude accelerations and less variability.&nbsp; However, a baseline fetal heart rate of &lt;110/min is abnormal at all gestational ages.</p><p><strong>(Choice E)</strong>&nbsp; Intraamniotic infection may cause changes in the fetal heart rate tracing; however, it typically causes fetal tachycardia (not bradycardia).&nbsp; In addition, there is usually fever and uterine tenderness, which are not seen in this patient.</p><p><strong>Educational objective:</strong><br>Patients with systemic lupus erythematosus have an increased risk of obstetric complications.&nbsp; Neonatal lupus can occur due to passive placental transfer of maternal anti-SSA (Ro) and anti-SSB (La) antibodies.&nbsp; Patients may develop fetal atrioventricular block, which appears on fetal heart rate tracing as persistent bradycardia.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 19642,
            "topic": "SLE",
            "titleId": 19642,
            "title": "SLE",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Congenital hypothyroidism",
                    "choiceNumber": 1,
                    "correctTaken": 2287,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal atrioventricular block",
                    "choiceNumber": 2,
                    "correctTaken": 9192,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal sleep cycle",
                    "choiceNumber": 3,
                    "correctTaken": 2885,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Incorrect gestational age dating",
                    "choiceNumber": 4,
                    "correctTaken": 139,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Polymicrobial intraamniotic infection",
                    "choiceNumber": 5,
                    "correctTaken": 2133,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24100008",
                    "mediaDataId": 0,
                    "title": "Overview of neonatal lupus.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24100008",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29116459",
                    "mediaDataId": 0,
                    "title": "Neonatal systemic lupus erythematosus syndrome: a comprehensive review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29116459",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 99,
            "othersAvgTimeSpent": 59,
            "notes": null,
            "peopleTaken": 16636,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 55,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 99,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 2549,
            "questionIndex": 2549,
            "questionText": "<p>A 24-year-old woman, gravida 2 para 1, at 28 weeks gestation comes to the office with her husband because she has felt no fetal movement for the past 3 days.&nbsp; The patient has had no abdominal pain, leakage of fluid, or vaginal bleeding.&nbsp; All testing during this pregnancy, including an anatomy ultrasound at 20 weeks gestation, has been normal.&nbsp; The patient&#39;s first child was delivered vaginally at term.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 120/80 mm Hg, and pulse is 94/min.&nbsp; Fetal heart tones are not heard on Doppler.&nbsp; Ultrasonography demonstrates a small-for-gestational-age fetus in breech presentation and an absence of fetal cardiac activity that is consistent with fetal demise.&nbsp; Digital cervical examination shows the cervix to be closed and long.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hemoglobin</td><td style=\"vertical-align:middle;\">11.2 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">Platelets</td><td style=\"vertical-align:middle;\">160,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Leukocytes</td><td style=\"vertical-align:middle;\">11,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Plasma fibrinogen</td><td style=\"vertical-align:middle;\">350 mg/dL (normal: 301-696)</td></tr></tbody></table><p>Which of the following is the most appropriate management recommendation for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T32823\"><table class=\"table-default-style table-header-footer-style\" style=\"width:481px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Intrauterine fetal demise</strong></p></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td><ul><li>Absent fetal cardiac activity at &#8805;20 weeks gestation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Aneuploidy</li><li>Fetal or placental anomalies</li><li>Fetal growth restriction</li><li>Congenital infection</li><li>Substance use (eg, tobacco, cocaine)</li><li>Maternal conditions (eg, hypertension, diabetes mellitus)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Evaluation</strong></p></td><td><p>Fetal</p><ul><li>Autopsy</li><li>Gross &amp; microscopic examination of placenta &amp; umbilical cord</li><li>Karyotype/genetic studies</li></ul><p>Maternal</p><ul><li>Kleihauer-Betke test</li><li>Antiphospholipid antibodies</li><li>Coagulation studies*</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><p>20-23 weeks</p><ul><li>Dilation &amp; evacuation OR vaginal delivery**</li></ul><p>&#8805;24 weeks</p><ul><li>Vaginal delivery**</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><p>Coagulopathy after several weeks of fetal retention</p></td></tr><tr><td colspan=\"2\"><p>*For history of recurrent pregnancy loss, family or personal history of venous thrombosis, or fetal growth restriction.</p><p><strong>**</strong>Cesarean delivery by maternal choice if history of prior classical cesarean/myomectomy.</p></td></tr></tbody></table></div><p>This patient at 28 weeks gestation with <strong>absent fetal cardiac activity on ultrasound</strong> has an <strong>intrauterine fetal demise</strong> (IUFD), or stillbirth, defined as fetal death at <strong>&#8805;20 weeks gestation</strong> occurring prior to the onset of labor.&nbsp; Most stillbirths are associated with uncomplicated pregnancies, but risk factors include aneuploidy, fetal growth restriction, and maternal tobacco use.</p><p>Once the diagnosis is confirmed on ultrasound, the parents should be informed as empathically as possible (eg, &#x22;I am sorry for your loss&#x22;).&nbsp; Because the diagnosis can be overwhelming, the next steps in management should be presented as gently and clearly as possible.</p><p>Patients with stillbirth require delivery.&nbsp; The safest mode is <strong>induction of labor</strong> for <strong>vaginal delivery</strong>.&nbsp; Medically stable patients, such as this one with normal vital signs and laboratory results, can undergo induction of labor immediately or <strong>within a week</strong> if the parents require additional time to process the diagnosis.&nbsp; This time frame is recommended because prolonged fetal retention increases the risk for maternal coagulopathy; therefore, waiting for spontaneous labor is not recommended <strong>(Choice C)</strong>.</p><p><strong>(Choice B)</strong>&nbsp; Cesarean deliveries are indicated for living breech fetuses due to neonatal risks associated with breech vaginal delivery (eg, hypoxic injury).&nbsp; Although patients with an IUFD may opt for cesarean delivery, it is not typically recommended because there is increased risk for maternal morbidity and because vaginal deliveries for stillborn infants are usually successful regardless of breech presentation.&nbsp; In addition, immediate delivery is not indicated in this patient.</p><p><strong>(Choice D)</strong>&nbsp; The stillbirth likely occurred when fetal movement ceased (eg, 3 days ago).&nbsp; Because it occurred within the past week and the patient appears medically stable, delivery is not required today.&nbsp; In addition, dilation and evacuation (D&amp;E) is not recommended at &#8805;24 weeks gestation due to increased fetal size, which increases the risk for maternal complications (eg, uterine perforation, cervical laceration).&nbsp; D&amp;E may be indicated at &lt;24 weeks gestation in patients whose condition is medically unstable and who require expedited delivery.</p><p><strong>Educational objective:</strong><br>Patients with an intrauterine fetal demise are typically recommended to undergo induction of labor for vaginal delivery.&nbsp; Delivery can be delayed for up to a week to allow time for parents to process the diagnosis; however, prolonged fetal retention can lead to maternal coagulopathy, so awaiting spontaneous labor is not recommended.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23772,
            "topic": "IUFD",
            "titleId": 23772,
            "title": "IUFD",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "&#x22;I am sorry for your loss; when you feel ready, I recommend we schedule an induction of labor, ideally within the next week.&#x22;",
                    "choiceNumber": 1,
                    "correctTaken": 3300,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;I know this is difficult; I recommend we perform a cesarean delivery immediately due to your risk for complications.&#x22;",
                    "choiceNumber": 2,
                    "correctTaken": 267,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;This is devastating news; I recommend you wait for spontaneous labor and allow your body to deliver naturally.&#x22;",
                    "choiceNumber": 3,
                    "correctTaken": 438,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;This may be hard to process, but because we don&#39;t know when this occurred, I recommend we perform dilation and evacuation today.&#x22;",
                    "choiceNumber": 4,
                    "correctTaken": 979,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "32080052",
                    "mediaDataId": 0,
                    "title": "Management of stillbirth: obstetric care consensus no, 10.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/32080052",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 164,
            "othersAvgTimeSpent": 78,
            "notes": null,
            "peopleTaken": 5052,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 164,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 12172,
            "questionIndex": 13352,
            "questionText": "<p>A 34-year-old woman, gravida 3 para 2, at 33 weeks gestation comes to the emergency department due to continued leakage of fluid.&nbsp; The patient reports intermittent vaginal spotting but has had no contractions.&nbsp; Fetal movement is normal.&nbsp; Her prenatal course has been complicated by group B <em>Streptococcus</em> bacteriuria treated in the first trimester.&nbsp; The patient has no other chronic medical conditions or previous surgeries.&nbsp; Temperature is 39.2 C (102.5 F), blood pressure is 90/56 mm Hg, and pulse is 109/min.&nbsp; Fundal height measures 30 cm.&nbsp; Speculum examination shows pooled fluid in the posterior fornix that turns nitrazine paper blue; the cervix appears visibly closed.&nbsp; A ferning pattern is visualized on microscopy.&nbsp; Fetal heart monitoring shows a rate of 170/min with moderate variability.&nbsp; Tocometry shows no contractions.&nbsp; A transabdominal ultrasound reveals a fetus in transverse lie; the single deepest vertical pocket of amniotic fluid is 1 cm.&nbsp; Which of the following is an indication for delivery in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t36642\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Intraamniotic infection (chorioamnionitis)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Prolonged rupture of membranes (&gt;18 hr)</li><li>Preterm prelabor rupture of membranes</li><li>Prolonged labor</li><li>Internal fetal/uterine monitoring devices</li><li>Repetitive vaginal examinations</li><li>Presence of genital tract pathogens</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><p>Maternal fever PLUS &ge;1 of the following:</p><ul><li>Fetal tachycardia (&gt;160/min)</li><li>Maternal leukocytosis</li><li>Purulent amniotic fluid</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Broad-spectrum antibiotics</li><li>Delivery</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Maternal: postpartum hemorrhage, endometritis</li><li>Neonatal: preterm birth, pneumonia, encephalopathy</li></ul></td></tr></tbody></table></div><p>This patient has <strong>preterm premature rupture of membranes</strong> (PPROM), defined as rupture of membranes (eg, pooling, nitrazine-positive fluid, ferning) prior to 37 weeks gestation in the absence of uterine contractions.&nbsp; Typically, the management of PPROM is expectant until 34 weeks gestation, followed by delivery <strong>(Choice C)</strong>.&nbsp; At 33 weeks gestation, patients are administered corticosteroids for fetal lung maturity and a course of prophylactic broad-spectrum (ie, latency) antibiotics.&nbsp; Latency antibiotics prevent intraamniotic infection, prolong pregnancy, and thereby reduce the risk of maternal (eg, endometritis) and neonatal (eg, early-onset neonatal sepsis, cerebral palsy) complications.</p><p>A complication of PPROM is <strong>intraamniotic infection</strong>&nbsp;(chorioamnionitis), which occurs due to exposure of the uterine cavity contents (eg, fetus, placenta) with ascending vaginal and enteric pathogens.&nbsp; Patients with intraamniotic infection present with <strong>fever</strong>, sustained <strong>fetal tachycardia &gt;160/min</strong>, maternal leukocytosis, and/or purulent amniotic fluid.&nbsp; Other clinical features may include maternal tachycardia and uterine fundal tenderness.&nbsp; When patients exhibit signs of overt infection, the risks of infection complications outweigh the risks of prematurity, and <strong>delivery is indicated</strong> regardless of gestational age.</p><p><strong>(Choice A)</strong>&nbsp; Fetal malpresentation (eg, <a href=\"12167\">transverse lie</a>) is not an indication for delivery in patients with intraamniotic infection.&nbsp; However, it does dictate the mode of delivery (ie, cesarean) once delivery is indicated.</p><p><strong>(Choice D)</strong>&nbsp; Patients with group B <em>Streptococcus</em> (GBS) colonization (eg, rectovaginal, bacteruria) are treated with antibiotic prophylaxis during labor to reduce the risk of neonatal sepsis.&nbsp; GBS colonization is not an indication for delivery in this patient.</p><p><strong>(Choice E)</strong>&nbsp; A uterine size-dates discrepancy is a &gt;2 cm difference in fundal height measurement from the gestational age, and may indicate abnormal fetal growth or abnormal amniotic fluid volumes (eg, oligohydramnios).&nbsp; This patient&#39;s uterine size-dates discrepancy and oligohydramnios are due to rupture of membranes; they are not indications for delivery.</p><p><strong>Educational objective:</strong><br>Management of preterm premature rupture of membranes diagnosed at &lt;34 weeks gestation is typically expectant.&nbsp; However, in patients with overt signs of intraamniotic infection (eg, fever, fetal tachycardia), delivery is indicated to decrease maternal and neonatal morbidity.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14528,
            "topic": "Chorioamnionitis",
            "titleId": 14528,
            "title": "Chorioamnionitis",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Fetal malpresentation",
                    "choiceNumber": 1,
                    "correctTaken": 2154,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal tachycardia",
                    "choiceNumber": 2,
                    "correctTaken": 10774,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Gestational age",
                    "choiceNumber": 3,
                    "correctTaken": 312,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Group B <em>Streptococcus</em> colonization",
                    "choiceNumber": 4,
                    "correctTaken": 1840,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine size-dates discrepancy",
                    "choiceNumber": 5,
                    "correctTaken": 1675,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "174",
                    "mediaDataId": 0,
                    "title": "Intraamniotic infection",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28514958",
                    "mediaDataId": 0,
                    "title": "Neonatal respiratory morbidity following exposure to chorioamnionitis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28514958",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26855098",
                    "mediaDataId": 0,
                    "title": "Evaluation and management of women and newborns with a maternal diagnosis of chorioamnionitis: summary of a workshop.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26855098",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 157,
            "othersAvgTimeSpent": 68,
            "notes": null,
            "peopleTaken": 16755,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 64,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 157,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 16613,
            "questionIndex": 18057,
            "questionText": "<p>A 28-year-old woman comes to the emergency department due to severe right lower quadrant pain.&nbsp; Yesterday, the patient noticed intermittent right lower abdominal pain associated with increased activity.&nbsp; She rested the remainder of the day, but the pain continued to increase.&nbsp; An hour ago, the pain suddenly became constant, severe, and associated with nausea and vomiting.&nbsp; The pain does not radiate.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 130/80 mm Hg, and pulse is 98/min.&nbsp; There is tenderness to palpation over the right lower quadrant with no rebound or guarding.&nbsp; Urine pregnancy test is negative.&nbsp; Which of the following additional information would be most helpful in establishing this patient&#39;s diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t34441\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Ovarian torsion</strong></p></td></tr><tr><td nowrap=\"nowrap\"><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Ovarian mass</li><li>Women of reproductive age</li><li>Infertility treatment with ovulation induction</li></ul></td></tr><tr><td nowrap=\"nowrap\"><p align=\"center\"><strong>Clinical presentation</strong></p></td><td><ul><li>Sudden-onset unilateral pelvic pain</li><li>Nausea &amp; vomiting</li><li>&plusmn; Palpable adnexal mass</li></ul></td></tr><tr><td nowrap=\"nowrap\"><p align=\"center\"><strong>Ultrasonography findings</strong></p></td><td><ul><li>Adnexal mass with absent Doppler flow to ovary</li></ul></td></tr><tr><td nowrap=\"nowrap\"><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Laparoscopy with detorsion</li><li>Ovarian cystectomy</li><li>Oophorectomy if necrosis or malignancy</li></ul></td></tr></tbody></table></div><p>In nonpregnant women, acute lower abdominal pain can have various causes involving the gastrointestinal, gynecologic, or urologic systems due to the proximity of their structures.&nbsp; Many of these causes have classic presenting symptoms that characterize the disease process and differentiate the diagnosis.</p><p>This patient&#39;s right lower quadrant pain is classic for <strong>ovarian torsion</strong>, which occurs due to <a href=\"5096\">rotation of the ovary</a> around the infundibulopelvic ligament, causing ovarian vessel occlusion.&nbsp; Although ovarian torsion can occur in all reproductive-aged women, those with a <strong>history of ovarian cysts</strong> (eg, hemorrhagic cyst) or masses (eg, mature cystic teratoma) are at increased risk because the greater size and density of the ovary make it prone to rotation and subsequent torsion.&nbsp; Patients initially have <strong>intermittent pain associated with activity</strong> (as in this patient) due to partial ovarian torsion; the pain resolves when the adnexa spontaneously untwists and blood flow returns.&nbsp; When this progresses to complete ovarian torsion, patients typically develop <strong>sudden-onset, severe, nonradiating pain</strong> (due to persistent ischemia) often associated with nausea and vomiting.</p><p>Ovarian torsion can be <strong>diagnosed clinically</strong>, but a Doppler ultrasound is usually performed to evaluate ovarian blood flow and confirm the diagnosis.&nbsp; Treatment is with surgical detorsion to prevent ovarian necrosis; cystectomy/oophorectomy may be required.</p><p><strong>(Choice A)</strong>&nbsp; Associated urinary symptoms can help establish a urologic cause (eg, pyelonephritis, nephrolithiasis) of acute right lower quadrant pain.&nbsp; However, patients with urologic conditions typically have suprapubic or flank pain that radiates to the right lower quadrant, making this diagnosis less likely.</p><p><strong>(Choice B)</strong>&nbsp; A family history of malignancy usually does not aid in the diagnosis of acute lower abdominal pain.&nbsp; Although some ovarian cancers are inherited, patients with ovarian cancer typically have a chronic, indolent course with associated weight loss, early satiety, and abdominal distension.</p><p><strong>(Choice D)</strong>&nbsp; Having multiple sexual partners is a risk factor for sexually transmitted infections and pelvic inflammatory disease, which can cause lower abdominal pain.&nbsp; However, patients typically have fever; constant, diffuse pelvic pain; and associated rebound and guarding.</p><p><strong>(Choice E)</strong>&nbsp; Recent sick contacts are a risk factor for gastroenteritis, which can present with nausea, vomiting, and abdominal pain; however, patients typically have diffuse, cramping abdominal pain that gradually increases; persistent vomiting; and diarrhea.</p><p><strong>Educational objective:</strong><br>Ovarian torsion typically causes intermittent lower abdominal pain followed by sudden-onset, severe, nonradiating unilateral pain with associated nausea and vomiting.&nbsp; Ovarian torsion can occur in all reproductive-aged women, particularly those with a history of ovarian cysts.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 20413,
            "topic": "Ovarian Torsion",
            "titleId": 20413,
            "title": "Ovarian Torsion",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Associated urinary symptoms",
                    "choiceNumber": 1,
                    "correctTaken": 608,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Family history of malignancy",
                    "choiceNumber": 2,
                    "correctTaken": 80,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "History of ovarian cysts",
                    "choiceNumber": 3,
                    "correctTaken": 9918,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Number of sexual partners",
                    "choiceNumber": 4,
                    "correctTaken": 537,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recent sick contacts",
                    "choiceNumber": 5,
                    "correctTaken": 77,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26212687",
                    "mediaDataId": 0,
                    "title": "Clinical risk factors for ovarian torsion.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26212687",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24126258",
                    "mediaDataId": 0,
                    "title": "Adnexal torsion: review of the literature.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24126258",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 155,
            "othersAvgTimeSpent": 57,
            "notes": null,
            "peopleTaken": 11220,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 88,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 155,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 11281,
            "questionIndex": 12436,
            "questionText": "<p>A 34-year-old woman, gravida 2 para 1, at 20 weeks gestation comes to the office in November for a routine prenatal visit.&nbsp; She is feeling well and has had no vaginal bleeding or cramping.&nbsp; Several weeks ago, the patient had 2 days of fever and pharyngitis that resolved spontaneously.&nbsp; Her 3-year-old son and several of his playmates at day care had similar symptoms.&nbsp; The pregnancy has otherwise been uncomplicated; prenatal screening results from 13 weeks gestation were as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td>HIV-1/2 antibody</td><td>negative</td></tr><tr><td>Rapid plasma reagin</td><td>positive, 1:64 titer</td></tr><tr><td>Treponemal antibody absorption test</td><td>negative</td></tr><tr><td>Rubella antibody IgG</td><td>positive</td></tr></tbody></table><p>The patient has no chronic medical conditions and is current on her vaccinations.&nbsp; Vital signs are normal.&nbsp; The uterine fundus is below the umbilicus.&nbsp; Ultrasound shows a fetus with bilateral periventricular intracranial calcifications and an enlarged liver with multiple intrahepatic calcifications.&nbsp; The estimated fetal weight is consistent with 16 weeks gestation.&nbsp; Which of the following pathogens is the most likely cause of this patient&#39;s ultrasound findings?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t43165\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Congenital cytomegalovirus</strong></p></td></tr><tr><td><p align=\"center\"><strong>Ultrasound findings</strong></p></td><td><ul><li>Periventricular calcifications</li><li>Ventriculomegaly</li><li>Microcephaly</li><li>Intrahepatic calcifications</li><li>Fetal growth restriction</li><li>Hydrops fetalis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Neonatal features</strong></p></td><td><ul><li>Petechiae</li><li>Hepatosplenomegaly</li><li>Chorioretinitis</li><li>Microcephaly</li></ul></td></tr><tr><td><p align=\"center\"><strong>Long-term sequelae</strong></p></td><td><ul><li>Sensorineural hearing loss</li><li>Seizures</li><li>Developmental delay</li></ul></td></tr></tbody></table></div><p>This patient&#39;s ultrasound findings are likely due to <strong>congenital cytomegalovirus (CMV)</strong> infection.&nbsp; CMV is commonly acquired via close contact with young children, as seen in this patient, and maternal infection can result in either a subclinical or mild febrile illness.&nbsp; During this maternal infection, <strong>transplacental (vertical) transmission</strong> can occur and cause fetal infection.&nbsp; CMV spreads throughout the fetus and preferentially replicates in the placenta, liver, and central nervous system, resulting in the clinical features of <strong>fetal growth restriction</strong>, an enlarged liver with multiple <strong>intrahepatic calcifications</strong>, and bilateral <strong>periventricular intracranial calcifications</strong> (ie, tissue necrosis).&nbsp; Additional ultrasound findings may include hydrops fetalis, microcephaly, and ventriculomegaly.&nbsp; Long-term sequelae include neurologic abnormalities, sensorineural hearing loss, seizures, and development delay.</p><p>Maternal infection is diagnosed via serology, and fetal infection is diagnosed via amniocentesis.&nbsp; Maternal antiviral therapy is not indicated as it has not been proven to prevent fetal infection.&nbsp; Therefore, management is generally expectant; however, pregnancy termination may be considered for fetuses with severe congenital CMV infection identified early during pregnancy.</p><p><strong>(Choice B)</strong>&nbsp; Although influenza is common in the fall and winter, influenza is neither vertically transmitted nor associated with fetal anomalies.</p><p><strong>(Choice C)</strong>&nbsp; <em>Listeria monocytogenes</em> infection, which typically occurs after consumption of an unpasteurized dairy product, can be vertically transmitted.&nbsp; However, fetal infection generally results in spontaneous abortion or preterm delivery of a fetus with multiple abscesses and granulomas (ie, granulomatous infantiseptica).&nbsp; Ultrasound findings typically include dilated loops of bowel and ascites.</p><p><strong>(Choice D)</strong>&nbsp; Parvovirus B19 infection is associated with fetal anemia and hydrops fetalis (eg, pleural effusion, ascites) rather than intracranial and intrahepatic calcifications.</p><p><strong>(Choice E)</strong>&nbsp; Congenital rubella syndrome can cause fetal growth restriction and hepatomegaly.&nbsp; However, this is unlikely in patients with a current vaccination status and immunity to rubella (positive IgG) on first-trimester screening.</p><p><strong>(Choice F)</strong>&nbsp; Congenital syphilis from a <em>Treponema pallidum</em> infection can cause fetal intracranial and intrahepatic calcifications.&nbsp; Although this patient has a positive rapid plasma reagin, the confirmatory treponemal antibody absorption test is negative, making this diagnosis unlikely.</p><p><strong>Educational objective:</strong><br>Congenital cytomegalovirus occurs due to transplacental (vertical) transmission.&nbsp; Ultrasound findings consistent with congenital cytomegalovirus infection include bilateral periventricular intracranial calcifications, intrahepatic calcifications, and fetal growth restriction.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 17932,
            "topic": "Cytomegalovirus",
            "titleId": 17932,
            "title": "Cytomegalovirus",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cytomegalovirus",
                    "choiceNumber": 1,
                    "correctTaken": 13479,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Influenza virus",
                    "choiceNumber": 2,
                    "correctTaken": 148,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<em>Listeria monocytogenes</em>",
                    "choiceNumber": 3,
                    "correctTaken": 257,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Parvovirus B19",
                    "choiceNumber": 4,
                    "correctTaken": 869,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rubella virus",
                    "choiceNumber": 5,
                    "correctTaken": 1004,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<em>Treponema pallidum</em>",
                    "choiceNumber": 6,
                    "correctTaken": 964,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29560263",
                    "mediaDataId": 0,
                    "title": "Maternal and fetal cytomegalovirus infection:  diagnosis, management, and prevention.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29560263",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26902990",
                    "mediaDataId": 0,
                    "title": "Diagnosis and antenatal management of congenital cytomegalovirus infection.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26902990",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 110,
            "othersAvgTimeSpent": 67,
            "notes": null,
            "peopleTaken": 16721,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 81,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 110,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 17246,
            "questionIndex": 18698,
            "questionText": "<p>A 36-year-old nulligravid woman comes to the clinic for preconception counseling due to advanced maternal age.&nbsp; The patient has epilepsy that is well controlled on several antiepileptic medications.&nbsp; Her husband has no medical conditions.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 128/76 mm Hg, pulse is 90/min, and respirations are 16/min.&nbsp; Examination shows a yellow-brown plaque with irregular borders measuring about 6 cm in diameter along the lower back.&nbsp; There are a few periungual fibromas on the hands and feet.&nbsp; Assume that the patient is heterozygous for her underlying disorder and that the couple will give birth to a boy.&nbsp; Which of the following is the likelihood that the boy will have this disorder?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t51099\"><div align=\"center\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Tuberous sclerosis complex</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>Mutation (inherited or de novo) in <em>TSC1</em> or <em>TSC2</em> gene</li><li>Autosomal dominant</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Dermatologic<ul style=\"list-style-type:circle;\"><li>Ash-leaf spots</li><li>Angiofibromas of the malar region</li><li>Shagreen patches</li></ul></li><li>Neurologic<ul style=\"list-style-type:circle;\"><li>CNS lesions (eg,&nbsp;subependymal tumors)</li><li>Epilepsy (eg,&nbsp;infantile spasms)</li><li>Intellectual disability</li><li>Autism &amp; behavioral disorders (eg,&nbsp;hyperactivity)</li></ul></li><li>Cardiovascular: rhabdomyomas</li><li>Renal: angiomyolipomas</li></ul></td></tr><tr><td><p align=\"center\"><strong>Surveillance</strong></p></td><td><ul><li>Tumor screening<ul style=\"list-style-type:circle;\"><li>Regular skin &amp; eye examinations</li><li>Serial MRI of the brain &amp; kidney</li><li>Baseline echocardiography &amp; serial&nbsp;ECG</li></ul></li><li>Baseline electroencephalography</li><li>Neuropsychiatric screening</li></ul></td></tr></tbody></table></div></div></div><p>This woman has epilepsy and skin findings concerning for <strong>tuberous sclerosis complex</strong> (TSC), a neurocutaneous disorder.&nbsp; Classic dermatologic manifestations include ash-leaf spots (hypopigmented macules), periungual fibromas (flesh-colored papules adjacent to the nail fold), malar <a href=\"476\">angiofibromas</a>, and a <strong>shagreen patch</strong> (orange peel&ndash;like plaque typically on the lower back).&nbsp; Most patients also have <strong>seizures</strong> and benign tumors in multiple organs (eg, skin, brain, kidney).&nbsp; The diagnosis is often clinical but can be confirmed by genetic testing.</p><p>TSC is caused by a mutation in the <em>TSC1</em> or <em>TSC2</em> gene; the mutation can occur de novo or may be inherited through <strong>autosomal dominant</strong> transmission.&nbsp; With <a href=\"3930\">autosomal dominant</a> disorders, a child needs to inherit only one copy of the mutant allele to be affected, and <strong>males</strong> and <strong>females</strong> are <strong>affected equally</strong>.&nbsp; In this case, one parent is heterozygous for the condition (ie, one mutant allele) and the other is healthy; therefore, the child of this couple has a <strong>50%</strong> chance of inheriting the disorder (regardless of whether the child is a boy or a girl).&nbsp; However, clinical features vary within family members, so the severity of disease cannot be predicted.</p><p><strong>(Choice A)</strong>&nbsp; If neither parent has a mutant allele, the child has no chance of inheriting the disorder; however, this woman has characteristic features of TSC.</p><p><strong>(Choice B)</strong>&nbsp; The likelihood that 2 carriers of an <a href=\"1837\">autosomal recessive</a> disorder will have a boy who is affected is 12.5% (likelihood of having a boy &times; likelihood of disease = 0.5 &times; 0.25).</p><p><strong>(Choice C)</strong>&nbsp; Assuming the sex of the child is unknown, the likelihood of this couple having a boy with TSC&nbsp;is 25% (likelihood of having a boy &times; likelihood of disease = 0.5 &times; 0.5).&nbsp; This case presumes that the child is a boy, making the likelihood of disease 50%.</p><p><strong>(Choice E)</strong>&nbsp; A child with a parent who is homozygous for TSC has a 100% chance of having the disorder.&nbsp; A son has a 100% chance of inheriting an <a href=\"24113\">X-linked recessive disorder</a> in which the mother is affected and the father is healthy.</p><p><strong>Educational objective:</strong><br>Tuberous sclerosis complex is a neurocutaneous disorder that causes seizures, characteristic skin findings (eg, shagreen patches, periungual fibromas), and benign tumors of various organs (eg, skin, brain, kidney).&nbsp; Inheritance is autosomal dominant; therefore, males and females are equally affected.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 19789,
            "topic": "Tuberous sclerosis",
            "titleId": 19789,
            "title": "Tuberous sclerosis",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "0%",
                    "choiceNumber": 1,
                    "correctTaken": 244,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "12.5%",
                    "choiceNumber": 2,
                    "correctTaken": 132,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "25%",
                    "choiceNumber": 3,
                    "correctTaken": 898,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "50%",
                    "choiceNumber": 4,
                    "correctTaken": 3588,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "100%",
                    "choiceNumber": 5,
                    "correctTaken": 298,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29924239",
                    "mediaDataId": 0,
                    "title": "Tuberous sclerosis complex: review based on new diagnostic criteria.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29924239",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 161,
            "othersAvgTimeSpent": 70,
            "notes": null,
            "peopleTaken": 5160,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 70,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 161,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 2404,
            "questionIndex": 2404,
            "questionText": "<p>A 33-year-old woman, gravida 2 para 1, at 26 weeks gestation comes to the clinic for a routine prenatal visit.&nbsp; Her pregnancy has been uncomplicated.&nbsp; The patient&#39;s prepregnancy BMI was 23 kg/m<font size=\"2\"><sup>2</sup></font>, and her initial laboratory results at 10 weeks gestation were as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hematocrit</td><td style=\"vertical-align:middle;\">34%</td></tr><tr><td style=\"vertical-align:middle;\">Hepatitis B surface antigen</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">HIV-1 antibody</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">Rapid plasma reagin</td><td style=\"vertical-align:middle;\">not detected</td></tr><tr><td style=\"vertical-align:middle;\">ABO/Rh type</td><td style=\"vertical-align:middle;\">A positive</td></tr><tr><td style=\"vertical-align:middle;\">Antibody screen</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">Urine culture</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\"><em>Chlamydia trachomatis</em> PCR</td><td style=\"vertical-align:middle;\">negative</td></tr></tbody></table><p>An ultrasound at 20 weeks gestation showed an anterior placenta, normal cervical length, and normal fetal anatomy.&nbsp; The patient&#39;s only concern today is lower leg swelling that occurs after prolonged standing but resolves with sitting or lying down.&nbsp; Her last pregnancy was complicated by Group B <em>Streptococcus</em> colonization requiring antibiotic prophylaxis during delivery.&nbsp; The patient has no chronic medical conditions.&nbsp; Blood pressure is 132/80 mm Hg and pulse is 65/min.&nbsp; Physical examination shows minimal pedal edema bilaterally.&nbsp; Fundal height is 27 cm and fetal heart rate is 140/min.&nbsp; Urinalysis is negative for protein and glucose.&nbsp; Which of the following tests should be obtained at this visit?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31445\"><table class=\"table-default-style table-footer-only-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Routine prenatal laboratory tests</strong></p></td></tr><tr><td><p align=\"center\"><strong>Initial prenatal visit</strong></p></td><td><ul><li>Rh D type &amp; antibody screen</li><li>Hemoglobin/hematocrit, MCV, ferritin</li><li>HIV, VDRL/RPR, HBsAg, anti-HCV Ab</li><li>Rubella &amp; varicella immunity</li><li>Urine culture</li><li>Urine dipstick for protein</li><li>Chlamydia PCR (if risk factors are present)</li><li>Pap test (if screening indicated)</li></ul></td></tr><tr><td><p align=\"center\"><strong>24-28 weeks</strong></p></td><td><ul><li>Hemoglobin/hematocrit</li><li>Antibody screen if Rh D-negative</li><li>1-hr 50-g GCT</li></ul></td></tr><tr><td><p align=\"center\"><strong>36-38 weeks</strong></p></td><td><ul><li>Group B <em>Streptococcus</em> rectovaginal culture</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>anti-HCV Ab</strong> = hepatitis C antibody; <strong>GCT</strong> = glucose challenge test; <strong>HBsAg</strong> = hepatitis B surface antigen; <strong>MCV</strong> = mean corpuscular volume; <strong>PCR</strong>&nbsp;= polymerase chain reaction;&nbsp;<strong>RPR</strong> = rapid plasma reagin.</p></td></tr></tbody></table></div><p>During the second and third trimesters of pregnancy, placental hormones increase both maternal insulin resistance and blood glucose levels to promote fetal growth.&nbsp; Patients with inadequate pancreatic function to overcome the increased insulin resistance develop <strong>gestational diabetes mellitus (GDM)</strong>.&nbsp; Risk factors include <strong>obesity, excessive weight gain</strong> during pregnancy, <strong>family history</strong> of diabetes mellitus, and a prior macrosomic infant.</p><p>Because uncontrolled maternal hyperglycemia increases the risk for obstetric complications (eg, miscarriage, congenital defects, fetal macrosomia, preeclampsia), all patients at risk for type 2 diabetes mellitus (eg, obesity, affected first-degree relative) require diabetic screening at the initial prenatal visit (eg, hemoglobin A1c, glucose challenge test).</p><p>Patients with <strong>no identifiable risk factors</strong> (such as this patient with normal BMI) require a routine <strong>oral glucose challenge test (GCT)</strong> at <strong>24-28 weeks gestation</strong>, which is typically when placental hormones induce insulin resistance.&nbsp; The most common testing approach consists of screening with a 1-hour 50-g GCT.&nbsp; If results are abnormal, a confirmatory 3-hour 100-g glucose tolerance test (GTT) is performed.</p><p><strong>(Choice B)</strong>&nbsp; 24-hour urine protein collections can diagnose preeclampsia.&nbsp; However, second-trimester testing is indicated only for systolic blood pressures &#8805;140 mm Hg systolic or diastolic &#8805;90 mm Hg.&nbsp; This patient&#39;s blood pressure of 132/80 mm Hg is normal for pregnancy, as is her positional lower extremity edema.</p><p><strong>(Choice C)</strong>&nbsp; A clean-catch urine culture is obtained in all patients at the initial prenatal visit to evaluate for asymptomatic bacteriuria, which is treated during pregnancy due to increased risk of ascending infection (eg, pyelonephritis).&nbsp; This patient is asymptomatic and had a negative urine culture at 10 weeks gestation; therefore, repeat culture is not indicated.</p><p><strong>(Choice D)</strong>&nbsp; Group B <em>Streptococcus</em> (GBS) rectovaginal cultures are collected at 36-38 weeks gestation.&nbsp; Positive testing requires intrapartum antibiotic prophylaxis to prevent vertical transmission and neonatal sepsis.&nbsp; Patients with GBS colonization in a prior pregnancy do not require earlier screening or treatment.</p><p><strong>(Choice E)</strong>&nbsp; Transvaginal ultrasound can diagnose a shortened cervix, which increases the risk for preterm delivery.&nbsp; Cervical length is routinely measured on the fetal anatomy ultrasound at 18-20 weeks gestation; additional measurements are not indicated in patients with normal cervical length.</p><p><strong>Educational objective:</strong><br>During the second and third trimesters, placental hormones increase maternal insulin resistance, which can result in pathologic maternal hyperglycemia and associated obstetric complications (eg, fetal macrosomia).&nbsp; Therefore, all patients at 24-28 weeks gestation require routine screening for gestational diabetes mellitus with a 50-g oral glucose challenge test.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 18237,
            "topic": "Gestational diabetes",
            "titleId": 18237,
            "title": "Gestational diabetes",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "50-g oral glucose challenge test",
                    "choiceNumber": 1,
                    "correctTaken": 13632,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "24-hour urine protein collection",
                    "choiceNumber": 2,
                    "correctTaken": 1947,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Clean catch urine culture",
                    "choiceNumber": 3,
                    "correctTaken": 1373,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Group B <em>Streptococcus</em> rectovaginal culture",
                    "choiceNumber": 4,
                    "correctTaken": 2379,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transvaginal ultrasound for cervical length",
                    "choiceNumber": 5,
                    "correctTaken": 904,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24194617",
                    "mediaDataId": 0,
                    "title": "Diabetes and pregnancy: an endocrine society clinical practice guideline.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24194617",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 80,
            "othersAvgTimeSpent": 69,
            "notes": null,
            "peopleTaken": 20267,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 67,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 80,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 3274,
            "questionIndex": 3274,
            "questionText": "<p>A 23-year-old woman, gravida 2 para 1, at 30 weeks gestation comes to the emergency department due to a sudden gush of clear vaginal fluid.&nbsp; The patient continues to have leakage of clear fluid but no abdominal pain or vaginal bleeding.&nbsp; Fetal movement has been normal.&nbsp; The patient had intermittent vaginal bleeding during the first trimester but no other complications during this pregnancy.&nbsp; Her prior pregnancy ended in a term vaginal delivery.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 110/70 mm Hg, and pulse is 82/min.&nbsp; The uterine fundus is nontender.&nbsp; Sterile speculum examination shows a closed cervix and vaginal pooling of nitrazine-positive, clear fluid.&nbsp; Ultrasound reveals a fetus in breech presentation and decreased amniotic fluid.&nbsp; Fetal heart rate tracing has a baseline of 130/min, moderate variability, and no decelerations.&nbsp; Tocometry shows no contractions.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"5024\" src=\"https://www.uworld.com/media/highresdefault/L29779.png\"  ></p><p>This patient at &lt;37 weeks gestation with vaginal pooling of <strong>nitrazine-positive fluid</strong> and a closed cervix (ie, prior to labor onset) has <strong>preterm prelabor rupture of membranes</strong> (PPROM).&nbsp; Risk factors are similar to those for preterm delivery (eg, multiple gestation, prior preterm delivery) but also include a history of prior PPROM, genital tract infection (eg, bacterial vaginosis), and <strong>antepartum bleeding</strong>, as in this patient.&nbsp; Management is dependent on gestational age and fetal/maternal status because the risks for fetal prematurity are balanced against maternal complications (eg, intraamniotic infection, abruptio placentae).</p><p>Patients with <strong>PPROM at &lt;34 weeks gestation</strong> are at high risk for prematurity-related fetal morbidity and mortality; therefore, expectant management is aimed at promoting in utero fetal development and consists of the following:</p><ul><li><p>Prophylactic <strong>latency antibiotics</strong>:&nbsp; PPROM is commonly due to a subclinical intraamniotic infection, and latency antibiotics prevent the infection from becoming fulminant, thereby increasing the time interval between membrane rupture and delivery (ie, prolonged latency).</p></li><li><p>Antenatal <strong>corticosteroids</strong> (eg, betamethasone):&nbsp; These are administered to promote fetal lung maturation (eg, pneumocyte development, surfactant release), thereby reducing neonatal morbidity and mortality.</p></li></ul><p>Delivery is indicated if there are signs of intraamniotic infection (eg, fetal tachycardia, uterine tenderness) or deteriorating fetal/maternal status or if the pregnancy has reached 34 weeks gestation <strong>(Choices B and E)</strong>.</p><p><strong>(Choices A and F)</strong>&nbsp; Cerclage is used in patients with a history of cervical insufficiency (eg, painless cervical dilation), and progesterone therapy (eg, intramuscular, vaginal) is offered to patients with a prior preterm delivery.&nbsp; These interventions are intended to prevent PPROM and preterm delivery from recurring.&nbsp; Neither is used in patients after PPROM has occurred.</p><p><strong>(Choice D)</strong>&nbsp; External cephalic version (ECV) is typically performed at &#8805;36 weeks gestation to manually correct fetal malpresentation (eg, breech).&nbsp; Ruptured membranes, decreased amniotic fluid, and fetal prematurity are all relative contraindications to ECV due to lower success rates and higher risks for fetal injury.</p><p><strong>Educational objective:</strong><br>Patients who have uncomplicated preterm prelabor rupture of membranes at &lt;34 weeks gestation are managed expectantly with antibiotics and corticosteroids to promote in utero fetal development.&nbsp; Delivery is indicated if there are signs of intraamniotic infection or deteriorating fetal/maternal status or if the pregnancy has reached 34 weeks gestation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23687,
            "topic": "Preterm premature rupture of the membranes",
            "titleId": 23687,
            "title": "Preterm premature rupture of the membranes",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cerclage",
                    "choiceNumber": 1,
                    "correctTaken": 506,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cesarean delivery",
                    "choiceNumber": 2,
                    "correctTaken": 2410,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Corticosteroids",
                    "choiceNumber": 3,
                    "correctTaken": 11654,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "External cephalic version",
                    "choiceNumber": 4,
                    "correctTaken": 975,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Induction of labor",
                    "choiceNumber": 5,
                    "correctTaken": 638,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Progesterone",
                    "choiceNumber": 6,
                    "correctTaken": 551,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "33093409",
                    "mediaDataId": 0,
                    "title": "ACOG practice bulletin no. 217:  prelabor rupture of membranes.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/33093409",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 148,
            "othersAvgTimeSpent": 57,
            "notes": null,
            "peopleTaken": 16734,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 70,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 148,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 12,
            "questionId": 2415,
            "questionIndex": 2415,
            "questionText": "<p>A 32-year-old woman, gravida 2 para 1, at 18 weeks gestation comes to the office for her first prenatal visit.&nbsp; She has noticed new facial hair and acne over the past few weeks.&nbsp; The patient has had no vaginal bleeding or abdominal pain.&nbsp; Some mild nausea earlier in the pregnancy has resolved.&nbsp; The patient has had no vomiting and is eating 5 small meals a day.&nbsp; Her prepregnancy BMI was 24 kg/m<font size=\"2\"><sup>2</sup></font> and she has gained 2.3 kg (5 lb) over the past 2 months.&nbsp; Examination shows acne on her chest and back and coarse hair in the distribution of the upper lip, chin, periareolar area, chest, and lower abdomen.&nbsp; The uterus is nontender and fundal height is 2 cm below the umbilicus.&nbsp; Ultrasonogram shows an intrauterine gestation consistent with dates and bilateral 7-cm solid masses in the ovaries.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t41907\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Causes of hyperandrogenism in pregnancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><p align=\"center\"><strong>Clinical features</strong></p></td></tr><tr><td><p align=\"center\"><strong>Placental<br>aromatase<br>deficiency</strong></p></td><td><ul><li>No ovarian mass</li><li>High maternal &amp; fetal virilization risk</li><li>Resolution of maternal symptoms after delivery</li></ul></td></tr><tr><td><p align=\"center\"><strong>Luteoma</strong></p></td><td><ul><li>Solid, unilateral/bilateral ovarian masses</li><li>Moderate maternal virilization risk; high fetal virilization risk</li><li>Spontaneous&nbsp;regression of masses after delivery</li></ul></td></tr><tr><td><p align=\"center\"><strong>Theca lutein<br>cyst</strong></p></td><td><ul><li>Cystic, bilateral ovarian masses</li><li>Moderate maternal virilization risk; low fetal virilization risk</li><li>Spontaneous&nbsp;regression of masses after delivery</li></ul></td></tr><tr><td><p align=\"center\"><strong>Sertoli-Leydig<br>tumor</strong></p></td><td><ul><li>Solid unilateral ovarian mass</li><li>High maternal &amp; fetal virilization risk</li><li>Surgery required (2nd trimester or postpartum)</li></ul></td></tr></tbody></table></div><p>This patient has new-onset <strong>hyperandrogenism during pregnancy</strong> (ie, gestational hyperandrogenism) based on the acne and male-pattern terminal hair.&nbsp; Gestational hyperandrogenism arises from either maternal (eg, ovarian masses) or fetal (eg, placental aromatase deficiency) sources that result in maternal and possible fetal virilization.&nbsp; This patient&#39;s hyperandrogenism is due to <strong>benign ovarian tumors</strong>, which typically present as <strong>bilateral ovarian masses</strong> on ultrasound.&nbsp; The most common benign ovarian tumors resulting in gestational hyperandrogenism are luteomas of pregnancy and theca lutein cysts.</p><ol><li><p><strong>Luteomas of pregnancy</strong>, as seen in this patient, often appear as solid, bilateral ovarian masses on ultrasound.&nbsp; Elevated &#946;-hCG levels stimulate the luteoma (composed of large lutein cells) to release androgens, which may cause maternal <strong>virilization</strong>; some patients are asymptomatic.&nbsp; Women who develop virilization symptoms are at high risk of delivering a female fetus with virilization.</p></li><li><p>Theca lutein cysts are cystic, bilateral ovarian masses that occur from ovarian hyperstimulation secondary to markedly elevated &#946;-hCG levels (eg, hydatidiform mole, multiple gestation).&nbsp; Theca lutein cysts may cause maternal virilization; however, there is a low risk of female fetal virilization.</p></li></ol><p>Management of bilateral, benign ovarian masses is <strong>observation and expectant management</strong>, as the masses and symptoms <strong>resolve spontaneously after delivery</strong> due to falling &#946;-hCG levels.</p><p><strong>(Choice A)</strong>&nbsp; Polycystic ovary syndrome causes hyperandrogenism, anovulation (eg, oligomenorrhea), and infertility in nonpregnant women.&nbsp; Clomiphene is a first-line infertility treatment in these patients but is not used during pregnancy.&nbsp; However, this diagnosis is unlikely in this patient, as the hirsutism and acne would likely predate the pregnancy and polycystic ovaries would likely be seen on ultrasound.</p><p><strong>(Choices B and C)</strong>&nbsp; Surgery with either an ovarian biopsy or oophorectomy may be indicated if a malignant ovarian tumor is suspected.&nbsp; Sertoli-Leydig tumors secrete testosterone, which can result in virilization.&nbsp; In contrast to the masses in this patient, these tumors often appear as unilateral, solid, complex masses on ultrasound.</p><p><strong>(Choice E)</strong>&nbsp; Suction curettage is indicated if a complete hydatidiform mole is seen on ultrasound (eg, &#x22;snowstorm&#x22; appearance).&nbsp; This patient has a normal intrauterine gestation.</p><p><strong>Educational objective:</strong><br>Hyperandrogenism in pregnancy is commonly due to benign, bilateral ovarian masses such as luteomas and theca lutein cysts.&nbsp; Patients with virilization during pregnancy and bilateral ovarian masses are observed and managed expectantly, as the symptoms and masses spontaneously regress after delivery.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 3170,
            "topic": "Ovarian cancer",
            "titleId": 3170,
            "title": "Ovarian cancer",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Clomiphene therapy",
                    "choiceNumber": 1,
                    "correctTaken": 755,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Diagnostic laparoscopy with ovarian biopsy",
                    "choiceNumber": 2,
                    "correctTaken": 2877,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Exploratory laparotomy with oophorectomy",
                    "choiceNumber": 3,
                    "correctTaken": 933,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Observation and expectant management",
                    "choiceNumber": 4,
                    "correctTaken": 11703,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Suction evacuation of the uterus",
                    "choiceNumber": 5,
                    "correctTaken": 423,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27967205",
                    "mediaDataId": 0,
                    "title": "Gestational hyperandrogenism in developmental programming.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27967205",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24151290",
                    "mediaDataId": 0,
                    "title": "Diagnosis and treatment of polycystic ovary syndrome:  an Endocrine Society clinical practice guideline.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24151290",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21144088",
                    "mediaDataId": 0,
                    "title": "Pregnancy luteomas:  clinical presentations and management strategies.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21144088",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 106,
            "othersAvgTimeSpent": 63,
            "notes": null,
            "peopleTaken": 16691,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 70,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 106,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 13,
            "questionId": 14807,
            "questionIndex": 16230,
            "questionText": "<p>A 30-year-old woman, gravida 3 para 1 aborta 1, at 26 weeks gestation comes to the office for evaluation of increased vaginal discharge that started yesterday.&nbsp; She now changes her pad every hour and has noticed some spotting.&nbsp; Her initial prenatal visit was 2 weeks ago, and laboratory evaluation revealed a positive urine culture.&nbsp; The patient has not started her antibiotics because she has no symptoms.&nbsp; Her last delivery was 2 years ago via term cesarean delivery for recurrent late fetal decelerations.&nbsp; Vital signs are normal.&nbsp; The abdomen is soft, and the uterus is nontender.&nbsp; On speculum examination, there is pooling of clear, nitrazine-positive fluid in the vagina; the cervix is visibly closed.&nbsp; Fetal heart rate tracing shows a baseline of 150/min, accelerations, and no decelerations.&nbsp; There are irregular contractions on tocodynamometry.&nbsp; Transabdominal ultrasound shows an anterior placenta and an amniotic fluid index of 3 cm.&nbsp; Which of the following most likely contributed to this patient&#39;s presentation?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t49528\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Preterm prelabor rupture of membranes (PPROM)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td><ul><li>Membrane rupture at &lt;37 weeks prior to labor onset</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Prior PPROM</li><li>Genitourinary infection (eg, ASB, BV)</li><li>Antepartum bleeding</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Vaginal pooling or fluid from cervix</li><li>Nitrazine-positive (blue) fluid</li><li>Ferning on microscopy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>&lt;34 weeks (reassuring): latency antibiotics, corticosteroids</li><li>&lt;34 weeks (nonreassuring): delivery</li><li>&#8805;34 weeks: delivery</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Preterm labor</li><li>Intraamniotic infection</li><li>Placental abruption</li><li>Umbilical cord prolapse</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ASB</strong> = asymptomatic bacteriuria;&nbsp; <strong>BV</strong> = bacterial vaginosis; <strong>PPROM</strong> = preterm prelabor rupture of membranes.</p></td></tr></tbody></table></div><p>This patient at 26 weeks gestation has a pool of nitrazine-positive vaginal fluid and a closed cervix, consistent with <strong>preterm prelabor rupture of membranes (PPROM)</strong>.&nbsp; Risk factors include prior PPROM; conditions that overdistend the membranes (eg, polyhydramnios); and conditions that inflame or weaken the membranes, such as&nbsp;antepartum bleeding, genital tract infection (eg, bacterial vaginosis, gonorrhea), or <strong>asymptomatic bacteriuria</strong>.</p><p>Due to the proximity of the bladder, perineum, and rectum, bacteria from one source can migrate readily to another; this is particularly common in pregnancy with bladder infections (even if asymptomatic), as the bacteria can spread to the vagina and uterus.&nbsp; As bacteria spreads to the uterus, the <strong>intrauterine bacterial enzymatic activity</strong> may cause <strong>contractions</strong> (by stimulating prostaglandin release) or <strong>increase membrane fragility</strong> (by degrading collagen or activating inflammatory cytokines), resulting in either preterm labor or PPROM.</p><p>Due to these risks, all patients require urine culture screening at their initial prenatal visit, and high-risk patients (eg, age &lt;25) undergo sexually transmitted infection screening.&nbsp; Those who screen positive require timely treatment and repeat cultures after treatment (ie, test of cure) to reduce risks of persistent infection.</p><p><strong>(Choice B)</strong>&nbsp; Extremes of maternal age (eg, age &lt;17 or &gt;35) are associated with preterm labor and PPROM; this patient is age 30.</p><p><strong>(Choice C)</strong>&nbsp; Multiparity is associated with precipitous labor and increased risk for postpartum hemorrhage, not PPROM.</p><p><strong>(Choice D)</strong>&nbsp; Patients with placenta previa can have antepartum bleeding with an increased risk of PPROM, likely due to blood causing inflammation and focal weakening of the fetal membranes.&nbsp; This patient has an anterior placenta, which is not a risk factor for PPROM.&nbsp; Her light spotting is likely the result of her rupture of membranes, but such spotting is unlikely to cause PPROM.</p><p><strong>(Choice E)</strong>&nbsp; Previous cervical surgeries or uterine procedures (eg, multiple dilations and evacuations) are associated with preterm delivery.&nbsp; Previous spontaneous abortion is not associated with PPROM or preterm delivery.</p><p><strong>(Choice F)</strong>&nbsp; Prior cesarean delivery increases the risk of abnormal placentation (eg, placenta accreta), not PPROM, in subsequent pregnancies.</p><p><strong>Educational objective:</strong><br>Genitourinary tract infection, particularly asymptomatic bacteriuria, is a risk factor for preterm prelabor rupture of membranes.&nbsp; Therefore, universal urine culture screening, timely treatment, and reculturing for test of cure are recommended in pregnancy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23687,
            "topic": "Preterm premature rupture of the membranes",
            "titleId": 23687,
            "title": "Preterm premature rupture of the membranes",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Asymptomatic bacteriuria",
                    "choiceNumber": 1,
                    "correctTaken": 11893,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maternal age",
                    "choiceNumber": 2,
                    "correctTaken": 83,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Multiparity",
                    "choiceNumber": 3,
                    "correctTaken": 755,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Placenta location",
                    "choiceNumber": 4,
                    "correctTaken": 1065,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Previous spontaneous abortion",
                    "choiceNumber": 5,
                    "correctTaken": 1448,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prior cesarean delivery",
                    "choiceNumber": 6,
                    "correctTaken": 1527,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "158",
                    "mediaDataId": 0,
                    "title": "Preterm prelabor rupture of membranes",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29266069",
                    "mediaDataId": 0,
                    "title": "ACOG practice bulletin no. 188 summary: prelabor rupture of membranes.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29266069",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24840939",
                    "mediaDataId": 0,
                    "title": "Synergy and interactions among biological pathways leading to preterm premature rupture of membranes.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24840939",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 148,
            "othersAvgTimeSpent": 74,
            "notes": null,
            "peopleTaken": 16771,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 148,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 14,
            "questionId": 18432,
            "questionIndex": 19900,
            "questionText": "<p>A 34-year-old woman, gravida 3 para 0 aborta 2, at 18 weeks gestation comes to the office for a routine prenatal visit.&nbsp; The patient feels well and has no concerns.&nbsp; She has no chronic medical conditions, and her only medication is a daily prenatal vitamin.&nbsp; The patient&#39;s prior pregnancies ended in 2 dilation and curettage procedures for spontaneous abortions due to fetal aneuploidy.&nbsp; She does not use tobacco, alcohol, or recreational drugs.&nbsp; Blood pressure is 126/84 mm Hg and pulse is 88/min.&nbsp; Prepregnancy BMI was 22 kg/m<font size=\"2\"><sup>2</sup></font>, and the patient has gained 7 kg (15.4 lb) so far during this pregnancy.&nbsp; Fetal heart tones are 148/min.&nbsp; Transabdominal ultrasound shows a singleton fetus in breech presentation measuring 18 weeks gestation.&nbsp; Amniotic fluid index and fetal anatomy are within normal limits.&nbsp; The placenta is anterior and low-lying, with numerous lacunae and myometrial thinning.&nbsp; Cervical length is 3.8 cm (normal: &gt;2.5).&nbsp; This patient is at greatest risk for which of the following pregnancy-related complications?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t66529\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Placenta accreta</strong></p></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td><ul><li>Morbidly adherent placental attachment to the myometrium</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Placenta previa + prior uterine surgery (eg, cesarean delivery, D&amp;C, myomectomy)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Prenatal diagnosis: US with placenta previa, numerous placental lacunae, myometrial thinning</li><li>Postpartum diagnosis: adherent placenta, postpartum hemorrhage</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Cesarean hysterectomy with placenta in situ</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>D&amp;C</strong> = dilation &amp; curettage; <strong>US</strong> = ultrasonography.</p></td></tr></tbody></table></div><p>This patient has ultrasound findings consistent with <strong>placenta accreta</strong>, the abnormal attachment of placental villi directly onto the uterine myometrium (rather than the decidua basalis) through defects in the decidua.&nbsp; Risk factors include <strong>prior uterine surgery</strong> (eg, <strong>dilation and curettage</strong>, cesarean delivery) because areas of uterine scarring cannot undergo normal decidualization.&nbsp; Patients also typically have concomitant <a href=\"2778\">placenta previa</a> because prior uterine surgery can decrease fundal perfusion and promote abnormal placentation in the lower uterus (eg, low-lying placenta).</p><p>Patients with placenta accreta are typically asymptomatic and often diagnosed incidentally on <strong>second-trimester ultrasound</strong>.&nbsp; Common findings include a low-lying placenta and signs of abnormal placental attachment or invasion into the uterine wall, such as <strong>myometrial thinning</strong> and <strong>numerous placental lacunae</strong> (ie, vascular spaces filled with maternal blood).</p><p>The result of this abnormal placental attachment is a <strong>morbidly adherent placenta</strong> that does not spontaneously detach after fetal delivery.&nbsp; Attempts to manually remove the placenta can disrupt the placental lacunae and cause profuse maternal bleeding (ie, <strong>postpartum hemorrhage</strong>).&nbsp; This bleeding can lead to hemorrhagic shock, disseminated intravascular coagulation, and maternal death.&nbsp; Patients diagnosed prenatally typically undergo planned cesarean hysterectomy to decrease these risks, but patients diagnosed at the time of delivery usually require emergency hysterectomy to achieve hemostasis.</p><p><strong>(Choice A)</strong>&nbsp; <a href=\"2483\">Abruptio placentae</a> is premature placental separation from the uterus.&nbsp; Risk factors include preeclampsia and tobacco use.&nbsp; In contrast, placenta accreta causes an adherent placenta, making premature placental separation unlikely.</p><p><strong>(Choice B)</strong>&nbsp; Risk factors for intraamniotic infection include prolonged rupture of membranes and genitourinary infection (eg, group B <em>Streptococcus</em>), not placenta accreta.</p><p><strong>(Choice D)</strong>&nbsp; Preeclampsia likely occurs due to <a href=\"38603\">insufficient trophoblast invasion</a> and resultant low uteroplacental perfusion.&nbsp; In contrast, patients with placenta accreta have excessive trophoblast invasion and placental hyperperfusion (eg, numerous lacunae).</p><p><strong>(Choice E)</strong>&nbsp; Risk factors for preterm labor include prior spontaneous preterm delivery, multiple gestation, short cervical length, and inadequate weight gain.&nbsp; This patient with a normal BMI has had adequate <a href=\"32799\">weight gain</a> and has no other risk factors.</p><p><strong>Educational objective:</strong><br>Placenta accreta is the abnormal attachment of placental villi directly onto the myometrium rather than the decidua basalis.&nbsp; It is often diagnosed incidentally on second-trimester ultrasound revealing a low-lying placenta, myometrial thinning, and numerous placental lacunae.&nbsp; Patients are at increased risk for postpartum hemorrhage because the placenta is morbidly adherent, and attempted removal can disrupt the placental lacunae, causing profuse maternal bleeding.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4183,
            "topic": "Postpartum hemorrhage",
            "titleId": 4183,
            "title": "Postpartum hemorrhage",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Abruptio placentae",
                    "choiceNumber": 1,
                    "correctTaken": 6026,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intraamniotic infection",
                    "choiceNumber": 2,
                    "correctTaken": 135,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Postpartum hemorrhage",
                    "choiceNumber": 3,
                    "correctTaken": 7113,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Preeclampsia with severe features",
                    "choiceNumber": 4,
                    "correctTaken": 458,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Preterm labor",
                    "choiceNumber": 5,
                    "correctTaken": 3068,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22645616",
                    "mediaDataId": 0,
                    "title": "Epidemiology, etiology, diagnosis, and management of placenta accreta.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22645616",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26135782",
                    "mediaDataId": 0,
                    "title": "Placenta accreta: diagnosis, management and the molecular biology of the morbidly adherent placenta.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26135782",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 99,
            "othersAvgTimeSpent": 67,
            "notes": null,
            "peopleTaken": 16800,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 42,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 99,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 15,
            "questionId": 2530,
            "questionIndex": 2530,
            "questionText": "<p>A 32-year-old woman, gravida 2 para 1, with dichorionic-diamniotic twins at 34 weeks gestation is brought to the emergency department after developing leakage of fluid an hour ago.&nbsp; While in the emergency department, the patient has a sudden large gush of fluid that is followed by heavy vaginal bleeding and constant lower abdominal pain.&nbsp; Her pregnancy has been complicated by gestational hypertension, but the patient has not required any antihypertensive therapy.&nbsp; The patient&#39;s last pregnancy ended in a cesarean delivery for breech presentation.&nbsp; Her prior prenatal ultrasounds showed 2 fundal placentas.&nbsp; Blood pressure is 160/100 mm Hg and pulse is 118/min.&nbsp; Fetal heart rate tracing shows both fetuses with baselines of 110/min and no variability.&nbsp; The uterus is firm, tender, and has a fundal height of 38 cm.&nbsp; Speculum examination shows approximately 75 mL of red blood in the vagina.&nbsp; After evacuation of the blood, a moderate amount of continued bleeding is observed coming from the cervical os that is 3 cm dilated.&nbsp; Which of the following is the most likely cause of this patient&#39;s presentation?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32602\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Abruptio placentae </strong></p></td></tr><tr><td><p align=\"center\"><strong>Definition </strong></p></td><td><ul><li>Placental detachment from the uterus before fetal delivery</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk factors </strong></p></td><td><ul><li>Hypertension, preeclampsia</li><li>Abdominal trauma</li><li>Prior abruptio placentae &nbsp;</li><li>Cocaine &amp; tobacco use</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation </strong></p></td><td><ul><li>Sudden-onset vaginal bleeding &nbsp;</li><li>Abdominal or back pain</li><li>High-frequency, low-intensity contractions</li><li>Rigid, tender uterus</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis </strong></p></td><td><ul><li>Clinical</li><li>Ultrasound: &plusmn; retroplacental hematoma &nbsp;</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications </strong></p></td><td><ul><li>Fetal hypoxia, preterm birth, mortality &nbsp;</li><li>Maternal hemorrhage, disseminated intravascular coagulation</li></ul></td></tr></tbody></table></div><p>This patient with <strong>vaginal bleeding</strong> and a <strong>tender, firm uterus</strong> after rupture of membranes most likely has <strong>abruptio placentae</strong>.&nbsp; <a href=\"2483\">Placental abruption</a> is the <strong>premature placental separation</strong> from the uterine wall prior to fetal delivery.&nbsp; It can occur following an uncontrolled gush of amniotic fluid, particularly in patients with <strong>uterine overdistension</strong> (eg, twin gestation, polyhydramnios) because the sudden loss of volume leads to rapid uterine decompression.&nbsp; The rapid decompression causes shearing of maternal decidual vessels and <strong>bleeding at the decidual-placental interface</strong>, which leads to increased intrauterine pressure (ie, tender, firm uterus), abdominal pain, and vaginal bleeding.&nbsp; Other risk factors include maternal <strong>hypertension</strong>, abdominal trauma, and tobacco use.</p><p>Some cases of abruptio placentae are self-limited and clinically insignificant; however, a large abruption can impair fetal perfusion (ie, <strong>fetal hypoxia</strong>) and increase the risk of demise, as evidenced by fetal heart rate tracing abnormalities (eg, bradycardia, minimal variability).&nbsp; Potential maternal complications include hemorrhage and disseminated intravascular coagulation.&nbsp; Therefore, acute abruption with active bleeding and evidence of fetal hypoxia requires emergent delivery.</p><p><strong>(Choice A)</strong>&nbsp; <a href=\"2906\">Placenta accreta</a>, the attachment of placental villi directly to the myometrium, can occur in patients with prior cesarean delivery due to implantation of an anterior placenta over the uterine scar.&nbsp; However, patients typically have postpartum hemorrhage.&nbsp; In addition, this patient&#39;s placentas are fundal, making this diagnosis less likely.</p><p><strong>(Choice B)</strong>&nbsp; <a href=\"1057\">Uterine rupture</a>, a full-thickness disruption of the uterine wall, may present in laboring patients with prior cesarean delivery and cause abdominal pain, vaginal bleeding, and fetal heart rate tracing abnormalities.&nbsp; However, patients classically have palpable fetal parts on abdominal examination and a uterus with decreasing rigidity and contractions due to decreased intrauterine pressure.</p><p><strong>(Choice C)</strong>&nbsp; <a href=\"28587\">Vasa previa</a>, fetal placental vessels overlying the cervix, can cause bleeding due to injury of fetal vessels with rupture of membranes; however, bleeding is typically painless.</p><p><strong>(Choice D)</strong>&nbsp; Laceration of cervical blood vessels can occur with birth trauma or surgical complications (eg, cesarean delivery, cerclage placement).&nbsp; It is not associated with uterine tenderness or fetal heart rate tracing abnormalities.</p><p><strong>Educational objective:</strong><br>Abruptio placentae is premature placental separation from the uterine wall that can lead to fetal hypoxia and maternal hemorrhage.&nbsp; Patients typically have abdominal pain, vaginal bleeding, and a firm, tender uterus.&nbsp; Risk factors include uterine overdistension, hypertension, abdominal trauma, and tobacco use.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14133,
            "topic": "Antepartum bleeding",
            "titleId": 14133,
            "title": "Antepartum bleeding",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Direct attachment of the placenta to the myometrium",
                    "choiceNumber": 1,
                    "correctTaken": 768,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Full-thickness disruption of the uterine wall",
                    "choiceNumber": 2,
                    "correctTaken": 964,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Injury to fetal placental vessels",
                    "choiceNumber": 3,
                    "correctTaken": 1582,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Laceration of cervical blood vessels",
                    "choiceNumber": 4,
                    "correctTaken": 325,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Premature placental separation",
                    "choiceNumber": 5,
                    "correctTaken": 13085,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21241259",
                    "mediaDataId": 0,
                    "title": "Placental abruption: epidemiology, risk factors and consequences.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21241259",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 159,
            "othersAvgTimeSpent": 76,
            "notes": null,
            "peopleTaken": 16724,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 78,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 159,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 16,
            "questionId": 2545,
            "questionIndex": 2545,
            "questionText": "<p>A 39-year-old woman, gravida 4 para 3, comes to the emergency department after 2 days of fever, heavy vaginal bleeding, and lower abdominal pain.&nbsp; Six days ago, at 8 weeks gestation, she had an elective abortion at an outside clinic.&nbsp; Since then, the patient&#39;s bleeding has become increasingly heavy and malodorous and is now soaking through a pad every 2-3 hours.&nbsp; She has no medical conditions, takes no medications, and has no allergies.&nbsp; Temperature is 39.8 C (103.6 F), blood pressure is 100/65 mm Hg, pulse is 108/min, and respirations are 16/min.&nbsp; Physical examination shows lower abdominal tenderness but no rigidity or guarding.&nbsp; Pelvic examination shows copious purulent and bloody discharge from the cervical os.&nbsp; Bimanual examination shows a tender, anteverted, soft uterus that is 12 weeks in size.&nbsp; Transvaginal ultrasound reveals a 12-cm uterus with an irregularly thickened echogenic endometrial stripe with active blood flow.&nbsp; The adnexa are normal bilaterally, and there is a small amount of free fluid in the pelvis.&nbsp; The patient is started on broad-spectrum intravenous antibiotics.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T81779\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Septic abortion</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><p>Retained POC from:</p><ul><li>Elective abortion with nonsterile technique</li><li>Missed or incomplete abortion (rare)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation</strong></p></td><td><ul><li>Fever, chills, abdominal pain</li><li>Sanguinopurulent vaginal discharge</li><li>Boggy, tender uterus; dilated cervix</li><li>Pelvic ultrasound: retained POC, thick endometrial stripe</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Intravenous fluids</li><li>Broad-spectrum antibiotics</li><li>Suction curettage</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>POC</strong> = products of conception.</p></td></tr></tbody></table></div><p>This patient&#39;s presentation is consistent with a <strong>septic abortion</strong>, which typically presents with fever, lower abdominal pain, heavy vaginal bleeding, and <strong>malodorous, purulent vaginal discharge</strong>.&nbsp; It can occur as a complication of any type of abortion but most frequently follows an unsterile and/or incomplete procedure for an elective abortion.&nbsp; Findings of purulent discharge and an <strong>enlarged, boggy, tender</strong> uterus on pelvic examination, as well as an ultrasound showing intrauterine echogenic material with blood flow, are consistent with inflammation and infection from retained products of conception.</p><p>Although the infection usually remains confined to the retained products of conception if untreated or observed, it can spread into the uterine myometrium and cause widespread infection.&nbsp; Because of these potential complications, a septic abortion is a <strong>medical emergency</strong> that requires prompt treatment to prevent progression to peritonitis, septic shock, and death.&nbsp; Treatment includes <strong>broad-spectrum antibiotics</strong> and <a href=\"1204\">uterine evacuation</a> with <strong>suction curettage</strong>, which removes the nidus of infection.</p><p><strong>(Choice A)</strong>&nbsp; Diagnostic laparoscopy is indicated in hemodynamically unstable patients with large amounts of pelvic free fluid (suggestive of a ruptured ectopic pregnancy).&nbsp; This patient has normal adnexa; in addition, the small amount of free fluid is expected due to retrograde blood flow through the fallopian tubes, making an ectopic pregnancy unlikely.&nbsp; In this case, laparoscopy would not adequately remove the nidus of infection.</p><p><strong>(Choice B)</strong>&nbsp; A hysterectomy is indicated if the patient has a pelvic abscess or if the patient&#39;s condition does not improve after suction curettage and 48 hours of broad-spectrum antibiotics.</p><p><strong>(Choice C)</strong>&nbsp; Methotrexate, a dihydrofolate reductase inhibitor, is used in the management of hemodynamically stable ectopic pregnancies and gestational trophoblastic neoplasia.&nbsp; Methotrexate is not used in abortion management and would not be used to treat this patient&#39;s infection.</p><p><strong>(Choice D)</strong>&nbsp; Mifepristone, an antiprogesterone, and misoprostol, a synthetic prostaglandin, are a regimen commonly used for both medical management of spontaneous abortions and elective terminations of pregnancy.&nbsp; Because of their slow onset of action, they are not used for the treatment of septic abortion, which requires prompt uterine evacuation.</p><p><strong>Educational objective:</strong><br>Septic abortion most commonly occurs after an unsterile and/or incomplete procedure for an elective abortion; it presents with fever, heavy vaginal bleeding, purulent discharge, and uterine tenderness.&nbsp; Septic abortion is a medical emergency that requires prompt treatment with broad-spectrum antibiotics and surgical evacuation of the uterus (eg, suction curettage).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 17495,
            "topic": "Abortion",
            "titleId": 17495,
            "title": "Abortion",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Diagnostic laparoscopy",
                    "choiceNumber": 1,
                    "correctTaken": 1838,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hysterectomy",
                    "choiceNumber": 2,
                    "correctTaken": 642,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Methotrexate",
                    "choiceNumber": 3,
                    "correctTaken": 385,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Mifepristone and misoprostol",
                    "choiceNumber": 4,
                    "correctTaken": 827,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Suction curettage",
                    "choiceNumber": 5,
                    "correctTaken": 13014,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25932831",
                    "mediaDataId": 0,
                    "title": "Treating spontaneous and induced septic abortions.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25932831",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "14718012",
                    "mediaDataId": 0,
                    "title": "Induced septic abortion: a major factor in maternal mortality and morbidity.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/14718012",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 76,
            "othersAvgTimeSpent": 66,
            "notes": null,
            "peopleTaken": 16706,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 78,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 76,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 17,
            "questionId": 14795,
            "questionIndex": 16218,
            "questionText": "<p>A 24-year-old primigravida with a twin pregnancy at 30 weeks gestation comes to the emergency department due to severe epigastric and right upper quadrant pain.&nbsp; The patient first developed the pain yesterday morning after eating breakfast.&nbsp; She took acetaminophen and an antacid but had no relief.&nbsp; She now has severe stabbing pain, has vomited 7 times today, and continues to have nausea.&nbsp; The patient has no chronic medical conditions or previous surgeries.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 136/86 mm Hg, and pulse is 108/min.&nbsp; BMI is 23 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Fetal heart rate monitoring shows 2 fetal heart rates with baselines of 160/min and moderate variability.&nbsp; The patient appears pale and has scleral icterus.&nbsp; The abdomen has tenderness to palpation over the right upper quadrant and epigastric region, but no rebound.&nbsp; The uterus is nontender and has no palpable contractions.</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">9.6 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">60,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">24,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td style=\"vertical-align:middle;\">1.4 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td style=\"vertical-align:middle;\">48 mg/dL</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Liver function studies</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Total bilirubin</td><td style=\"vertical-align:middle;\">5.3 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Alkaline phosphatase</td><td style=\"vertical-align:middle;\">170 U/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">87 U/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">99 U/L</td></tr></tbody></table><p>Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t49138\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Acute fatty liver of pregnancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Nausea, vomiting</li><li>Right upper quadrant/epigastric pain</li><li>Fulminant liver failure</li></ul></td></tr><tr><td>&nbsp;<p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>Profound hypoglycemia</li><li>&uarr; Aminotransferases (2-3&times; normal)</li><li>&uarr; Bilirubin</li><li>Thrombocytopenia</li><li>Disseminated intravascular coagulopathy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Immediate delivery</li></ul></td></tr></tbody></table></div><p>This patient has <strong>acute fatty liver of pregnancy</strong> (AFLP), a rare but life-threatening condition that develops in the third trimester, particularly in patients with multiple gestation.&nbsp; AFLP is an intrinsic hepatic disease likely due to defective maternal-fetal fatty acid metabolism.&nbsp; It causes hepatic inflammation (eg, epigastric/right upper quadrant pain, leukocytosis, elevated aminotransferases) and subsequent <strong>fulminant liver failure</strong> (eg, scleral icterus, hyperbilirubinemia, <strong>profound hypoglycemia</strong>).&nbsp; As AFLP progresses, patients can develop multiorgan system failure, including <strong>disseminated intravascular coagulopathy</strong> (eg, hemolytic anemia, thrombocytopenia) and acute kidney injury (from hepatorenal syndrome).</p><p>As the mother decompensates, the placenta hypoperfuses, which can result in fetal hypoxemia, acidosis, and subsequent death.&nbsp; Due to <strong>high maternal and fetal mortality rates</strong>, management of AFLP is with maternal stabilization and <strong>immediate delivery</strong>, regardless of gestational age.</p><p><strong>(Choice A)</strong>&nbsp; A 24-hour urine protein test evaluates for preeclampsia with severe features, which may also present in the third trimester with right upper quadrant pain and signs of end-organ damage (eg, elevated creatinine).&nbsp; This patient does not have hypertension (ie, systolic &#8805;140 mm Hg or diastolic &#8805;90 mm Hg), making this diagnosis less likely.</p><p><strong>(Choice B)</strong>&nbsp; Emergency cholecystectomy is performed for complicated acute cholecystitis (ie, gallbladder perforation or gangrene), which may present with postprandial right upper quadrant pain and an elevated alkaline phosphatase level.&nbsp; Acute cholecystitis does not cause hyperbilirubinemia or profound hypoglycemia.&nbsp; In addition, the source of this patient&#39;s elevated alkaline phosphatase level is likely the placenta.</p><p><strong>(Choices D and E)</strong>&nbsp; MRI and ultrasound are preferred imaging modalities in pregnancy due to low risk of fetal radiation exposure; they are performed in patients with an uncertain diagnosis.&nbsp; Neither is required to diagnose AFLP, and delaying delivery increases fetal and maternal mortality.&nbsp; Liver biopsy is not needed for the diagnosis of AFLP and increases this patient&#39;s bleeding risk due to thrombocytopenia and possible coagulopathy from liver dysfunction.</p><p><strong>Educational objective:</strong><br>Acute fatty liver of pregnancy presents in the third trimester with hepatic inflammation (eg, epigastric/right upper quadrant pain, leukocytosis, elevated aminotransferases) and fulminant liver failure (eg, profound hypoglycemia).&nbsp; Due to high maternal and fetal mortality rates, management is immediate delivery.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 5164,
            "topic": "Acute fatty liver of pregnancy",
            "titleId": 5164,
            "title": "Acute fatty liver of pregnancy",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "24-hour urine protein collection",
                    "choiceNumber": 1,
                    "correctTaken": 942,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Emergency cholecystectomy",
                    "choiceNumber": 2,
                    "correctTaken": 4272,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Immediate delivery",
                    "choiceNumber": 3,
                    "correctTaken": 9999,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "MRI of the abdomen",
                    "choiceNumber": 4,
                    "correctTaken": 1091,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ultrasound-guided liver biopsy",
                    "choiceNumber": 5,
                    "correctTaken": 473,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "169",
                    "mediaDataId": 0,
                    "title": "Acute fatty liver of pregnancy",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28291236",
                    "mediaDataId": 0,
                    "title": "Acute fatty liver disease of pregnancy: updates in pathogenesis, diagnosis, and management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28291236",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26658682",
                    "mediaDataId": 0,
                    "title": "Pregnancy and liver disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26658682",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 223,
            "othersAvgTimeSpent": 81,
            "notes": null,
            "peopleTaken": 16777,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 60,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 223,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 18,
            "questionId": 4745,
            "questionIndex": 4745,
            "questionText": "<p>A 28-year-old woman, gravida 2 para 0 abortus 1, at 32 weeks gestation comes to the emergency department because she has not felt her baby move for the past few hours.&nbsp; This pregnancy has been complicated by placenta previa, but she has had no contractions, vaginal bleeding, or leakage of fluid.&nbsp; The patient&#39;s other prenatal testing was normal.&nbsp; With her first pregnancy, she had a spontaneous abortion at 8 weeks gestation that required dilation and curettage.&nbsp; The patient&#39;s only medical condition is asthma, for which she uses corticosteroid and bronchodilator inhalers.&nbsp; On physical examination, fetal heart tones are not heard with a Doppler device.&nbsp; Transabdominal ultrasound is performed and reveals no fetal cardiac activity, a finding consistent with intrauterine fetal demise.&nbsp; The patient asks how this could have happened to her baby.&nbsp; Which of the following is the most appropriate response?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T32823\"><table class=\"table-default-style table-header-footer-style\" style=\"width:481px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Intrauterine fetal demise</strong></p></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td><ul><li>Absent fetal cardiac activity at &#8805;20 weeks gestation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Aneuploidy</li><li>Fetal or placental anomalies</li><li>Fetal growth restriction</li><li>Congenital infection</li><li>Substance use (eg, tobacco, cocaine)</li><li>Maternal conditions (eg, hypertension, diabetes mellitus)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Evaluation</strong></p></td><td><p>Fetal</p><ul><li>Autopsy</li><li>Gross &amp; microscopic examination of placenta &amp; umbilical cord</li><li>Karyotype/genetic studies</li></ul><p>Maternal</p><ul><li>Kleihauer-Betke test</li><li>Antiphospholipid antibodies</li><li>Coagulation studies*</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><p>20-23 weeks</p><ul><li>Dilation &amp; evacuation OR vaginal delivery**</li></ul><p>&#8805;24 weeks</p><ul><li>Vaginal delivery**</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><p>Coagulopathy after several weeks of fetal retention</p></td></tr><tr><td colspan=\"2\"><p>*For history of recurrent pregnancy loss, family or personal history of venous thrombosis, or fetal growth restriction.</p><p><strong>**</strong>Cesarean delivery by maternal choice if history of prior classical cesarean/myomectomy.</p></td></tr></tbody></table></div><p><strong>Intrauterine fetal demise</strong> (IUFD), or stillbirth, refers to fetal death at &#8805;20 weeks gestation and prior to delivery.&nbsp; Patients often have <strong>decreased or absent fetal movement</strong>.&nbsp; On evaluation, no fetal heart tones are audible on Doppler sonography, and ultrasonography visually confirms the absence of fetal cardiac activity.</p><p>The <strong>pathophysiology</strong> of IUFD can be <strong>maternal, fetal, or placental</strong> in origin.&nbsp; Therefore, evaluation includes the following:</p><ul><li><p>Fetal autopsy and karyotyping or genetic studies</p></li><li><p>Gross and microscopic evaluation of the placenta for thrombosis, abruption, infection, or other disease</p></li><li><p>Maternal laboratory testing for antiphospholipid syndrome and fetomaternal hemorrhage</p></li><li><p>Other testing (eg, evaluation for thrombophilia, cultures) to confirm or exclude other etiologies based on the patient&#39;s medical history</p></li></ul><p>Identifying a possible cause not only provides patients with an answer, but also helps determine the recurrence risk and optimal management of future pregnancies.&nbsp; Even after thorough evaluation, up to half of IUFDs have <strong>no identifiable cause</strong>.&nbsp; Therefore, patients should be counseled in advance that testing may be negative.</p><p><strong>(Choice A)</strong>&nbsp; Chromosomal abnormalities are common causes of first-trimester spontaneous abortions.&nbsp; However, at &#8805;20 weeks gestation, genetic abnormalities typically cause anomalies (eg, cardiac defect) that are visible during ultrasonography.&nbsp; This patient&#39;s ultrasounds were normal, making a genetic defect less likely.</p><p><strong>(Choice B)</strong>&nbsp; Infections (eg, parvovirus, syphilis, cytomegalovirus, <em>Listeria monocytogenes</em>) can cause preterm IUFD.&nbsp; However, they are usually associated with maternal symptoms (eg, fever, malaise) or abnormal fetal ultrasound results, making this diagnosis less likely.</p><p><strong>(Choice C)</strong>&nbsp; Some medications (eg, ACE inhibitors, lithium) are teratogens and cause congenital anomalies; other substances (eg, cocaine) can cause placental abruption, obstetric hemorrhage, and IUFD.&nbsp; However, corticosteroid and bronchodilator inhalers are not associated with IUFD.</p><p><strong>(Choice D)</strong>&nbsp; <a href=\"19154\">Placenta previa</a>, the implantation of the placenta over the internal os, increases the risk for placental injury and bleeding that can lead to IUFD.&nbsp; However, patients typically have vaginal bleeding, which is not seen in this patient.</p><p><strong>Educational objective:</strong><br>Intrauterine fetal demise refers to fetal death at &#8805;20 weeks gestation and prior to delivery.&nbsp; The etiology can be maternal, placental, or fetal in origin, but, most often, the cause is unknown.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23772,
            "topic": "IUFD",
            "titleId": 23772,
            "title": "IUFD",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "&#x22;Because of your prior miscarriage, this is likely due to a chromosomal abnormality.&#x22;",
                    "choiceNumber": 1,
                    "correctTaken": 779,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;The most common reason is an underlying infection inside the uterus, which could not have been prevented.&#x22;",
                    "choiceNumber": 2,
                    "correctTaken": 500,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;This can sometimes occur as a complication of long-term use of your asthma medications.&#x22;",
                    "choiceNumber": 3,
                    "correctTaken": 323,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Unfortunately, this is likely a complication of your placenta previa.&#x22;",
                    "choiceNumber": 4,
                    "correctTaken": 1075,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;We can order further tests on the baby, but, sadly, we may not ever know the cause.&#x22;",
                    "choiceNumber": 5,
                    "correctTaken": 14038,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19300347",
                    "mediaDataId": 0,
                    "title": "ACOG practice bulletin no. 102: management of stillbirth.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19300347",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 239,
            "othersAvgTimeSpent": 55,
            "notes": null,
            "peopleTaken": 16715,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 84,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 239,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 19,
            "questionId": 3279,
            "questionIndex": 3279,
            "questionText": "<p>A 37-year-old woman, gravida 1 para 0, at 34 weeks gestation comes to the office for a routine prenatal visit.&nbsp; She reports good fetal movement with some lower abdominal pressure.&nbsp; Other than a cough and nasal congestion during the first trimester, the patient has had an uneventful pregnancy.&nbsp; First-trimester screening and fetal anatomy ultrasound were both normal.&nbsp; She is taking labetalol for hypertension that was diagnosed 5 years ago.&nbsp; The patient drinks 2 cups of coffee daily and follows a strict low-carbohydrate diet.&nbsp; She does not use tobacco, alcohol, or recreational drugs.&nbsp; Prepregnancy weight was 60 kg (132.3 lb) with a BMI of 26 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The patient is a nurse at an elementary school and plans to work until her due date.&nbsp; On examination, weight is 68 kg (149.9 lb), blood pressure is 142/82 mm Hg, and fundal height is 30 cm.&nbsp; Ultrasound reveals head and femur measurements consistent with 32 weeks gestation and abdominal circumference consistent with 27 weeks.&nbsp; A normal amount of amniotic fluid and a posterior placenta are present.&nbsp; Estimated fetal weight is at the 8th percentile for gestational age.&nbsp; Which of the following is the most likely cause of this fetus&#39; condition?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31082\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Fetal growth restriction</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Symmetric</strong></p></td><td><p align=\"center\"><strong>Asymmetric</strong></p></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td colspan=\"2\"><ul><li>Ultrasonographically estimated fetal weight &lt;10th&nbsp;percentile or birth weight &lt;3rd&nbsp;percentile for gestational age</li></ul></td></tr><tr><td><p align=\"center\"><strong>Onset</strong></p></td><td><ul><li>1st trimester</li></ul></td><td><ul><li>2nd/3rd trimester</li></ul></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>Chromosomal abnormalities</li><li>Congenital infection</li></ul></td><td><ul><li>Uteroplacental insufficiency</li><li>Maternal malnutrition</li></ul></td></tr><tr><td><p align=\"center\"><strong>&nbsp;Clinical<br />features</strong></p></td><td><ul><li>Global growth lag</li></ul></td><td><ul><li>Head-sparing growth lag</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td colspan=\"2\"><ul><li>Regular nonstress testing</li><li>Weekly biophysical profiles</li><li>Serial umbilical artery Doppler sonography</li><li>Serial growth ultrasonography</li></ul></td></tr></tbody></table></div><p><strong>Fetal growth restriction (FGR)</strong> is defined as an estimated fetal <strong>weight &lt;10th percentile</strong> or birth weight &lt;3rd percentile for gestational age.&nbsp; Fetuses with growth restriction have increased risk for intrauterine demise and neonatal morbidity/mortality (eg, preterm delivery).</p><p>FGR can be characterized as either symmetric or asymmetric:</p><ul><li><p>Symmetric FGR is uniform and equal global growth impairment (eg, head, femur, abdomen) that begins in the first trimester due to an early developmental insult (eg, aneuploidy, congenital infection).</p></li><li><p>In contrast, <strong>asymmetric FGR</strong> is <strong>disproportionate</strong> growth impairment due to <strong>uteroplacental insufficiency</strong> and subsequent chronic fetal hypoxia.&nbsp; Maternal conditions, such as hypertension and pregestational diabetes mellitus, predispose to abnormal placental development that causes progressive placental dysfunction during the late <strong>second and/or third trimester</strong>.&nbsp; The fetus adapts to impaired blood flow and reduced oxygen delivery by redistributing blood to vital organs (eg, brain) and away from nonvital organs (eg, abdomen), causing a <strong>head-sparing growth</strong> pattern.</p></li></ul><p>In this patient, the fetal head is 2 weeks smaller, but the abdomen is 7 weeks smaller than expected for gestational age, indicating asymmetric FGR.&nbsp; Maternal <strong>hypertension</strong> is the most likely cause.&nbsp; Even when well controlled, hypertension can cause underdevelopment of the spiral arteries in the placenta, resulting in increased vascular resistance and reduced blood flow.</p><p><strong>(Choices A and D)</strong>&nbsp; Very high amounts of caffeine (&gt;300 mg) and severe caloric restriction (eg, eating disorder, hyperemesis gravidarum) can lead to asymmetric growth restriction.&nbsp; However, this patient (with a prepregnancy BMI of 26 kg/m<font size=\"2\"><sup>2</sup></font> and a 8 kg [17.6 lb] weight increase) has <a href=\"32799\">gained appropriate weight</a> and consumes a mild to moderate amount of caffeine (&lt;200 mg), making these unlikely causes of growth restriction.</p><p><strong>(Choice B)</strong>&nbsp; First-trimester congenital infection (eg, toxoplasmosis, syphilis, cytomegalovirus, rubella, varicella) is an early developmental insult resulting in symmetric growth restriction.&nbsp; Often, evidence of early infection is seen on fetal anatomic ultrasound (eg, intracranial calcifications, ventriculomegaly).&nbsp; This patient had a normal ultrasound, and this fetus has asymmetric growth.</p><p><strong>(Choice E)</strong>&nbsp; Chromosomal aneuploidy is a common cause of symmetric FGR.&nbsp; However, this patient had a normal first-trimester chromosomal screening and anatomy ultrasound (ie, no fetal malformations).</p><p><strong>Educational objective:</strong><br>Asymmetric fetal growth restriction (FGR) is due to second- and third-trimester placental insufficiency (eg, hypertension) that results in restricted abdominal growth that is more pronounced than the restricted head growth.&nbsp; Symmetric FGR is due to congenital disorders or first-trimester infections.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 22123,
            "topic": "Fetal growth restriction",
            "titleId": 22123,
            "title": "Fetal growth restriction",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Caffeine consumption",
                    "choiceNumber": 1,
                    "correctTaken": 610,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Congenital infection",
                    "choiceNumber": 2,
                    "correctTaken": 2992,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maternal hypertension",
                    "choiceNumber": 3,
                    "correctTaken": 8151,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Poor maternal nutrition",
                    "choiceNumber": 4,
                    "correctTaken": 4557,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Trisomy 21",
                    "choiceNumber": 5,
                    "correctTaken": 406,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30681542",
                    "mediaDataId": 0,
                    "title": "ACOG practice bulletin no. 204: fetal growth restriction.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30681542",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 260,
            "othersAvgTimeSpent": 74,
            "notes": null,
            "peopleTaken": 16716,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 49,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 260,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 20,
            "questionId": 11205,
            "questionIndex": 12355,
            "questionText": "<p>A 19-year-old woman comes to the office due to vaginal bleeding and cramping that started 2 hours ago.&nbsp; The patient has no nausea, vomiting, fever, chills, or abnormal discharge.&nbsp; Her last menstrual period was 10 weeks ago.&nbsp; She has no chronic medical conditions and takes no medications.&nbsp; The patient does not drink alcohol but smokes a pack of cigarettes daily and uses recreational drugs on occasion.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 120/70 mm Hg, and pulse is 76/min.&nbsp; BMI is 23 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; On physical examination, the abdomen is soft and nontender.&nbsp; Pelvic examination reveals a 10-week-sized, nontender uterus; a closed cervix; and a small amount of bright red blood in the vaginal vault.&nbsp; A urine pregnancy test is positive.&nbsp; A urine drug screen is positive for amphetamines.&nbsp; Ultrasound confirms a 10-week intrauterine gestation with a normal fetal heart rate.&nbsp; This patient is at risk for which of the following pregnancy complications?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T86839\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Recreational drug use in pregnancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Adolescent pregnancy</li><li>Late/intermittent prenatal care</li><li>Insufficient gestational weight gain</li></ul></td></tr><tr><td><p align=\"center\"><strong>Obstetric complications</strong></p></td><td><ul><li>Spontaneous abortion</li><li>Preterm birth</li><li>Preeclampsia</li><li>Abruptio placentae</li><li>Fetal growth restriction</li><li>Intrauterine fetal demise</li></ul></td></tr></tbody></table></div><p><strong>Recreational drug use during pregnancy</strong> is common.&nbsp; Risk factors include adolescent pregnancy, late or intermittent prenatal care, and insufficient pregnancy weight gain.&nbsp; Because recreational drug use in pregnancy is associated with an <strong>increased risk of obstetric complications</strong> and long-term fetal complications (eg, cognitive delay), <strong>all patients require screening</strong> at the initial prenatal visit.</p><p>This patient has vaginal bleeding, a closed cervix, and a viable fetus on ultrasound, a presentation consistent with a <strong>threatened abortion</strong>.&nbsp; Urine drug testing reveals <strong>amphetamine use</strong>.&nbsp; Amphetamine crosses the placenta and produces both alpha-adrenergic and beta-adrenergic effects; alpha-adrenergic stimulation leads to vasoconstriction and increased vascular resistance in placental vessels, which may explain why amphetamine use is associated with an increased risk of spontaneous abortion, preeclampsia, abruptio placentae, <strong>fetal growth restriction</strong>, preterm delivery, and <strong>intrauterine fetal demise</strong>.&nbsp; Tobacco and cocaine use in pregnancy share these complications, likely through a similar mechanism.</p><p>Pregnant patients with a positive screen for recreational drug use should be followed with serial urine drug tests and counseled regarding options for managing cessation.</p><p><strong>(Choice A)</strong>&nbsp; <a href=\"2683\">Brachial plexus injuries</a> are complications associated with <a href=\"5890\">shoulder dystocia</a>.&nbsp; The main risk factor for shoulder dystocia is fetal macrosomia due to hyperglycemia (ie, maternal diabetes mellitus).&nbsp; In contrast, amphetamine use is associated with fetal growth restriction, making brachial plexus injuries less likely.</p><p><strong>(Choice B)</strong>&nbsp; Cervical insufficiency, due to inherent or acquired cervical structural weakness, causes painless second-trimester cervical dilation and pregnancy loss.&nbsp; Risk factors include connective tissue disorders (eg, Ehlers-Danlos syndrome) and prior cervical surgery (eg, conization).</p><p><strong>(Choices D and F)</strong>&nbsp; Although amphetamines cross the placenta, they are not linked to congenital anomalies.&nbsp; <a href=\"1917\">Gastroschisis</a> is associated with first-trimester use of nonsteroidal anti-inflammatory drugs.&nbsp; Neural tube defects are associated with folic acid deficiency, which is less common since the enactment of mandatory folate fortification of enriched cereal grain products.&nbsp; Amphetamines do not increase the risk for either structural defect.</p><p><strong>(Choice E)</strong>&nbsp; Risk factors for fetal malpresentation (eg, breech) include uterine fibroids, prematurity, and multiple gestation.</p><p><strong>(Choice G)</strong>&nbsp; Polyhydramnios is associated with poorly controlled maternal diabetes mellitus and fetal anomalies that interfere with swallowing (eg, esophageal atresia).</p><p><strong>(Choice H)</strong>&nbsp; Risk factors for <a href=\"28587\">vasa previa</a> include placenta previa, multiple gestation, and in vitro fertilization.</p><p><strong>Educational objective:</strong><br>Amphetamine use in pregnancy increases the risk for spontaneous abortion, preeclampsia, abruptio placentae, fetal growth restriction, preterm delivery, and intrauterine fetal demise.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 12187,
            "topic": "Maternal substance abuse",
            "titleId": 12187,
            "title": "Maternal substance abuse",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "8",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Brachial plexus injury",
                    "choiceNumber": 1,
                    "correctTaken": 18,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cervical insufficiency",
                    "choiceNumber": 2,
                    "correctTaken": 438,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal growth restriction",
                    "choiceNumber": 3,
                    "correctTaken": 13845,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Gastroschisis",
                    "choiceNumber": 4,
                    "correctTaken": 172,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Malpresentation",
                    "choiceNumber": 5,
                    "correctTaken": 162,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Neural tube defect",
                    "choiceNumber": 6,
                    "correctTaken": 1085,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Polyhydramnios",
                    "choiceNumber": 7,
                    "correctTaken": 167,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vasa previa",
                    "choiceNumber": 8,
                    "correctTaken": 782,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25599434",
                    "mediaDataId": 0,
                    "title": "Methamphetamines and pregnancy outcomes.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25599434",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26386836",
                    "mediaDataId": 0,
                    "title": "Substance use in the perinatal period.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26386836",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 162,
            "othersAvgTimeSpent": 56,
            "notes": null,
            "peopleTaken": 16669,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 83,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 162,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 21,
            "questionId": 27302,
            "questionIndex": 117959,
            "questionText": "<p><u><strong>Patient Information</strong></u><br><strong>Age:</strong> 29 years<br><strong>Gender:</strong> F, self-identified<br><strong>Race/Ethnicity:</strong> unspecified<br><strong>Site of Care:</strong> office</p><p><u><strong>History</strong></u><br><strong>Reason for Visit/Chief Concern:</strong> establish prenatal care<br><strong>History of Present Illness:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>gravida 2 para 1</li><li>last menstrual period 12 weeks ago; previously with regular monthly menses</li></ul><p><strong>Past Medical History:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>none</li></ul><p><strong>Obstetric and Gynecologic History:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>prior term spontaneous vaginal delivery 3 years ago</li><li>history of cervical intraepithelial neoplasia 3, with cervical conization 8 months ago</li></ul><p><strong>Medications:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>prenatal vitamin</li></ul><p><strong>Allergies:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>no known drug allergies</li></ul><p><strong>Family History:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>noncontributory</li></ul><p><strong>Psychosocial History:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>no tobacco, alcohol, or recreational drugs</li></ul><p><u><strong>Physical Examination</strong></u></p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"forceleft\"><tbody><tr><td><strong>Temp</strong></td><td><strong>Pulse</strong></td><td><strong>Resp</strong></td><td><strong>BP</strong></td><td><strong>O</strong><font size=\"2\"><sub><strong>2</strong></sub></font>&nbsp;<strong>Sat</strong></td><td><strong>Ht</strong></td><td><strong>Wt</strong></td><td><strong>BMI</strong></td></tr><tr><td>36.9 C<br>(98.4 F)</td><td>83/min</td><td>18/min</td><td>124/73<br>mm Hg</td><td>99 %<br>on RA</td><td>68 cm<br>(5ft 8in)</td><td>56.7 kg<br>(125 lb)</td><td>19 kg/m<font size=\"2\"><sup>2</sup></font></td></tr></tbody></table>&nbsp;<ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>Appearance: well-appearing, no distress</li><li>HEENT: no thyromegaly</li><li>Pulmonary: clear to auscultation</li><li>Cardiac: normal rate and rhythm</li><li>Abdominal: soft, nontender, nondistended</li><li>Pelvic: cervix normal in appearance; small, mobile uterus; no adnexal masses</li></ul><p><u><strong>Diagnostic Studies</strong></u></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>Urine pregnancy test: positive</li><li>Transvaginal ultrasonography: 12-week intrauterine fetus with cardiac activity</li></ul><p><u><strong>Question:</strong></u>&nbsp; The patient&#39;s history puts her at greatest risk for which of the following complications in this pregnancy?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T108970\" style=\"overflow-x:auto;\" tid=\"78999\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Cervical excisional procedures</strong></p></td></tr><tr><td><p align=\"center\"><strong>Indications</strong></p></td><td><p>Cervical intraepithelial neoplasia grades 2 &amp; 3*</p></td></tr><tr><td><p align=\"center\"><strong>Procedure types</strong></p></td><td><ul><li>Cold knife cone</li><li>Loop electrosurgical excision procedure</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Cervical stenosis</li><li>Preterm birth</li><li>Preterm prelabor rupture of membranes</li><li>Second-trimester pregnancy loss</li></ul></td></tr><tr><td colspan=\"2\"><p>*Observation preferred for cervical intraepithelial neoplasia 2 in young women.</p></td></tr></tbody></table></div><p>This patient has a history of cervical intraepithelial neoplasia 3 and subsequently underwent a <strong>cold knife conization (CKC)</strong>, a <strong>cervical excisional procedure</strong>, for treatment 8 months ago.&nbsp; Cervical excisional procedures (eg, loop electrosurgical excision procedure, CKC) excise the entirety of the transformation zone with surrounding areas of the endocervical canal.&nbsp; Although these procedures are highly effective cervical dysplasia treatments, they have clinically significant <strong>late-developing sequelae</strong>, particularly <a href=\"4803\">CKCs</a>, which allow greater depth and access to the endocervical canal.</p><p>Specific pregnancy complications, including the following, occur because removal of the dysplastic tissue also excises normal cervical stroma and cervical glands:</p><ul><li><p>Loss of cervical stroma is thought to <strong>reduce tensile strength</strong> and cervical plasticity, which can result in either a <strong>second-trimester pregnancy loss</strong> or a <strong>preterm birth</strong>.</p></li><li><p>Loss of cervical glands reduces cervical mucus (ie, a barrier to infection), which <strong>increases the susceptibility to ascending infection</strong> and increases the risk for <strong>preterm prelabor rupture of membranes</strong> (because infection is a trigger for rupture of membranes).</p></li></ul><p>Pregnant patients with a history of CKC may undergo cervical length measurements to evaluate their risk for preterm birth.</p><p><strong>(Choice A)</strong>&nbsp; <a href=\"1056\">Abruptio placentae</a>&nbsp;is premature detachment of the placenta from the uterus prior to fetal delivery; risk factors include prior abruption, hypertension, and cocaine or tobacco use.&nbsp; This patient has none of these risk factors.</p><p><strong>(Choice B)</strong>&nbsp; Maternal risk factors for <a href=\"26805\">fetal growth restriction</a>&nbsp;include malnutrition, hypertension, and vascular disease; none of these are seen in this patient.</p><p><strong>(Choice C)</strong>&nbsp; Risk factors for gestational diabetes mellitus (GDM) include a history of GDM or glucose intolerance, family history of diabetes mellitus, and obesity, none of which are seen in this patient.</p><p><strong>(Choice D)</strong>&nbsp; Scar tissue from uterine surgeries (eg, cesarean delivery, myomectomy) alters uterine vascularity, which can lead to placental development in the lower uterine segment, thereby increasing the risk for <a href=\"4209\">placenta previa</a>.&nbsp; The cervix, however, is distinct from the lower uterine segment; therefore, cervical procedures such as CKC do not increase the risk for abnormal placentation.</p><p><strong>(Choice E)</strong>&nbsp; High-risk factors for <a href=\"8825\">preeclampsia</a>&nbsp;include prior preeclampsia, chronic kidney disease, chronic hypertension, diabetes mellitus, multiple gestation, and autoimmune disease; moderate-risk factors include nulliparity and age &#8805;35.&nbsp; This patient has none of these risk factors.</p><p><strong>Educational objective:</strong><br>Cervical excisional procedures increase the risk for preterm birth in future pregnancies due to loss of cervical stroma (ie, reduced tensile strength) and cervical glands (ie, reduced protection against infection).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 3372,
            "topic": "Cervical cancer",
            "titleId": 3372,
            "title": "Cervical cancer",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Abruptio placentae",
                    "choiceNumber": 1,
                    "correctTaken": 29,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal growth restriction",
                    "choiceNumber": 2,
                    "correctTaken": 76,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Gestational diabetes mellitus",
                    "choiceNumber": 3,
                    "correctTaken": 3,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Placenta previa",
                    "choiceNumber": 4,
                    "correctTaken": 147,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Preeclampsia",
                    "choiceNumber": 5,
                    "correctTaken": 8,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Preterm birth",
                    "choiceNumber": 6,
                    "correctTaken": 4791,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27469988",
                    "mediaDataId": 0,
                    "title": "Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27469988",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 205,
            "othersAvgTimeSpent": 52,
            "notes": null,
            "peopleTaken": 5054,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 95,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 205,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 22,
            "questionId": 15279,
            "questionIndex": 16703,
            "questionText": "<p>A 24-year-old woman, gravida 1 para 0, at 37 weeks gestation comes to the office for a routine prenatal visit.&nbsp; The patient has no concerns today.&nbsp; Her fetus is active, and she has no contractions, vaginal bleeding, or leakage of fluid.&nbsp; The patient&#39;s pregnancy was dated by a first-trimester ultrasound, and her 18-week ultrasound revealed normal fetal anatomy.&nbsp; At 26 weeks gestation, her 1-hour glucose screen was abnormal, but her 3-hour glucose tolerance test was normal.&nbsp; The patient has no medical conditions and has had no surgeries.&nbsp; Blood pressure is 112/68 mm Hg and pulse is 90/min.&nbsp; Fundal height is 42 cm and fetal heart rate is 138/min.&nbsp; Because of the uterine size-dates discrepancy, an ultrasound is performed, which reveals an intrauterine fetus in the cephalic position with an amniotic fluid index of 30 cm (normal: 8-24 cm).&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>Fundal height (ie, uterine size) is measured during second- and third-trimester prenatal visits as an indirect assessment of fetal growth and amniotic fluid volume.&nbsp; This patient&#39;s <strong>uterine size-larger-than-dates discrepancy</strong> (42 cm at 37 weeks gestation) prompted an ultrasound evaluation that reveals <strong>polyhydramnios</strong>, defined as an amniotic fluid index &#8805;24 cm or a deepest vertical pocket of &#8805;8 cm.&nbsp; Polyhydramnios occurs due to an imbalance of fluid production (ie, fetal urination) and removal (ie, fetal swallowing).&nbsp; Although some patients have an identifiable cause (eg, diabetes mellitus, fetal tracheoesophageal fistula), most cases are <strong>idiopathic</strong>, as in this patient.</p><p>Patients with polyhydramnios may have abdominal discomfort (from increased uterine size), dyspnea (due to maternal lung compression), and preterm contractions (from increased intrauterine pressure); however, most patients are asymptomatic.&nbsp; Management is based on severity, maternal symptoms, and gestational age:</p><ul><li><p>Patients with severe or symptomatic polyhydramnios at preterm gestation are at increased risk for obstetric complications, including preterm labor and preterm prelabor rupture of membranes.&nbsp; Therefore, these patients may benefit from amnioreduction (ie, amniotic fluid removal by <a href=\"6298\">amniocentesis</a>) <strong>(Choice A)</strong>.</p></li><li><p>In contrast, patients with <strong>mild</strong>, <strong>asymptomatic</strong> polyhydramnios at <strong>term gestation</strong>, such as this patient, can undergo <strong>expectant management</strong> because obstetric outcomes are unchanged by increased antenatal fetal surveillance or intervention.</p></li></ul><p><strong>(Choice B)</strong>&nbsp; Betamethasone is administered to patients at risk for preterm delivery (ie, &lt;37 weeks gestation) to reduce the risk of neonatal respiratory distress syndrome.</p><p><strong>(Choices C and F)</strong>&nbsp; In patients with mild, asymptomatic polyhydramnios, delivery planning (eg, cesarean delivery, induction of labor) is based on routine obstetric indications only (eg, nonreassuring fetal heart rate, postterm gestation).</p><p><strong>(Choice E)</strong>&nbsp; Indomethacin is a cyclooxygenase inhibitor that reduces amniotic fluid volume by decreasing prostaglandin synthesis, fetal renal blood flow, and fetal urine output.&nbsp; It is contraindicated in patients at &#8805;32 weeks gestation due to the risk of premature fetal ductus arteriosus closure.</p><p><strong>Educational objective:</strong><br>Most cases of polyhydramnios (ie, amniotic fluid index &#8805;24 cm) are idiopathic and asymptomatic.&nbsp; Patients at term gestation with mild, asymptomatic polyhydramnios are expectantly managed.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 11178,
            "topic": "Polyhydramnios",
            "titleId": 11178,
            "title": "Polyhydramnios",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amnioreduction",
                    "choiceNumber": 1,
                    "correctTaken": 2162,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Betamethasone",
                    "choiceNumber": 2,
                    "correctTaken": 661,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cesarean delivery",
                    "choiceNumber": 3,
                    "correctTaken": 1008,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Expectant management",
                    "choiceNumber": 4,
                    "correctTaken": 8120,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Indomethacin",
                    "choiceNumber": 5,
                    "correctTaken": 160,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Induction of labor",
                    "choiceNumber": 6,
                    "correctTaken": 4580,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30681545",
                    "mediaDataId": 0,
                    "title": "ACOG committee opinion no. 764: medically indicated late-preterm and early-term deliveries.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30681545",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30048635",
                    "mediaDataId": 0,
                    "title": "SMFM consult series #46: evaluation and management of polyhydramnios.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30048635",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 123,
            "othersAvgTimeSpent": 66,
            "notes": null,
            "peopleTaken": 16691,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 49,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 123,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 23,
            "questionId": 3281,
            "questionIndex": 3281,
            "questionText": "<p>A 32-year-old woman, gravida 3 para 2, at 41 weeks gestation comes to the office for a routine prenatal visit.&nbsp; She has had no contractions, vaginal bleeding, or leakage of fluid.&nbsp; Fetal movement is normal.&nbsp; The patient&#39;s pregnancy has been uncomplicated.&nbsp; An ultrasound at 18 weeks gestation showed normal fetal anatomy and a posterior placenta.&nbsp; She has no chronic medical conditions and has had no previous surgeries.&nbsp; Her other pregnancies ended in vaginal deliveries at term.&nbsp; The patient takes a daily prenatal vitamin and does not use tobacco, alcohol, or illicit drugs.&nbsp; Blood pressure is 110/80 mm Hg and pulse is 80/min.&nbsp; BMI is 28 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Fundal height is 40 cm.&nbsp; The cervix is 1 cm dilated and 10% effaced.&nbsp; Nonstress test is reactive.&nbsp; The patient would like to await spontaneous labor rather than undergo an induction.&nbsp; Delaying delivery to 42 weeks gestation in this patient increases the risk of which of the following pregnancy-related complications?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t41381\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Late-term &amp; postterm pregnancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td><ul><li>Late-term: &ge;41 weeks gestation</li><li>Post-term: &ge;42 weeks gestation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Prior postterm pregnancy</li><li>Nulliparity</li><li>Obesity</li><li>Age &ge;35</li><li>Fetal anomalies (eg, anencephaly)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Fetal/neonatal<ul style=\"list-style-type:circle;\"><li>Macrosomia</li><li>Dysmaturity syndrome</li><li>Oligohydramnios</li><li>Demise</li></ul></li><li>Maternal<ul style=\"list-style-type:circle;\"><li>Severe obstetric laceration</li><li>Cesarean delivery</li><li>Postpartum hemorrhage</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Frequent fetal monitoring (eg, nonstress test)</li><li>Delivery prior to 43 weeks gestation</li></ul></td></tr></tbody></table></div><p>This patient has a <strong>late-term pregnancy</strong>, defined as <strong>&#8805;41 weeks gestation</strong>.&nbsp; Late- and post-term (&#8805;42 weeks gestation) pregnancies are at risk of decreased placental function due to age-related placental changes (eg, infarctions, calcifications) that cause increased placental vascular resistance.&nbsp; Progressive placental dysfunction can lead to <strong>uteroplacental insufficiency</strong> and chronic fetal hypoxemia, which cause central nervous system suppression and intrauterine fetal demise.&nbsp; To prevent this suppression, blood is preferentially distributed to the brain rather than peripheral tissue.&nbsp; This redistribution can be evidenced on ultrasound as <strong>oligohydramnios</strong> (single deepest pocket &lt;2 cm or amniotic fluid index &lt;5 cm) as amniotic fluid is dependent on renal perfusion and urine production.</p><p>Because the risk of uteroplacental insufficiency increases with gestational age, patients with late- and post-term pregnancies require frequent fetal monitoring (eg, nonstress test, ultrasound for amniotic fluid volume).&nbsp; Patients with findings suggestive of uteroplacental insufficiency, such as late decelerations or oligohydramnios, require delivery to prevent <strong>intrauterine fetal demise</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Risk factors for abruptio placentae include hypertension, cocaine use, abdominal trauma, and a prior abruptio placentae.&nbsp; It is not associated with post-term pregnancy.</p><p><strong>(Choice B)</strong>&nbsp; Late- and post-term pregnancies are at risk for fetal macrosomia (weight &#8805;4.5 kg [9.9 lb]) and severe maternal obstetric lacerations.&nbsp; In contrast, low fetal birth weight (&lt;2.5 kg [5.5 lb]) typically occurs in preterm infants.</p><p><strong>(Choice D)</strong>&nbsp; Risk factors for placenta accreta include prior cesarean delivery (particularly in patients with a placenta previa in the current pregnancy) and prior uterine myomectomy.</p><p><strong>(Choice E)</strong>&nbsp; Polyhydramnios (single deepest pocket &#8805;8 cm or an amniotic fluid index of &#8805;24 cm) is associated with congenital fetal malformations (eg, esophageal atresia, anencephaly) and maternal diabetes mellitus.</p><p><strong>(Choice F)</strong>&nbsp; Risk factors for preeclampsia include extremes of maternal age (eg, &lt;18, &gt;40), nulliparity, chronic hypertension, diabetes mellitus, and renal disease.</p><p><strong>Educational objective:</strong><br>Patients with late-term (&#8805;41 weeks gestation) and post-term (&#8805;42 weeks gestation) pregnancies are at increased risk for oligohydramnios, a marker for placental insufficiency and an indication for delivery.&nbsp; They are therefore routinely evaluated for this and other markers of placental insufficiency (eg, late decelerations).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 19194,
            "topic": "Prenatal Care",
            "titleId": 19194,
            "title": "Prenatal Care",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Abruptio placentae",
                    "choiceNumber": 1,
                    "correctTaken": 3888,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Low fetal birth weight",
                    "choiceNumber": 2,
                    "correctTaken": 536,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oligohydramnios",
                    "choiceNumber": 3,
                    "correctTaken": 8599,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Placenta accreta",
                    "choiceNumber": 4,
                    "correctTaken": 663,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Polyhydramnios",
                    "choiceNumber": 5,
                    "correctTaken": 1748,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Preeclampsia",
                    "choiceNumber": 6,
                    "correctTaken": 1225,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25050770",
                    "mediaDataId": 0,
                    "title": "Practice bulletin no. 146:  management of late-term and postterm pregnancies.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25050770",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24753906",
                    "mediaDataId": 0,
                    "title": "Postterm pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24753906",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 105,
            "othersAvgTimeSpent": 57,
            "notes": null,
            "peopleTaken": 16659,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 52,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 105,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 24,
            "questionId": 11161,
            "questionIndex": 12311,
            "questionText": "<p>A 38-year-old woman, gravida 1 aborta 1, comes to the office for follow-up a week after suction curettage.&nbsp; The patient initially presented 7 weeks after her last menstrual period for an initial prenatal appointment.&nbsp; At that time, she had breast tenderness but no abdominal pain, nausea, or vaginal bleeding.&nbsp; During that visit, ultrasound revealed an empty gestational sac.&nbsp; &#946;-hCG level was 53,256 IU/L.&nbsp; The patient returned a week later and a repeat ultrasound confirmed a missed abortion.&nbsp; Suction curettage was performed and the pathological specimen from the procedure indicated a diagnosis of hydatidiform mole.&nbsp; Today, the patient has minimal bleeding but no pain, fevers, chills, or abnormal vaginal discharge.&nbsp; Blood pressure is 110/80 mm Hg and weight is 55 kg (121.3 lb).&nbsp; Pelvic examination shows minimal dark red blood in the vaginal vault and no active bleeding.&nbsp; On bimanual examination, the uterus is small and nontender.&nbsp; No adnexal masses are palpable.&nbsp; &#946;-hCG level is 1,412 IU/L.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"6070\" src=\"https://www.uworld.com/media/highresdefault/L31167.png\"  ></p><p>A complete <strong>hydatidiform mole (HM)</strong> is the result of <a href=\"3832\">abnormal fertilization</a> of an empty ovum by either two sperms or one whose genome then duplicates.&nbsp; The resulting gestation contains hypertrophic and hydropic trophoblastic villi that cause a marked elevation in the &#946;-hCG level.&nbsp; HM is a premalignant disease that can develop into <strong>gestational trophoblastic neoplasia</strong> (GTN), such as choriocarcinoma.&nbsp; &#946;-hCG is secreted by all gestational trophoblastic diseases (eg, hydatidiform mole, choriocarcinoma) and is therefore used as a marker for disease progression and/or remission.</p><p>Treatment of HM involves uterine evacuation via suction curettage and <strong>surveillance for the development of GTN</strong>.&nbsp; This surveillance relies on serial &#946;-hCG levels: after suction curettage, &#946;-hCG levels are followed weekly until they are undetectable; a plateau or increase in the &#946;-hCG level is diagnostic of GTN.&nbsp; Once the &#946;-hCG becomes undetectable on weekly measurements, monthly monitoring of &#946;-hCG levels begins.&nbsp; During the 6 months of monthly monitoring, a newly detectable &#946;-hCG level is diagnostic of GTN.</p><p>Therefore, during the surveillance period, <strong>contraception</strong> is required so that a new pregnancy (which increases &#946;-hCG levels) does not cloud the diagnosis and treatment for GTN.&nbsp; Because GTN rarely develops &gt;6 months after suction curettage for a hydatidiform mole, patients interested in attempting pregnancy may do so after 6 months of undetectable &#946;-hCG levels.</p><p><strong>(Choices A, C, and D)</strong>&nbsp; It can take as long as 8 weeks after uterine evacuation for &#946;-hCG levels to become undetectable.&nbsp; This patient&#39;s decreased &#946;-hCG level is consistent given the recent suction curettage.&nbsp; If the &#946;-hCG levels began to plateau or increase, GTN would be diagnosed.&nbsp; First-line treatment for GTN includes methotrexate (chemotherapy) or hysterectomy.&nbsp; A repeat suction curettage is not indicated in the management of gestational trophoblastic disease (eg, HM or GTN).</p><p><strong>(Choice E)</strong>&nbsp; CA-125 is a tumor marker for epithelial ovarian cancer and is not indicated in the management of gestational trophoblastic disease.</p><p><strong>Educational objective:</strong><br>Patients with hydatidiform mole (HM) are at risk for gestational trophoblastic neoplasia (GTN).&nbsp; Management of HM is by suction curettage, followed by serial &#946;-hCG levels until levels are undetectable for at least 6 months.&nbsp; Contraception is required during this surveillance period so that a new pregnancy (which also increases &#946;-hCG levels) does not interfere with the diagnosis and treatment of GTN.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 18244,
            "topic": "Gestational trophoblastic disease",
            "titleId": 18244,
            "title": "Gestational trophoblastic disease",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Chemotherapy",
                    "choiceNumber": 1,
                    "correctTaken": 402,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Contraception for at least 6 months",
                    "choiceNumber": 2,
                    "correctTaken": 3804,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hysterectomy",
                    "choiceNumber": 3,
                    "correctTaken": 61,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Repeat suction curettage",
                    "choiceNumber": 4,
                    "correctTaken": 560,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serial CA-125 levels",
                    "choiceNumber": 5,
                    "correctTaken": 275,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "179",
                    "mediaDataId": 0,
                    "title": "Hydatidiform mole",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "36286620",
                    "mediaDataId": 0,
                    "title": "Advances in diagnostics and management of gestational trophoblastic disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/36286620",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "34669197",
                    "mediaDataId": 0,
                    "title": "Diagnosis and management of gestational trophoblastic disease: 2021 update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/34669197",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 126,
            "othersAvgTimeSpent": 76,
            "notes": null,
            "peopleTaken": 5104,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 75,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 126,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 25,
            "questionId": 4198,
            "questionIndex": 4198,
            "questionText": "<p>A day-old boy is evaluated in the nursery for minimal right-hand movement.&nbsp; He was born at 39 weeks gestation by forceps-assisted, vaginal delivery to a mother with insulin-controlled gestational diabetes mellitus and obesity.&nbsp; The delivery was complicated by shoulder dystocia.&nbsp; Birth weight was 4.4 kg (9 lb 11 oz).&nbsp; Examination of the right upper extremity shows extension of the wrist, hyperextension of the metacarpophalangeal joints, and flexion of the interphalangeal joints.&nbsp; Grasp reflex is absent.&nbsp; Moro and biceps reflexes are intact.&nbsp; No crepitus is present.&nbsp; The left arm is normal.&nbsp; There is slight ptosis of the right eyelid, and the right pupil is 2.5 mm smaller than the left.&nbsp; The remainder of the examination is unremarkable.&nbsp; Which of the following is the most likely cause of this patient&#39;s presentation?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T46936\" style=\"overflow-x:auto;\" tid=\"21322\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Complications of shoulder dystocia</strong></p></td></tr><tr><td style=\"width: 30%;\"><p align=\"center\"><strong>Fractured clavicle</strong></p></td><td><ul><li>Clavicular crepitus/bony irregularity</li><li>&#8595; Moro reflex due to pain on affected side</li><li>Intact biceps &amp; grasp reflexes</li></ul></td></tr><tr><td><p align=\"center\"><strong>Fractured humerus</strong></p></td><td><ul><li>Upper arm crepitus/bony irregularity</li><li>&#8595; Moro reflex due to pain on affected side</li><li>Intact biceps &amp; grasp reflexes</li></ul></td></tr><tr><td><p align=\"center\"><strong>Erb-Duchenne palsy</strong></p></td><td><ul><li>&#8595; Moro &amp; biceps reflexes on affected side</li><li>Waiter&#39;s tip<ul style=\"list-style-type:circle;\"><li>Extended elbow</li><li>Pronated forearm</li><li>Flexed wrist &amp; fingers</li></ul></li><li>Intact grasp reflex</li></ul></td></tr><tr><td><p align=\"center\"><strong>Klumpke palsy</strong></p></td><td><ul><li>Clawhand<ul style=\"list-style-type:circle;\"><li>Extended wrist</li><li>Hyperextended metacarpophalangeal joints</li><li>Flexed interphalangeal joints</li><li>Absent grasp reflex</li></ul></li><li>Horner syndrome (ptosis, miosis)</li><li>Intact Moro &amp; biceps reflexes</li></ul></td></tr><tr><td><p align=\"center\"><strong>Perinatal asphyxia</strong></p></td><td><ul><li>Variable presentation depending on duration of hypoxia</li><li>Altered mental status (eg, irritability, lethargy), respiratory or feeding difficulties, poor tone, seizure</li></ul></td></tr></tbody></table></div><p>This infant has <a href=\"718\">Klumpke palsy</a>, a brachial plexus injury related to the <strong>shoulder dystocia</strong> during delivery.&nbsp; A <a href=\"77641\">maneuver</a>&nbsp;performed to reduce the anterior impacted shoulder is delivery of the posterior arm, which is swept anteriorly across the fetal abdomen/chest and then pulled out of the maternal vagina.&nbsp; This maneuver reduces shoulder diameter, allowing the anterior shoulder to collapse and deliver.&nbsp; However, excessive traction of the <strong>eighth cervical (C8) and first thoracic (T1) nerves</strong> during delivery of the posterior arm can result in the rare complication of hand paralysis with a <strong>clawhand</strong> appearance.&nbsp; Associated damage to the sympathetic fibers that run along C8 and T1 manifests as ipsilateral <strong>miosis</strong> and <strong>ptosis</strong> (<a href=\"719\">Horner syndrome</a>).</p><p>The prognosis depends on whether the damage was due to nerve stretching or compression as opposed to avulsion.&nbsp; Horner syndrome portends a suboptimal outcome.&nbsp; Treatment usually involves gentle massage and <strong>physical therapy to prevent contractures</strong>.&nbsp; In most cases, function returns within a few months.&nbsp; If there is no improvement by age 3-9 months, surgical intervention may be considered.</p><p><strong>(Choices A and B)</strong>&nbsp; Brachial plexus injury can sometimes accompany clavicular and humerus fractures; however, this patient does not have crepitus or bony irregularity over the clavicle or humerus, making fracture unlikely.</p><p><strong>(Choice D)</strong>&nbsp; <a href=\"724\">Erb-Duchenne palsy</a>&nbsp;is the most common type of brachial plexus injury and involves the fifth and sixth cervical nerves, leading to the waiter&#39;s tip posture.&nbsp; The affected arm may have decreased or absent Moro reflexes, but grasp reflex remains intact.</p><p><strong>(Choice E)</strong>&nbsp; Perinatal asphyxia results from compromised placental or pulmonary gas exchange.&nbsp; Severe hypoxia leads to poor perfusion and acidosis, initially in peripheral tissues followed by the brain.&nbsp; This infant has neither systemic symptoms nor encephalopathy, making perinatal asphyxia unlikely.</p><p><strong>(Choice F)</strong>&nbsp; Perinatal ischemic stroke can result in abnormal arm movement with upper motor neuron signs (eg, hyperreflexia, hypertonia).&nbsp; This infant&#39;s symptoms are isolated to the lower brachial plexus, making cerebral infarction unlikely.</p><p><strong>Educational objective:</strong><br>Klumpke palsy is a rare complication of shoulder dystocia caused by injury to the eighth cervical and first thoracic nerves.&nbsp; The presentation can include hand paralysis (ie, clawhand) and ipsilateral Horner syndrome.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 17708,
            "topic": "Brachial plexus",
            "titleId": 17708,
            "title": "Brachial plexus",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Fracture of the right clavicle",
                    "choiceNumber": 1,
                    "correctTaken": 779,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fracture of the right humerus",
                    "choiceNumber": 2,
                    "correctTaken": 56,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Injury to the eighth cervical nerve and first thoracic nerve",
                    "choiceNumber": 3,
                    "correctTaken": 2361,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Injury to the fifth and sixth cervical nerves",
                    "choiceNumber": 4,
                    "correctTaken": 1202,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perinatal asphyxia",
                    "choiceNumber": 5,
                    "correctTaken": 205,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perinatal ischemic stroke",
                    "choiceNumber": 6,
                    "correctTaken": 400,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20141905",
                    "mediaDataId": 0,
                    "title": "Current concepts in the management of brachial plexus birth palsy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20141905",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 107,
            "othersAvgTimeSpent": 88,
            "notes": null,
            "peopleTaken": 5003,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 47,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 107,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 26,
            "questionId": 2569,
            "questionIndex": 2569,
            "questionText": "<p>A 32-year-old woman, gravida 2 para 1, at 16 weeks gestation comes to the office to initiate prenatal care.&nbsp; Two months ago, the patient had an episode of cramping and vaginal bleeding; an ultrasound performed in the emergency department revealed an 8-week fetal pole with cardiac motion.&nbsp; She has had no pelvic pain or vaginal bleeding since.&nbsp; The patient has not sought routine prenatal care before today because she recently relocated to the area due to a job change.&nbsp; She had a term vaginal delivery 5 years ago and has no chronic medical conditions.&nbsp; The patient has been unable to take her prenatal vitamins consistently due to daily nausea and vomiting.&nbsp; BMI is 38 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Vital signs are normal.&nbsp; Fundal height is 17 cm.&nbsp; Results of the quadruple marker test are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td>Maternal serum alpha-fetoprotein</td><td>decreased</td></tr><tr><td>&#946;-hCG</td><td>increased</td></tr><tr><td>Unconjugated estriol</td><td>decreased</td></tr><tr><td>Inhibin A</td><td>increased</td></tr></tbody></table><p>Which of the following is the most likely cause of these laboratory results?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T80875\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"5\"><p align=\"center\"><strong>Second-trimester quadruple screening</strong></p></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><p align=\"center\"><strong>MSAFP</strong></p></td><td><p align=\"center\"><strong>&#946;-hCG</strong></p></td><td><p align=\"center\"><strong>Estriol</strong></p></td><td><p align=\"center\"><strong>Inhibin A</strong></p></td></tr><tr><td><p align=\"center\">Trisomy 18</p></td><td><p align=\"center\">&#8595;</p></td><td><p align=\"center\">&#8595;</p></td><td><p align=\"center\">&#8595;</p></td><td><p align=\"center\">Normal</p></td></tr><tr><td><p align=\"center\">Trisomy 21</p></td><td><p align=\"center\">&#8595;</p></td><td><p align=\"center\">&#8593;</p></td><td><p align=\"center\">&#8595;</p></td><td><p align=\"center\">&#8593;</p></td></tr><tr><td><p align=\"center\">Neural tube or abdominal wall defect</p></td><td><p align=\"center\">&#8593;</p></td><td><p align=\"center\">Normal</p></td><td><p align=\"center\">Normal</p></td><td><p align=\"center\">Normal</p></td></tr><tr><td colspan=\"5\"><p><strong>MSAFP</strong> = maternal serum &#945;-fetoprotein.</p></td></tr></tbody></table></div><p>The <strong>quadruple marker test</strong> screens for congenital defects and <strong>fetal aneuploidy</strong>.&nbsp; Performed in the <strong>second trimester</strong>, it measures 4 markers in the maternal serum: alpha-fetoprotein (AFP), estriol, &#946;-hCG, and inhibin A.&nbsp; Then the measurements are compared to median levels for women at the same gestational age.</p><p><strong>Trisomy 21</strong>, the cause of Down syndrome, produces a classic pattern of abnormal marker levels.</p><ul><li><p><strong>Low maternal serum AFP and unconjugated estriol</strong> levels correlate with decreased fetal levels, possibly due to suboptimal fetal tissue production or function.</p></li><li><p><strong>Increased &#946;-hCG and inhibin A</strong> are secreted by the placenta, possibly due to compensatory placental hyperfunction.</p></li></ul><p>Positive screening results require confirmation by amniocentesis in which fetal cells are obtained for karyotyping and genetic analysis.&nbsp; A fetal <strong>anatomy ultrasound</strong> is also performed to screen for fetal anomalies.</p><p><strong>(Choice A)</strong>&nbsp; Complete hydatidiform moles can elevate &#946;-hCG levels and cause hyperemesis gravidarum (eg, daily nausea/vomiting) and a uterine size-greater-than-dates discrepancy (eg, fundal height 17 cm at only 16 weeks gestation).&nbsp; However, first-trimester ultrasound would reveal the absence of an embryo/fetus and the classic snowstorm appearance corresponding to hydropic villi.&nbsp; This patient&#39;s ultrasound revealed a fetal pole with cardiac motion.</p><p><strong>(Choice B)</strong>&nbsp; First-trimester ultrasonography, like this patient&#39;s 8-week ultrasound, is accurate within a week of gestational age (ie, highly accurate method for pregnancy dating).&nbsp; In contrast, incorrect dating can occur in the absence of a first-trimester ultrasound and result in abnormal marker levels.</p><p><strong>(Choice C)</strong>&nbsp; High maternal weight (eg, BMI 38 kg/m<font size=\"2\"><sup>2</sup></font>) lowers the maternal serum concentrations of all 4 markers because increased maternal blood volume dilutes the markers, which are produced in fetal and placental tissue.</p><p><strong>(Choice D)</strong>&nbsp; Multiple-gestation pregnancies are associated with elevated AFP due to increased fetal tissue volume and fetoprotein production.&nbsp; In contrast, AFP is low in this patient, and her early ultrasound revealed a singleton pregnancy.</p><p><strong>(Choice E)</strong>&nbsp; Neural tube defects and abdominal wall defects are associated with increased maternal serum AFP levels only because the defects allow more AFP to leak into the amniotic fluid and become absorbed into maternal circulation.</p><p><strong>Educational objective:</strong><br>On the quadruple marker test, low levels of maternal serum alpha-fetoprotein (AFP) and unconjugated estriol plus elevated levels of &#946;-hCG and inhibin A may indicate trisomy 21 (Down syndrome).&nbsp; Confirmation is with amniocentesis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 12637,
            "topic": "Down syndrome",
            "titleId": 12637,
            "title": "Down syndrome",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Complete hydatidiform mole",
                    "choiceNumber": 1,
                    "correctTaken": 525,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Incorrect gestational age dating",
                    "choiceNumber": 2,
                    "correctTaken": 634,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maternal obesity",
                    "choiceNumber": 3,
                    "correctTaken": 674,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Multiple gestation",
                    "choiceNumber": 4,
                    "correctTaken": 357,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Open neural tube defect",
                    "choiceNumber": 5,
                    "correctTaken": 1169,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Trisomy 21",
                    "choiceNumber": 6,
                    "correctTaken": 13259,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "35279726",
                    "mediaDataId": 0,
                    "title": "Antenatal screening for chromosomal abnormalities.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/35279726",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "32293844",
                    "mediaDataId": 0,
                    "title": "Fetal aneuploidy: screening and diagnostic testing.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/32293844",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 142,
            "othersAvgTimeSpent": 59,
            "notes": null,
            "peopleTaken": 16618,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 80,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 142,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 27,
            "questionId": 14717,
            "questionIndex": 16135,
            "questionText": "<p>A 29-year-old woman, gravida 1 para 0, at 21 weeks gestation comes to the office for a fetal anatomy ultrasound.&nbsp; She feels well and has had no vaginal bleeding, leakage of fluid, or contractions, but she has not yet felt any fetal movement.&nbsp; The patient has no chronic medical conditions and her pregnancy has been uncomplicated.&nbsp; Vital signs are normal.&nbsp; Ultrasound reveals minimal amniotic fluid, consistent with oligohydramnios.&nbsp; A singleton male fetus is in the breech presentation.&nbsp; Fetal heart rate is 170/min.&nbsp; Fetal lungs appear hypoplastic and have no surrounding pleural fluid bilaterally.&nbsp; The fetal abdomen has a large fluid-filled mass arising from the pelvis, consistent with a distended bladder.&nbsp; Bilateral fetal kidneys are enlarged and have thin renal cortices.&nbsp; Which of the following is the most likely underlying cause of these ultrasound findings?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"756\" src=\"https://www.uworld.com/media/L14012.jpg\" ></p><p>This fetus has <strong>posterior urethral valves (PUV)</strong>, a congenital disorder commonly diagnosed on <a href=\"39075\">prenatal ultrasound</a>.&nbsp; PUV is the result of abnormal, persistent urethral folds that cause <strong>bladder outlet obstruction</strong> in males resulting in:</p><ul><li><p>urinary obstruction, leading to a dilated posterior urethra and <strong>bladder distension</strong> (eg, fluid-filled abdominal mass).&nbsp; With increasing backup of urine, <strong>hydronephrosis</strong> may develop (eg, enlarged kidneys with thin renal cortices).</p></li><li><p>decreased fetal urine output and subsequent <strong>oligohydramnios</strong>, as amniotic fluid is primarily composed of fetal urine.&nbsp; Therefore, conditions that decrease urine production or output (ie, obstruction) result in low amniotic fluid.</p></li></ul><p>Prolonged and early-onset oligohydramnios, as seen in this fetus at 21 weeks gestation, is associated with high morbidity and mortality.&nbsp; The most significant sequela is <strong>pulmonary hypoplasia</strong> (ie, neonatal respiratory syndrome) because amniotic fluid is required for fetal lung development.&nbsp; Additional complications include flat facies and limb deformities (ie, <a href=\"5036\">Potter sequence</a>).&nbsp; Treatment of PUV may include fetal surgery; however, prognosis is typically poor.</p><p><strong>(Choice A)</strong>&nbsp; Bilateral renal agenesis is also associated with oligohydramnios and hypoplastic lungs; however, ultrasound would reveal absent (rather than enlarged) kidneys and a small (rather than distended) bladder.</p><p><strong>(Choices B and G)</strong>&nbsp; Duodenal atresia and <a href=\"963\">tracheoesophageal fistula</a> cause polyhydramnios because fetuses with these anomalies cannot completely ingest, and thereby remove, amniotic fluid via the gastrointestinal tract.&nbsp; This fetus has oligohydramnios.</p><p><strong>(Choice C)</strong>&nbsp; Neuroblastoma is a common pediatric cancer that may present as an adrenal mass overlying the kidney.&nbsp; However, it is a solid (not fluid-filled) mass that typically does not cause bladder outlet obstruction.</p><p><strong>(Choice D)</strong>&nbsp; Nonimmune <a href=\"23610\">fetal hydrops</a> is due to a variety of etiologies that cause excessive fluid accumulation in fetal interstitial tissues (ie, third spacing).&nbsp; Affected fetuses typically present with polyhydramnios and effusions (eg, pericardial, pleural), rather than oligohydramnios and hypoplastic lungs with no surrounding pleural fluid.</p><p><strong>(Choice E)</strong>&nbsp; Polycystic kidney disease may result in enlarged kidneys and oligohydramnios due to abnormally functioning fetal kidneys.&nbsp; However, affected fetuses would have a small-to-normal-sized bladder due to decreased urine production (rather than obstruction).</p><p><strong>Educational objective:</strong><br>Posterior urethral valves is a congenital disorder resulting from persistent urethral folds that cause bladder outlet obstruction.&nbsp; Most cases are diagnosed via prenatal ultrasound by signs of urinary obstruction, including bladder distension and hydronephrosis.&nbsp; Significant obstruction can result in an increased risk of fetal morbidity and mortality because oligohydramnios (from decreased urine output) can cause pulmonary hypoplasia.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 21343,
            "topic": "Posterior urethral valve",
            "titleId": 21343,
            "title": "Posterior urethral valve",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bilateral renal agenesis",
                    "choiceNumber": 1,
                    "correctTaken": 1300,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Duodenal atresia",
                    "choiceNumber": 2,
                    "correctTaken": 99,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Neuroblastoma",
                    "choiceNumber": 3,
                    "correctTaken": 93,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nonimmune fetal hydrops",
                    "choiceNumber": 4,
                    "correctTaken": 649,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Polycystic kidney disease",
                    "choiceNumber": 5,
                    "correctTaken": 1466,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Posterior urethral valves",
                    "choiceNumber": 6,
                    "correctTaken": 12917,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Tracheoesophageal fistula",
                    "choiceNumber": 7,
                    "correctTaken": 260,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24524801",
                    "mediaDataId": 0,
                    "title": "Ultrasound diagnosis of fetal renal abnormalities.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24524801",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27570093",
                    "mediaDataId": 0,
                    "title": "Fetal bladder outlet obstruction: embryopathology, in utero intervention and outcome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27570093",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 83,
            "othersAvgTimeSpent": 59,
            "notes": null,
            "peopleTaken": 16784,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 77,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 83,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 28,
            "questionId": 2541,
            "questionIndex": 2541,
            "questionText": "<p>A 29-year-old woman, gravida 2 para 1, at 10 weeks gestation comes to the emergency department due to vaginal bleeding with passage of large clots and intense lower abdominal cramping.&nbsp; The bleeding began 3 hours ago, and she reports worsening dizziness on standing.&nbsp; The patient initiated prenatal care a week ago, and ultrasound at that time revealed a 9-week gestation with a normal fetal heart rate.&nbsp; Today, temperature is 37 C (98.6 F), blood pressure is 90/65 mm Hg, pulse is 110/min, and respirations are 17/min.&nbsp; Large clots of blood are evacuated from the vagina during pelvic examination, after which active bleeding from an open cervical os is noted.&nbsp; Blood type is AB, Rh negative.&nbsp; Hemoglobin is 8.0 g/dL.&nbsp; Bedside transvaginal ultrasound reveals a 9-week-sized fetus in the lower uterine segment with no cardiac activity.&nbsp; Intravenous fluids are begun.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T31136\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Spontaneous abortion</strong></p></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td><ul><li>Pregnancy loss &lt;20 weeks</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Advanced maternal age</li><li>Previous spontaneous abortion</li><li>Substance use disorder</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p><p align=\"center\"><strong>options</strong></p></td><td><ul><li>Expectant</li><li>Medical induction (misoprostol)</li><li>Suction curettage if infection or hemodynamic instability</li></ul></td></tr><tr><td><p align=\"center\"><strong>Additional</strong></p><p align=\"center\"><strong>management</strong></p></td><td><ul><li>Rho(D) immunoglobulin</li><li>Pathology examination</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Hemorrhage</li><li>Retained products of conception</li><li>Septic abortion</li><li>Uterine perforation</li><li>Intrauterine adhesions</li></ul></td></tr></tbody></table></div><p>This patient at 10 weeks gestation has heavy vaginal bleeding, cramping, a <strong>dilated cervix</strong>, and an ultrasound revealing an intrauterine gestation in the lower uterine segment (ie, no passage of products of conception through the cervical os), a presentation consistent with <strong>inevitable abortion</strong>.</p><p>Management of <a href=\"1306\">inevitable abortion</a> is dependent on patient preference and hemodynamic stability.&nbsp; Surgical management via <strong>suction curettage</strong> is indicated for <strong>symptomatic</strong> (eg, dizziness on standing) and <strong>hemodynamically unstable</strong> (eg, hypotensive, tachycardic) patients with anemia from acute blood loss.&nbsp; <a href=\"1204\">Suction curettage</a> removes the retained products of conception, allowing the uterus to fully contract around open arterial vessels, which stops the bleeding.&nbsp; In addition, this patient requires Rho(D) immunoglobulin to prevent isoimmunization from Rh incompatibility.</p><p><strong>(Choices A and C)</strong>&nbsp; Medical (eg, misoprostol) or expectant management is appropriate in hemodynamically stable patients with minimal bleeding.&nbsp; Both types of management avoid the risk for surgical complications (eg, uterine perforation, intrauterine adhesions) but typically require a longer time until treatment is completed and are therefore inappropriate for a symptomatic, bleeding patient whose condition is hemodynamically unstable.</p><p><strong>(Choice B)</strong>&nbsp; Oxytocin is not effective in stimulating uterine contractions or expelling retained products of conception during the first or second trimesters because few oxytocin receptors are in the uterus during early pregnancy.</p><p><strong>(Choice D)</strong>&nbsp; This patient&#39;s uterine bleeding will likely stop after the uterus has been evacuated.&nbsp; A hysterectomy would be indicated for persistent bleeding after suction curettage only if all other treatments (eg, uterine tamponade, uterine artery embolization) have failed.</p><p><strong>Educational objective:</strong><br>Inevitable abortion presents with heavy vaginal bleeding, cramping, and a dilated cervix without passage of gestational tissue.&nbsp; Surgical management (eg, suction curettage) is indicated for patients whose condition is hemodynamically unstable.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 17495,
            "topic": "Abortion",
            "titleId": 17495,
            "title": "Abortion",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Administration of misoprostol",
                    "choiceNumber": 1,
                    "correctTaken": 3541,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Administration of oxytocin",
                    "choiceNumber": 2,
                    "correctTaken": 1046,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Expectant management",
                    "choiceNumber": 3,
                    "correctTaken": 2698,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hysterectomy",
                    "choiceNumber": 4,
                    "correctTaken": 131,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Suction curettage",
                    "choiceNumber": 5,
                    "correctTaken": 9347,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19514696",
                    "mediaDataId": 0,
                    "title": "First trimester bleeding.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19514696",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "15863551",
                    "mediaDataId": 0,
                    "title": "Expectant, medical, or surgical management of first-trimester miscarriage: a meta analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/15863551",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 225,
            "othersAvgTimeSpent": 62,
            "notes": null,
            "peopleTaken": 16763,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 56,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 225,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 29,
            "questionId": 14265,
            "questionIndex": 15673,
            "questionText": "<p>A 24-year-old woman, gravida 1 para 0, at 28 weeks gestation comes to the office for a routine prenatal visit.&nbsp; She reports active fetal movement and has had no vaginal bleeding, leakage of fluid, or contractions.&nbsp; The patient has no chronic medical conditions and has had no prior surgery.&nbsp; She does not use tobacco, alcohol, or illicit drugs.&nbsp; At her initial visit in the first trimester, prenatal testing results were as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\"><em>Chlamydia trachomatis</em></td><td style=\"vertical-align:middle;\">positive</td></tr><tr><td style=\"vertical-align:middle;\">Hepatitis B surface antigen</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">HIV-1/2 antigen/antibody</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">Rapid plasma reagin</td><td style=\"vertical-align:middle;\">negative</td></tr></tbody></table><p>The patient and her partner were treated with azithromycin, and the patient had subsequent negative <em>C trachomatis</em> testing a month later.&nbsp; Blood pressure is 118/74 mm Hg and pulse is 90/min.&nbsp; BMI is 34 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Fundal height is 28 cm and fetal heart tones are 130/min.&nbsp; A 1-hour glucose challenge, complete blood count, and <em>C trachomatis</em> test are ordered.&nbsp; Which of the following additional screening tests are indicated for this patient at today&#39;s 28-week gestation prenatal visit?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t55779\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>High-risk sexually transmitted infection screening in pregnancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>High-risk patients</strong></p></td><td><ul><li>Age &lt;25</li><li>Prior sexually transmitted infection</li><li>High-risk sexual activity (eg, multiple partners, commercial sex work)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Required screening</strong></p></td><td><ul><li>Performed at initial prenatal visit &amp; 3rd trimester:<ul style=\"list-style-type:circle;\"><li>HIV</li><li>Syphilis</li><li>Hepatitis B &amp; C viruses</li><li>Gonorrhea</li><li><em>Chlamydia</em></li></ul></li></ul></td></tr></tbody></table></div><p>At the initial prenatal visit, all patients undergo HIV, hepatitis B virus, and syphilis screening because these <strong>sexually transmitted infections</strong> (STIs) can cause congenital infection with devastating fetal consequences, and vertical transmission is typically preventable with early identification and treatment.</p><p>In addition, patients with risk factors (ie, <strong>high-risk patients</strong>) also require gonorrhea and chlamydia screening because these infections can cause preterm prelabor rupture of membranes and neonatal infection (ie, conjunctivitis).&nbsp; These risk factors include:</p><ul><li><p><strong>Age &lt;25</strong></p></li><li><p><strong>Prior STI</strong></p></li><li><p>High-risk sexual activity (eg, multiple partners, commercial sex work)</p></li></ul><p>Because these high-risk patients have an increased risk of new STI exposure, they also require <strong>repeat screening for all STIs</strong> in the <strong>third trimester</strong>.</p><p>This high-risk patient tested positive for chlamydia in the first trimester, underwent treatment, and had negative repeat testing a month later.&nbsp; However, she requires repeat third trimester (ie, &#8805;28 weeks gestation) testing for all STIs (eg, <em>C trachomatis</em>, rapid plasma reagin assay, HIV) due to the risk of reinfection (eg, untreated or undertreated partner).</p><p><strong>(Choice A)</strong>&nbsp; Cervicovaginal fetal fibronectin (fFN) is secreted during labor and helps distinguish between preterm and false labor in patients with preterm contractions.&nbsp; However, asymptomatic patients such as this one do not undergo fFN testing due to high false-positive rates.</p><p><strong>(Choice B)</strong>&nbsp; Group B <em>Streptococcus</em> rectovaginal culture is typically collected at 36-38 weeks gestation (ie, near anticipated delivery) to identify patients at risk for neonatal transmission.&nbsp; Earlier testing is indicated in patients with risk factors for early delivery (eg, preterm labor, multiple gestation).</p><p><strong>(Choice D)</strong>&nbsp; An ultrasound for cervical length assesses the risk of preterm delivery in patients with preterm contractions, prior preterm delivery, or a shortened cervix identified on prior ultrasound.&nbsp; It is not typically performed in the third trimester due to normal cervical shortening.</p><p><strong>Educational objective:</strong><br>Sexually transmitted infections (STIs) in pregnancy can cause obstetric and fetal complications (eg, preterm prelabor rupture of membranes, congenital infection).&nbsp; Therefore, all patients undergo STI screening at the initial prenatal visit, and high-risk patients (eg, age &lt;25, prior STI) require repeat screening in the third trimester.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 15559,
            "topic": "Syphilis",
            "titleId": 15559,
            "title": "Syphilis",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cervicovaginal fetal fibronectin",
                    "choiceNumber": 1,
                    "correctTaken": 1593,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Group B <em>Streptococcus</em> rectovaginal culture",
                    "choiceNumber": 2,
                    "correctTaken": 3467,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rapid plasma reagin assay",
                    "choiceNumber": 3,
                    "correctTaken": 6352,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ultrasound for cervical length",
                    "choiceNumber": 4,
                    "correctTaken": 5240,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30193283",
                    "mediaDataId": 0,
                    "title": "Screening for syphilis infection in pregnant women: U.S. Preventive Services Task Force reaffirmation recommendation statement.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30193283",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27929270",
                    "mediaDataId": 0,
                    "title": "Sexually transmitted infections: recommendations from the U.S. Preventive Services Task Force.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27929270",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 97,
            "othersAvgTimeSpent": 60,
            "notes": null,
            "peopleTaken": 16672,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 38,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 97,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 30,
            "questionId": 11282,
            "questionIndex": 12437,
            "questionText": "<p>A 37-year-old woman, gravida 2 para 1, comes to the emergency department due to painful contractions and leakage of fluid.&nbsp; She has not received prenatal care during this pregnancy and is at 24 weeks gestation by a sure, regular last menstrual period.&nbsp; The patient has no chronic medical conditions.&nbsp; She precipitously delivers a male fetus with no cardiac activity.&nbsp; Examination of the fetus shows edematous, peeling skin.&nbsp; The scalp is edematous, but the palate appears normal and there are no dysmorphic facial features.&nbsp; The fetal abdomen is tense and fluid-filled.&nbsp; The placenta appears thickened and edematous.&nbsp; Maternal laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"width:123.95pt;\">Hemoglobin</td><td style=\"width:110.7pt;\">11.2 g/dL</td></tr><tr><td style=\"width:123.95pt;\">Blood type</td><td style=\"width:110.7pt;\">O, Rh negative</td></tr><tr><td style=\"width:123.95pt;\">Indirect Coombs test</td><td style=\"width:110.7pt;\">negative</td></tr><tr><td style=\"width:123.95pt;\">HIV-1 antibody</td><td style=\"width:110.7pt;\">negative</td></tr></tbody></table><p>Which of the following is the most likely etiology of this patient&#39;s fetal demise?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t49920\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Fetal hydrops</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>&#8593; cardiac output demand causing heart failure</li><li>&#8593; fluid movement into interstitial spaces (third spacing)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Pericardial effusion</li><li>Pleural effusion</li><li>Ascites</li><li>Skin edema</li><li>Placental edema</li><li>Polyhydramnios</li></ul></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>Immune<ul style=\"list-style-type:circle;\"><li>Rh(D) alloimmunization</li></ul></li><li>Nonimmune<ul style=\"list-style-type:circle;\"><li>Parvovirus B19 infection</li><li>Fetal aneuploidy</li><li>Cardiovascular abnormalities</li><li>Thalassemia (eg, hemoglobin Barts)</li></ul></li></ul></td></tr></tbody></table></div><p>This fetal demise is most likely due to nonimmune <strong>hydrops fetalis</strong> (<a href=\"23610\">fetal hydrops</a>), a sequela&nbsp;of high-output fetal heart failure characterized by excessive fluid accumulation in interstitial spaces.&nbsp; The most common infectious etiology of hydrops fetalis is maternal parvovirus B19 infection.</p><p>Most adults with <strong>parvovirus B19 infection</strong> are asymptomatic; however, parvovirus B19 during pregnancy can have devastating fetal consequences due to viral cytotoxicity to fetal erythrocyte precursors.&nbsp; With increasingly <strong>severe fetal anemia</strong>, the fetal heart tries to compensate for hypoxemia by increasing cardiac output.&nbsp; However, eventually it cannot compensate, and <strong>high-output fetal heart failure</strong> develops.&nbsp; As with other cases of heart failure, fetuses develop third spacing of fluid, resulting in <strong>ascites</strong> (ie, tense fluid-filled abdomen) and <strong>generalized skin edema</strong> (and subsequent peeling).&nbsp; Other clinical features include pleural or pericardial effusions and <strong>placental edema</strong>.</p><p>Fetuses with hydrops fetalis are at high risk for <strong>fetal demise</strong>; this risk increases with infection acquired at earlier gestational ages.&nbsp; Due to this risk, patients with fetal hydrops undergo serial ultrasounds and possible early delivery.</p><p><strong>(Choices A and C)</strong>&nbsp; Both fetal aneuploidy (eg, trisomy 18) and <a href=\"757\">fetal alcohol spectrum disorder</a> (ie, chronic maternal alcohol use) can have associated congenital cardiac defects (eg, atrioventricular septal defect) that can lead to heart failure and hydrops fetalis.&nbsp; However, these fetuses are typically growth-restricted and have limb abnormalities (eg, shortened long bones, clubfoot) or dysmorphic facial features (eg, hypoplastic midface, flattened nasal bridge).&nbsp; Parvovirus B19 infection is not associated with bony or facial dysmorphic features.</p><p><strong>(Choice B)</strong>&nbsp; Congenital hypothyroidism can cause swollen, edematous skin (ie, myxedema) due to glycosaminoglycan deposits in the dermis.&nbsp; However, it does not cause ascites or placental edema, making this diagnosis unlikely.</p><p><strong>(Choice E)</strong>&nbsp; <a href=\"1151\">Rh(D) alloimmunization</a> occurs when Rh(D)-negative mothers develop anti-D antibodies from delivering an Rh(D)-positive infant.&nbsp; In subsequent pregnancies, existing maternal anti-D antibodies attack Rh(D)-positive fetal erythrocytes, causing severe anemia and fetal hydrops.&nbsp; Although this patient is Rh(D)-negative, her antibody screen is negative, making this diagnosis unlikely.</p><p><strong>Educational objective</strong>:<br>Parvovirus B19 infection in pregnancy can cause severe fetal anemia due to viral cytotoxicity to fetal erythrocyte precursors.&nbsp; Fetal anemia increases cardiac output, which can lead to high-output fetal heart failure, subsequent hydrops fetalis (eg, skin edema, ascites), and possible fetal demise.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 13609,
            "topic": "Parvovirus",
            "titleId": 13609,
            "title": "Parvovirus",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Chronic maternal alcohol use",
                    "choiceNumber": 1,
                    "correctTaken": 198,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Congenital hypothyroidism",
                    "choiceNumber": 2,
                    "correctTaken": 440,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal aneuploidy",
                    "choiceNumber": 3,
                    "correctTaken": 624,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Parvovirus B19 infection",
                    "choiceNumber": 4,
                    "correctTaken": 10655,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rh(D) alloimmunization",
                    "choiceNumber": 5,
                    "correctTaken": 4960,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "689",
                    "mediaDataId": 0,
                    "title": "Hydrops fetalis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29096233",
                    "mediaDataId": 0,
                    "title": "Parvovirus B19 infection in pregnancy-awareness and opportunities.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29096233",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28398685",
                    "mediaDataId": 0,
                    "title": "Parvovirus B19 infection during pregnancy and risks to the fetus.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28398685",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 164,
            "othersAvgTimeSpent": 63,
            "notes": null,
            "peopleTaken": 16877,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 164,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 31,
            "questionId": 15070,
            "questionIndex": 16494,
            "questionText": "<p>A 23-year-old woman, gravida 1 para 0, comes to the office for an initial prenatal visit.&nbsp; She had a positive home pregnancy test 2 weeks ago and started taking a daily prenatal vitamin at that time.&nbsp; The patient had some light vaginal bleeding 3 weeks ago, which has resolved.&nbsp; She has had no nausea, vomiting, or pelvic pain.&nbsp; The patient was diagnosed with type 1 diabetes mellitus at age 5 and has an insulin pump.&nbsp; She has no other chronic medical conditions.&nbsp; Blood pressure is 120/74 mm Hg and pulse is 80/min.&nbsp; BMI is 22 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Pelvic examination shows an enlarged uterus and a closed cervix.&nbsp; Ultrasound shows a twin intrauterine gestation; both twins measure at 7 weeks gestation and have normal heart rates.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hemoglobin</td><td style=\"vertical-align:middle;\">12.4 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">Platelets</td><td style=\"vertical-align:middle;\">260,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Hemoglobin A1c</td><td style=\"vertical-align:middle;\">8.4%</td></tr><tr><td style=\"vertical-align:middle;\">TSH</td><td style=\"vertical-align:middle;\">1.8 &micro;U/mL</td></tr></tbody></table><p>Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t40818\"><table class=\"table-default-style table-header-footer-style\" style=\"width:614px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Preeclampsia</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Nulliparity</li><li>Obesity</li><li>Preexisting medical condition (eg, SLE, chronic hypertension)</li><li>Multiple gestation</li><li>Advanced maternal age</li></ul></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td><ul><li>New-onset hypertension* (SBP &ge;140 or DBP &ge;90&nbsp;mm&nbsp;Hg)<br />at &ge;20&nbsp;weeks</li></ul><p style=\"margin-left:.25in;\">&nbsp; &nbsp; &nbsp;AND</p><ul><li>Proteinuria OR signs/symptoms of other end-organ damage</li></ul></td></tr><tr><td><p align=\"center\"><strong>Severe features</strong></p></td><td><ul><li>Severe-range hypertension (SBP &ge;160 or DBP &ge;110&nbsp;mm&nbsp;Hg)</li><li>Platelets &lt;100,000/mm<sup>3</sup></li><li>Creatinine &gt;1.1 mg/dL or 2x normal</li><li>Elevated transaminases &gt;2x upper limit of normal</li><li>Pulmonary edema</li><li>Vision&nbsp;or cerebral symptoms (eg, headache)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>&lt;37 weeks &amp; no severe features: expectant</li><li>&ge;37 weeks (or &ge;34&nbsp;weeks with severe features): delivery</li><li>Severe-range blood pressure: IV labetalol, IV hydralazine,<br />PO nifedipine</li><li>Seizure prophylaxis: magnesium sulfate</li></ul></td></tr><tr><td colspan=\"2\"><p>*On 2 measurements &ge;4 hr apart.</p><p><strong>DBP</strong>&nbsp;=&nbsp;diastolic blood pressure; <strong>IV</strong>&nbsp;=&nbsp;intravenous; <strong>PO</strong>&nbsp;=&nbsp;by mouth; <strong>SBP</strong>&nbsp;=&nbsp;systolic blood pressure; <strong>SLE</strong>&nbsp;=&nbsp;systemic lupus erythematosus.</p></td></tr></tbody></table></div><p>Patients with <strong>type 1 diabetes mellitus (T1DM)</strong> are at risk for <strong>diabetic nephropathy</strong> (eg, proteinuria) and <strong>vascular disease</strong> (eg, hypertension), which are independent risk factors for preeclampsia (hypertension of pregnancy with associated proteinuria and/or signs of end-organ damage).&nbsp; Therefore, T1DM is one of several conditions that <strong>increases the risk for preeclampsia</strong>; others include chronic hypertension, systemic lupus erythematosus, and <strong>multiple gestation</strong> (eg, twins).&nbsp; Patients at high risk for preeclampsia are prescribed daily low-dose aspirin beginning at 12 weeks gestation.</p><p>High-risk patients also require a <strong>24-hour urine collection for total protein</strong> at the <strong>initial prenatal visit</strong> to establish a baseline (prepregnancy) proteinuria assessment.&nbsp; The ability to evaluate changes in proteinuria levels helps determine whether blood pressure (BP) elevations later in pregnancy are due to gestational hypertension or preeclampsia, which affects antepartum management and delivery timing:</p><ul><li><p>Patients with gestational hypertension have BP elevations with no significant changes in proteinuria.&nbsp; These individuals are typically treated as outpatients and delivered at 37-39 weeks gestation.</p></li><li><p>In contrast, patients with preeclampsia typically have BP elevations and worsening proteinuria.&nbsp; These individuals may require inpatient care and preterm delivery (&lt;37 weeks gestation).</p></li></ul><p>A 24-hour urine collection also identifies patients with nephrotic-range proteinuria (&gt;3.5 g/day), who are at risk for thromboembolism and require anticoagulation during pregnancy and postpartum.</p><p><strong>(Choice B)</strong>&nbsp; Cerclage placement decreases preterm delivery risk in patients with a short cervix (&#8804;2.5 cm) on ultrasound or those with a prior preterm delivery due to cervical insufficiency (ie, painless cervical dilation).</p><p><strong>(Choice C)</strong>&nbsp; Hemoglobin electrophoresis is indicated for patients with anemia (ie, hemoglobin &lt;11 g/dL in the first trimester) to evaluate for hemoglobinopathies (eg, sickle cell trait, thalassemia).&nbsp; This patient&#39;s hemoglobin level is normal.</p><p><strong>(Choice D)</strong>&nbsp; Progesterone therapy (eg, intramuscular, vaginal) is offered to patients with a prior spontaneous preterm delivery.&nbsp; Although multiple gestations are at increased risk for preterm delivery, progesterone therapy is not routinely recommended; it does not improve outcomes in patients without a prior preterm birth.&nbsp; This is the patient&#39;s first pregnancy.</p><p><strong>(Choice E)</strong>&nbsp; Quantitative &#946;-hCG levels are measured in a pregnancy of unknown location (ie, suspected ectopic pregnancy) or gestational trophoblastic disease (eg, hydatidiform mole) to aid diagnosis and treatment.&nbsp; &#946;-hCG levels do not affect management in a viable intrauterine pregnancy (singleton or multiple gestation) on ultrasound.</p><p><strong>Educational objective:</strong><br>In patients at high risk for preeclampsia (eg, type 1 diabetes mellitus, multiple gestation), a 24-hour urine collection for total protein at the initial prenatal visit establishes baseline renal function and dictates management (ie, delivery timing) if hypertension and/or worsening proteinuria develops later in pregnancy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4219,
            "topic": "Preeclampsia",
            "titleId": 4219,
            "title": "Preeclampsia",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "24-hour urine collection for total protein",
                    "choiceNumber": 1,
                    "correctTaken": 8048,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cerclage placement",
                    "choiceNumber": 2,
                    "correctTaken": 712,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hemoglobin electrophoresis",
                    "choiceNumber": 3,
                    "correctTaken": 1196,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Progesterone therapy",
                    "choiceNumber": 4,
                    "correctTaken": 2640,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Quantitative &#946;-hCG level",
                    "choiceNumber": 5,
                    "correctTaken": 4162,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28574296",
                    "mediaDataId": 0,
                    "title": "Prediction of preeclampsia in type 1 diabetes in early pregnancy by clinical predictors: a systematic review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28574296",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28975446",
                    "mediaDataId": 0,
                    "title": "Determinants of preeclampsia in women with type 1 diabetes.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28975446",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29939936",
                    "mediaDataId": 0,
                    "title": "ACOG committee opinion no. 743 summary: low-dose aspirin use during pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29939936",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 126,
            "othersAvgTimeSpent": 77,
            "notes": null,
            "peopleTaken": 16758,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 126,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 32,
            "questionId": 15737,
            "questionIndex": 17174,
            "questionText": "<p>A 33-year-old woman, gravida 3 para 0 aborta 2, at 28 weeks gestation comes to the office for a routine prenatal visit.&nbsp; The patient has had no contractions, vaginal bleeding, or leakage of fluid.&nbsp; Fetal movement is normal.&nbsp; Her pregnancy is complicated by type 1 diabetes mellitus that has become increasingly difficult to control with her insulin regimen.&nbsp; During the past month, most of the patient&#39;s postprandial blood glucose levels have been above 200 mg/dL.&nbsp; An anatomy ultrasound at 20 weeks gestation was normal; a follow-up growth ultrasound at 24 weeks gestation was at the 30th percentile.&nbsp; Blood pressure is 124/82 mm Hg and pulse is 88/min.&nbsp; Fundal height is 24 cm.&nbsp; Nonstress test is reactive and reassuring.&nbsp; Ultrasound reveals a cephalic fetus measuring at the 4th percentile for gestational age and an amniotic fluid index of 3 cm (normal: &gt;5 cm).&nbsp; Which of the following is the best next step in management?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient has <strong>fetal growth restriction</strong> (FGR), an estimated fetal weight at &lt;10th percentile for gestational age.&nbsp; FGR can be a complication of <strong>maternal vascular disease</strong> (eg, type 1 diabetes mellitus, chronic hypertension), which causes chronic placental vasoconstriction and ischemia with resultant <strong>uteroplacental insufficiency</strong>.&nbsp; As uteroplacental insufficiency worsens (ie, placental perfusion decreases), fetal oxygenation and nutrition also decrease.&nbsp; In response, fetal growth slows and blood is preferentially shunted from the fetal kidneys to the brain, causing FGR and associated <strong>oligohydramnios</strong> (ie, amniotic fluid index &#8804;5 cm), as seen in this patient.</p><p>Patients with FGR have a high risk for <strong>intrauterine fetal demise</strong> and require an immediate <strong>umbilical artery Doppler ultrasound</strong> to assess placental perfusion <strong>(Choice D)</strong>.&nbsp; This test measures intravascular flow and resistance in the umbilical artery, with increasing resistance indicating decreasing placental perfusion and worsening fetal hypoxia.&nbsp; These measurements are used to identify patients who require <strong>urgent delivery</strong> to minimize the risk of fetal demise.</p><p><strong>(Choice A)</strong>&nbsp; Cervical nucleic acid amplification testing for <em>Neisseria gonorrhoeae</em> and <em>Chlamydia trachomatis</em> is performed at the initial prenatal visit to prevent neonatal infection; however, neither organism causes FGR.&nbsp; In addition, repeat third-trimester testing is indicated only in high-risk patients (eg, age &lt;25).</p><p><strong>(Choice B)</strong>&nbsp; Fetal aneuploidy (eg, trisomy 21) can cause FGR and oligohydramnios; however, presentation is typically at an earlier gestation.&nbsp; This patient&#39;s anatomy ultrasound at 20 weeks gestation was normal, making this diagnosis unlikely.</p><p><strong>(Choice C)</strong>&nbsp; Fetal fibronectin testing determines the risk of preterm delivery in patients with preterm contractions.&nbsp; This patient has had no contractions.</p><p><strong>Educational objective:</strong><br>Maternal vascular disease (eg, type 1 diabetes mellitus) can cause uteroplacental insufficiency, which typically presents with fetal growth restriction (FGR) and oligohydramnios.&nbsp; Due to the high risk of intrauterine fetal demise, patients with FGR require umbilical artery Doppler ultrasound to assess placental perfusion and the need for urgent delivery.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 21778,
            "topic": "Oligohydramnios",
            "titleId": 21778,
            "title": "Oligohydramnios",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cervical nucleic acid amplification testing",
                    "choiceNumber": 1,
                    "correctTaken": 297,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal aneuploidy testing",
                    "choiceNumber": 2,
                    "correctTaken": 2154,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal fibronectin testing",
                    "choiceNumber": 3,
                    "correctTaken": 1345,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Repeat ultrasound in 2 weeks",
                    "choiceNumber": 4,
                    "correctTaken": 1370,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Umbilical artery Doppler ultrasound",
                    "choiceNumber": 5,
                    "correctTaken": 11467,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30681542",
                    "mediaDataId": 0,
                    "title": "ACOG practice bulletin no. 204: fetal growth restriction.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30681542",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29019748",
                    "mediaDataId": 0,
                    "title": "Doppler US in the evaluation of fetal growth and perinatal health.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29019748",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22464066",
                    "mediaDataId": 0,
                    "title": "Doppler assessment of the fetus with intrauterine growth restriction.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22464066",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 117,
            "othersAvgTimeSpent": 69,
            "notes": null,
            "peopleTaken": 16633,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 69,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 117,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 33,
            "questionId": 11095,
            "questionIndex": 12237,
            "questionText": "<p>A 41-year-old woman comes to the emergency department due to heavy vaginal bleeding.&nbsp; Her last normal menstrual period was 4 months ago, but she has had irregular spotting since.&nbsp; Earlier today, the patient began to have increasingly heavy vaginal bleeding with passage of small clots and pelvic pain.&nbsp; She also has had increasing hot flashes, night sweats, and palpitations over the past 3 weeks but no chest pain, shortness of breath, or orthopnea.&nbsp; The patient had a Roux-en-Y gastric bypass 7 years ago and has lost 45 kg (99 lb).&nbsp; She is sexually active and was treated for pelvic inflammatory disease 6 months ago.&nbsp; Temperature is 37.7 C (99.9 F), blood pressure is 150/90 mm Hg, and pulse is 118/min.&nbsp; BMI is 35.00 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination shows the patient to be anxious.&nbsp; The skin is warm and smooth.&nbsp; Cardiac examination reveals tachycardia but a regular rhythm.&nbsp; The lungs are clear to auscultation bilaterally.&nbsp; Pelvic examination shows a moderate amount of blood in the vaginal vault and a closed cervix.&nbsp; Bimanual examination reveals an enlarged uterus at the umbilicus.&nbsp; A fetal heartbeat is unable to be identified by Doppler.&nbsp; TSH is 0.1 &micro;U/mL.&nbsp; Serum &#946;-hCG level is elevated.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31152\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hydatidiform mole </strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation </strong></p></td><td><ul><li>Abnormal vaginal bleeding &plusmn;&nbsp;hydropic tissue</li><li>Uterine enlargement &gt; gestational age</li><li>Abnormally elevated &beta;-hCG levels</li><li>Theca lutein ovarian cysts</li><li>Hyperemesis gravidarum</li><li>Preeclampsia with severe features &nbsp;</li><li>Hyperthyroidism</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk factors </strong></p></td><td><ul><li>Extremes of maternal age</li><li>History of hydatidiform mole</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis </strong></p></td><td><ul><li>&quot;Snowstorm&quot; appearance on ultrasonography</li><li>Quantitative serum &beta;-hCG</li><li>Histologic evaluation of uterine contents</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management </strong></p></td><td><ul><li>Dilation &amp; suction curettage</li><li>Serial serum &beta;-hCG post evacuation</li><li>Contraception for 6 months</li></ul></td></tr></tbody></table></div><p>This patient&#39;s presentation of <strong>heavy vaginal bleeding</strong> (due to passage of hydropic villi), overt hyperthyroidism, elevated &#946;-hCG, and an <strong>enlarged uterus</strong> is concerning for a <strong>hydatidiform mole</strong> (HM).&nbsp; Risk factors for HM include vitamin A deficiency (eg, Roux-en-Y surgery) and extremes of maternal age.&nbsp; Patients age &gt;40 with HM are also at risk for more severe complications.</p><p>HM is a nonviable, abnormal gestation comprising hypertrophic and hydropic placental trophoblastic villi.&nbsp; The trophoblastic hypertrophy leads to markedly elevated hCG levels.&nbsp; Because hCG (both alpha and beta subunits) and TSH have a similar structure, elevations in hCG can mimic TSH and cause an increase in triiodothyronine (T3) and thyroxine (T4) concentrations.&nbsp; The <strong>markedly elevated hCG</strong> levels associated with HM can therefore cause <strong>overt hyperthyroidism</strong> (eg, hot flashes, tachycardia, smooth warm skin, low TSH), as seen in this patient.&nbsp; These complications resolve after treatment as the hCG level decreases and the T3 and T4 levels normalize.</p><p><strong>(Choice A)</strong>&nbsp; An ectopic pregnancy typically presents with unilateral pelvic pain and vaginal bleeding.&nbsp; Because it is extrauterine in location, an ectopic pregnancy is not associated with an enlarged uterus.&nbsp; In addition, there is no association with hyperthyroidism.</p><p><strong>(Choice B)</strong>&nbsp; Endometrial cancer can present with abnormal vaginal bleeding and mild uterine enlargement, but there is no association between endometrial cancer and an elevated hCG level or hyperthyroid state.</p><p><strong>(Choice D)</strong>&nbsp; An inevitable abortion presents with vaginal bleeding and a dilated cervix.&nbsp; This patient&#39;s cervix is closed, and inevitable abortions typically occur in the first trimester, which would not cause a uterine fundal height equivalent to 16 weeks gestation (eg, 4 cm below the umbilicus).</p><p><strong>(Choice E)</strong>&nbsp; <a href=\"18923\">Sarcoma botryoides</a> (eg, embryonal rhabdomyosarcoma) typically presents in infancy and early childhood as nonfriable nodules protruding from the vagina that look like a cluster of grapes.&nbsp; hCG is negative in these patients.</p><p><strong>(Choice F)</strong>&nbsp; Struma ovarii, an ovarian germ cell tumor comprising &gt;50% mature thyroid tissue, can secrete thyroid hormone and cause hyperthyroidism.&nbsp; However, patients typically have an ovarian mass, not uterine enlargement.&nbsp; In addition, &#946;-hCG levels are not elevated.</p><p><strong>Educational objective:</strong><br>A hydatidiform mole, a type of gestational trophoblastic disease, can present with vaginal bleeding, overt hyperthyroidism, and a markedly elevated hCG level.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 18244,
            "topic": "Gestational trophoblastic disease",
            "titleId": 18244,
            "title": "Gestational trophoblastic disease",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Ectopic pregnancy",
                    "choiceNumber": 1,
                    "correctTaken": 527,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometrial cancer",
                    "choiceNumber": 2,
                    "correctTaken": 47,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hydatidiform mole",
                    "choiceNumber": 3,
                    "correctTaken": 2420,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inevitable abortion",
                    "choiceNumber": 4,
                    "correctTaken": 880,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sarcoma botryoides",
                    "choiceNumber": 5,
                    "correctTaken": 45,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Struma ovarii",
                    "choiceNumber": 6,
                    "correctTaken": 1205,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26556906",
                    "mediaDataId": 0,
                    "title": "Gestational trophoblastic disorders: an update in 2015.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26556906",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 187,
            "othersAvgTimeSpent": 127,
            "notes": null,
            "peopleTaken": 5124,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 47,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 187,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 34,
            "questionId": 12859,
            "questionIndex": 14166,
            "questionText": "<p>A 32-year-old woman, gravida 2 para 0 aborta 1, at 29 weeks gestation comes to the office for a prenatal visit.&nbsp; She has had no vaginal bleeding or contractions.&nbsp; Fetal movement is normal.&nbsp; The pregnancy is dated by an 8-week ultrasound because the patient was unsure of her last menstrual period.&nbsp; Ultrasound at that time showed a 2-cm, pedunculated fibroid at the fundus but was otherwise normal.&nbsp; Repeat ultrasound at 20 weeks gestation showed no fetal abnormalities; the fibroid again measured 2 cm.&nbsp; The patient has no chronic medical conditions.&nbsp; Laboratory results at 28 weeks gestation are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hemoglobin</td><td style=\"vertical-align:middle;\">11 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">Blood type</td><td style=\"vertical-align:middle;\">O negative</td></tr><tr><td style=\"vertical-align:middle;\">Anti-D antibody screen</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">1-hr glucose challenge test</td><td style=\"vertical-align:middle;\">203 mg/dL</td></tr></tbody></table><p>Vital signs at today&#39;s visit are normal.&nbsp; Fundal height is 35 cm.&nbsp; Fetal heart tones are 155/min.&nbsp; Which of the following is the most likely underlying cause of this patient&#39;s uterine size&ndash;dates discrepancy?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t34535\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Amniotic fluid index</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Oligohydramnios (AFI &lt;5 cm)</strong></p></td><td><p align=\"center\"><strong>Polyhydramnios (AFI &#8805;24 cm)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Causes</strong></p></td><td><ul><li>Preeclampsia</li><li>Abruptio placentae</li><li>Uteroplacental insufficiency</li><li>Renal anomalies</li><li>NSAIDs</li></ul></td><td><ul><li>Esophageal/duodenal atresia</li><li>Anencephaly</li><li>Multiple gestation</li><li>Congenital infection</li><li>Diabetes mellitus</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Meconium aspiration</li><li>Preterm delivery</li><li>Umbilical cord compression</li></ul></td><td><ul><li>Fetal malpresentation</li><li>Umbilical cord prolapse</li><li>Preterm labor</li><li>Preterm prelabor rupture of membranes</li></ul></td></tr><tr><td colspan=\"3\"><p style=\"margin-left:.1in;\"><strong>AFI</strong> = amniotic fluid index;<strong> NSAIDs</strong> = nonsteroidal anti-inflammatory drugs.</p></td></tr></tbody></table></div><p>This patient at 29 weeks gestation whose fundal height is 35 cm has a <strong>uterine size&ndash;dates discrepancy</strong>.&nbsp; Fundal height (ie, uterine size) is measured during routine prenatal visits in the second and third trimesters as an indirect assessment of fetal growth and amniotic fluid volume.&nbsp; After 20 weeks gestation, fundal height in centimeters should directly correlate to gestational age in weeks with a small variation (eg, &plusmn;2-3 cm); therefore, this patient&#39;s 6-cm uterine size&ndash;dates discrepancy (35 &#8722; 29 = 6 cm) is abnormal <strong>(Choice C)</strong>.</p><p>In this patient, who has a 1-hour glucose challenge test (GCT) of &#8805;200 mg/dL, the most likely cause of a uterine size&ndash;dates discrepancy is <strong>gestational diabetes mellitus (GDM)</strong>.&nbsp; A presumptive diagnosis of GDM can be made with a very elevated 50-g 1-hour GCT (eg, &#8805;200 mg/dL) or confirmed with a 100-g <a href=\"5083\">3-hour GTT</a>.</p><p>GDM causes a <strong>uterine size&ndash;greater-than-dates</strong> discrepancy by the following mechanisms:</p><ul><li>Excess maternal blood glucose crosses the placenta, causing fetal hyperglycemia and increased production of insulin and insulin-like growth factor.&nbsp; This promotes fetal growth and fat deposition, resulting in <strong>fetal macrosomia</strong>.</li><li>Fetal hyperglycemia induces osmotic diuresis and polyuria, which increase amniotic fluid volume, resulting in <strong>polyhydramnios</strong>.</li></ul><p>A uterine size&ndash;dates discrepancy requires further evaluation with ultrasound to measure fetal growth and amniotic fluid volume.</p><p><strong>(Choice B)</strong>&nbsp; Incorrect pregnancy dating is a common cause of uterine size&ndash;dates discrepancies.&nbsp; However, this patient&#39;s pregnancy is dated by an early first-trimester ultrasound, which is the most precise method (ie, within 5-7 days) for establishing gestational age.</p><p><strong>(Choice D)</strong>&nbsp; Rh alloimmunization can cause <a href=\"23610\">hydrops fetalis</a> with associated polyhydramnios and subsequent uterine enlargement.&nbsp; Although this patient is Rh negative and therefore at risk for Rh alloimmunization, her anti-D antibody screening is negative, making this diagnosis unlikely.</p><p><strong>(Choice E)</strong>&nbsp; A large uterine leiomyoma (ie, <a href=\"4394\">fibroid</a>) may increase fundal height measurement; however, a small (eg, 2-cm) fibroid is unlikely to account for such a large uterine size&ndash;dates discrepancy.&nbsp; Although fibroids can change size during pregnancy, they typically grow in the first trimester, and the majority (&gt;50%) remain stable in size.</p><p><strong>Educational objective:</strong><br>A uterine size&ndash;dates discrepancy exists when the fundal height measures larger or smaller than expected for gestational age.&nbsp; Gestational diabetes mellitus causes a uterine size&ndash;greater-than-dates discrepancy by promoting fetal macrosomia and/or increased amniotic fluid volumes (ie, polyhydramnios).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 11178,
            "topic": "Polyhydramnios",
            "titleId": 11178,
            "title": "Polyhydramnios",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Gestational diabetes mellitus",
                    "choiceNumber": 1,
                    "correctTaken": 12115,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Incorrect pregnancy dating",
                    "choiceNumber": 2,
                    "correctTaken": 1962,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal fundal height variation",
                    "choiceNumber": 3,
                    "correctTaken": 330,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rh alloimmunization",
                    "choiceNumber": 4,
                    "correctTaken": 134,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine leiomyoma",
                    "choiceNumber": 5,
                    "correctTaken": 2000,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24729436",
                    "mediaDataId": 0,
                    "title": "Etiology and perinatal outcome of polyhydramnios.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24729436",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24771905",
                    "mediaDataId": 0,
                    "title": "Polyhydramnios: causes, diagnosis and therapy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24771905",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 90,
            "othersAvgTimeSpent": 64,
            "notes": null,
            "peopleTaken": 16541,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 73,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 90,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 35,
            "questionId": 22001,
            "questionIndex": 105851,
            "questionText": "<p>A 29-year-old woman, gravida 1 para 1, comes to the office for a preconception visit.&nbsp; Two years ago, the patient had a healthy baby following an uncomplicated spontaneous vaginal delivery at term.&nbsp; However, several days after the delivery, the patient was readmitted to the hospital with significant dyspnea, orthopnea, and lower extremity edema.&nbsp; She was diagnosed with peripartum cardiomyopathy, and an echocardiogram at that time revealed a left ventricular ejection fraction of 21%.&nbsp; Given the severity of her cardiomyopathy, she was told she should not carry another pregnancy because it would be detrimental to her health.&nbsp; However, in the past 2 years she has seen improvement in her symptoms, and her walking and exercise tolerance has increased.&nbsp; Her most recent echocardiograms have consistently shown a left ventricular ejection fraction of 28%.&nbsp; Because of her symptom improvement, the patient would like to attempt another pregnancy.&nbsp; Which of the following is the most appropriate response to this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T80509\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Absolute contraindications to pregnancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Conditions in which pregnancy is contraindicated</strong></p></td><td><ul><li>Pulmonary arterial hypertension</li><li>Peripartum cardiomyopathy with residual LV dysfunction</li><li>Heart failure with LVEF &lt;30%</li><li>Severe coarctation</li><li>Severe mitral stenosis</li><li>Severe symptomatic aortic stenosis</li><li>Severe aortic dilation (eg, Marfan syndrome)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Recommend against pregnancy at preconception counseling visit</li><li>If pregnant, discuss abortion; if abortion declined, regular cardiology follow-up</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>LV</strong> = left ventricle; <strong>LVEF</strong> = left ventricular ejection fraction.</p></td></tr></tbody></table></div><p>The <strong>preconception visit</strong> allows patients with a variety of medical conditions to discuss the risks and benefits of pregnancy while formulating plans to optimize their medical comorbidities to reduce maternal-fetal morbidity and mortality.</p><p>In some cases, such as this patient with <strong>peripartum cardiomyopathy (PPCM)</strong> and a persistently reduced ejection fraction (&lt;30%), the risk of maternal mortality during pregnancy is so high that pregnancy is not recommended.&nbsp; This is because PPCM causes left ventricular dilation and subsequent systolic dysfunction.&nbsp; In patients with partial recovery of the ejection fraction (normal: &gt;50%), the hemodynamic stress of pregnancy is associated with a <strong>high maternal mortality</strong> due to left ventricular arrhythmias, thromboembolic events, worsening ventricular function, and even sudden death.&nbsp; The risk of death is substantial with a reduced ejection fraction, as seen in this patient, despite symptom improvement <strong>(Choices B and C)</strong>.</p><p>Although reproductive decisions are personal choices, the potential complications of pregnancy must be addressed to prevent harm.&nbsp; However, when pregnancy poses a substantial risk to the life of the mother, <strong>directive counseling</strong>&mdash;a type of counseling employed when there is <strong>only 1 safe, reasonable</strong>, and clearly superior evidenced-based option&mdash;should be performed.&nbsp; In these cases, the primary duty of the physician is to act in the best interest of the patient (ie, beneficence) and avoid potentially harmful adverse effects (ie, nonmaleficence), even if it conflicts with patient autonomy.&nbsp; Therefore, the most appropriate course is to <strong>not recommend pregnancy</strong> in this patient, even if the patient understands the risk and still desires pregnancy&nbsp;<strong>(Choice D)</strong>.&nbsp; If the patient becomes pregnant and declines abortion, regular cardiology follow-up is indicated.</p><p>Other contraindications to pregnancy include pulmonary arterial hypertension, heart failure with a left ventricular ejection fraction &lt;30%, severe aortic dilation, and severe mitral or aortic stenosis.</p><p><strong>Educational objective:</strong><br>Patients with absolute contraindications to pregnancy (eg, peripartum cardiomyopathy, pulmonary arterial hypertension) should undergo directive counseling with the recommendation to avoid pregnancy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 24456,
            "topic": "Peripartum cardiomyopathy",
            "titleId": 24456,
            "title": "Peripartum cardiomyopathy",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "&#x22;Another pregnancy poses significant risk to your health, and I cannot recommend that you get pregnant.&#x22;",
                    "choiceNumber": 1,
                    "correctTaken": 10889,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Given the improvement in your symptoms and cardiac function, you can now safely carry another pregnancy to term.&#x22;",
                    "choiceNumber": 2,
                    "correctTaken": 52,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;If your symptoms continue to improve, we can rediscuss a possible pregnancy 2 years from now.&#x22;",
                    "choiceNumber": 3,
                    "correctTaken": 2140,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Pregnancy can cause worsening cardiac function and even death, but if you understand these risks, you can try for another pregnancy.&#x22;",
                    "choiceNumber": 4,
                    "correctTaken": 3571,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 64,
            "othersAvgTimeSpent": 49,
            "notes": null,
            "peopleTaken": 16652,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 64,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": null,
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": null,
    "flashCardList": null,
    "questionModes": [
        {
            "id": 4,
            "name": "CUSTOM"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}